false2023Q312/31000178133521500017813352023-01-012023-09-300001781335us-gaap:CommonStockMember2023-01-012023-09-300001781335otis:A0000NotesDue2023Member2023-01-012023-09-300001781335otis:A0318NotesDue2026Member2023-01-012023-09-300001781335otis:A0934NotesDue2031Member2023-01-012023-09-3000017813352023-10-16xbrli:shares0001781335us-gaap:ProductMember2023-07-012023-09-30iso4217:USD0001781335us-gaap:ProductMember2022-07-012022-09-300001781335us-gaap:ServiceMember2023-07-012023-09-300001781335us-gaap:ServiceMember2022-07-012022-09-3000017813352023-07-012023-09-3000017813352022-07-012022-09-30iso4217:USDxbrli:shares0001781335us-gaap:ProductMember2023-01-012023-09-300001781335us-gaap:ProductMember2022-01-012022-09-300001781335us-gaap:ServiceMember2023-01-012023-09-300001781335us-gaap:ServiceMember2022-01-012022-09-3000017813352022-01-012022-09-3000017813352023-09-3000017813352022-12-310001781335us-gaap:AdditionalPaidInCapitalMember2023-06-300001781335us-gaap:TreasuryStockCommonMember2023-06-300001781335us-gaap:RetainedEarningsMember2023-06-300001781335us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001781335us-gaap:ParentMember2023-06-300001781335us-gaap:NoncontrollingInterestMember2023-06-3000017813352023-06-300001781335us-gaap:RetainedEarningsMember2023-07-012023-09-300001781335us-gaap:ParentMember2023-07-012023-09-300001781335us-gaap:NoncontrollingInterestMember2023-07-012023-09-300001781335us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001781335us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001781335us-gaap:TreasuryStockCommonMember2023-07-012023-09-300001781335us-gaap:AdditionalPaidInCapitalMember2023-09-300001781335us-gaap:TreasuryStockCommonMember2023-09-300001781335us-gaap:RetainedEarningsMember2023-09-300001781335us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001781335us-gaap:ParentMember2023-09-300001781335us-gaap:NoncontrollingInterestMember2023-09-300001781335us-gaap:AdditionalPaidInCapitalMember2022-06-300001781335us-gaap:TreasuryStockCommonMember2022-06-300001781335us-gaap:RetainedEarningsMember2022-06-300001781335us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300001781335us-gaap:ParentMember2022-06-300001781335us-gaap:NoncontrollingInterestMember2022-06-3000017813352022-06-300001781335us-gaap:RetainedEarningsMember2022-07-012022-09-300001781335us-gaap:ParentMember2022-07-012022-09-300001781335us-gaap:NoncontrollingInterestMember2022-07-012022-09-300001781335us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300001781335us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300001781335us-gaap:TreasuryStockCommonMember2022-07-012022-09-300001781335us-gaap:AdditionalPaidInCapitalMember2022-09-300001781335us-gaap:TreasuryStockCommonMember2022-09-300001781335us-gaap:RetainedEarningsMember2022-09-300001781335us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300001781335us-gaap:ParentMember2022-09-300001781335us-gaap:NoncontrollingInterestMember2022-09-3000017813352022-09-300001781335us-gaap:AdditionalPaidInCapitalMember2022-12-310001781335us-gaap:TreasuryStockCommonMember2022-12-310001781335us-gaap:RetainedEarningsMember2022-12-310001781335us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001781335us-gaap:ParentMember2022-12-310001781335us-gaap:NoncontrollingInterestMember2022-12-310001781335us-gaap:RetainedEarningsMember2023-01-012023-09-300001781335us-gaap:ParentMember2023-01-012023-09-300001781335us-gaap:NoncontrollingInterestMember2023-01-012023-09-300001781335us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300001781335us-gaap:AdditionalPaidInCapitalMember2023-01-012023-09-300001781335us-gaap:TreasuryStockCommonMember2023-01-012023-09-300001781335us-gaap:AdditionalPaidInCapitalMember2021-12-310001781335us-gaap:TreasuryStockCommonMember2021-12-310001781335us-gaap:RetainedEarningsMember2021-12-310001781335us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001781335us-gaap:ParentMember2021-12-310001781335us-gaap:NoncontrollingInterestMember2021-12-3100017813352021-12-310001781335us-gaap:RetainedEarningsMember2022-01-012022-09-300001781335us-gaap:ParentMember2022-01-012022-09-300001781335us-gaap:NoncontrollingInterestMember2022-01-012022-09-300001781335us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-09-300001781335us-gaap:AdditionalPaidInCapitalMember2022-01-012022-09-300001781335us-gaap:TreasuryStockCommonMember2022-01-012022-09-300001781335srt:MinimumMember2023-09-300001781335srt:MaximumMember2023-09-3000017813352023-10-012023-09-30xbrli:pure0001781335otis:NewEquipmentMember2022-12-310001781335otis:NewEquipmentMember2023-01-012023-09-300001781335otis:NewEquipmentMember2023-09-300001781335otis:ServicesMember2022-12-310001781335otis:ServicesMember2023-01-012023-09-300001781335otis:ServicesMember2023-09-300001781335country:RU2022-06-300001781335country:RU2022-07-012022-09-300001781335country:RU2022-01-012022-09-300001781335otis:UnsubordinatedCommercialPaperMemberus-gaap:UnsecuredDebtMember2023-09-300001781335otis:FiveYearRevolvingCreditFacilityAmendedMemberus-gaap:UnsecuredDebtMember2023-03-100001781335otis:FiveYearRevolvingCreditFacilityAmendedMemberus-gaap:UnsecuredDebtMember2023-03-102023-03-100001781335otis:FiveYearRevolvingCreditFacilityAmendedMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:RevolvingCreditFacilityMember2023-03-102023-03-100001781335otis:FiveYearRevolvingCreditFacilityAmendedMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMember2023-03-102023-03-100001781335otis:FiveYearRevolvingCreditFacilityAmendedMemberus-gaap:UnsecuredDebtMember2023-09-300001781335otis:Notes5250Due2028Memberus-gaap:UnsecuredDebtMember2023-08-160001781335otis:Notes5250Due2028Memberus-gaap:UnsecuredDebtMember2023-08-162023-08-160001781335otis:Notes0000Due2023Memberus-gaap:UnsecuredDebtMember2023-09-30iso4217:JPY0001781335otis:Notes0000Due2023Member2023-09-300001781335otis:Notes0000Due2023Member2022-12-310001781335otis:Notes2056Due2025Member2023-09-300001781335otis:Notes2056Due2025Member2022-12-310001781335otis:Notes037Due2026Member2023-09-300001781335otis:Notes037Due2026Memberus-gaap:UnsecuredDebtMember2023-09-300001781335otis:Notes037Due2026Member2022-12-310001781335otis:Notes0318Due2026Member2023-09-300001781335otis:Notes0318Due2026Memberus-gaap:UnsecuredDebtMember2023-09-300001781335otis:Notes0318Due2026Member2022-12-310001781335otis:Notes2293Due2027Member2023-09-300001781335otis:Notes2293Due2027Member2022-12-310001781335otis:Notes5250Due2028Member2023-09-300001781335otis:Notes5250Due2028Member2022-12-310001781335otis:Notes2565Due2030Member2023-09-300001781335otis:Notes2565Due2030Member2022-12-310001781335otis:Notes0934Due2031Member2023-09-300001781335us-gaap:UnsecuredDebtMemberotis:Notes0934Due2031Member2023-09-300001781335otis:Notes0934Due2031Member2022-12-310001781335otis:Notes3112Due2040Member2023-09-300001781335otis:Notes3112Due2040Member2022-12-310001781335otis:Notes3362Due2050Member2023-09-300001781335otis:Notes3362Due2050Member2022-12-310001781335otis:OtherIncludingFinanceLeasesMember2023-09-300001781335otis:OtherIncludingFinanceLeasesMember2022-12-310001781335us-gaap:ShortTermDebtMember2023-09-300001781335us-gaap:ShortTermDebtMember2022-12-310001781335us-gaap:LongTermDebtMember2023-09-300001781335us-gaap:LongTermDebtMember2022-12-310001781335us-gaap:ShortTermDebtMember2023-07-012023-09-300001781335us-gaap:ShortTermDebtMember2022-07-012022-09-300001781335us-gaap:ShortTermDebtMember2023-01-012023-09-300001781335us-gaap:ShortTermDebtMember2022-01-012022-09-300001781335us-gaap:LongTermDebtMember2023-07-012023-09-300001781335us-gaap:LongTermDebtMember2022-07-012022-09-300001781335us-gaap:LongTermDebtMember2023-01-012023-09-300001781335us-gaap:LongTermDebtMember2022-01-012022-09-300001781335us-gaap:PensionPlansDefinedBenefitMember2023-07-012023-09-300001781335us-gaap:PensionPlansDefinedBenefitMember2022-07-012022-09-300001781335us-gaap:PensionPlansDefinedBenefitMember2023-01-012023-09-300001781335us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-09-300001781335us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-07-012023-09-300001781335us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-01-012023-09-300001781335us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-01-012022-09-300001781335us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-07-012022-09-300001781335us-gaap:StockCompensationPlanMember2023-07-012023-09-300001781335us-gaap:StockCompensationPlanMember2022-07-012022-09-300001781335us-gaap:StockCompensationPlanMember2023-01-012023-09-300001781335us-gaap:StockCompensationPlanMember2022-01-012022-09-300001781335otis:LiabilityAwardsShareBasedCompensationArrangementMember2023-07-012023-09-300001781335otis:LiabilityAwardsShareBasedCompensationArrangementMember2022-07-012022-09-300001781335otis:LiabilityAwardsShareBasedCompensationArrangementMember2023-01-012023-09-300001781335otis:LiabilityAwardsShareBasedCompensationArrangementMember2022-01-012022-09-300001781335us-gaap:TreasuryStockCommonMember2023-07-012023-09-300001781335us-gaap:TreasuryStockCommonMember2023-01-012023-09-300001781335us-gaap:TreasuryStockCommonMember2022-07-012022-09-300001781335us-gaap:TreasuryStockCommonMember2022-01-012022-09-300001781335us-gaap:AccumulatedTranslationAdjustmentMember2023-06-300001781335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-06-300001781335us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-06-300001781335us-gaap:AccumulatedTranslationAdjustmentMember2023-07-012023-09-300001781335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-07-012023-09-300001781335us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-07-012023-09-300001781335us-gaap:AccumulatedTranslationAdjustmentMember2023-09-300001781335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-09-300001781335us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-09-300001781335us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310001781335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310001781335us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310001781335us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-09-300001781335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-09-300001781335us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-09-300001781335us-gaap:AccumulatedTranslationAdjustmentMember2022-06-300001781335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-06-300001781335us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-06-300001781335us-gaap:AccumulatedTranslationAdjustmentMember2022-07-012022-09-300001781335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-07-012022-09-300001781335us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-07-012022-09-300001781335us-gaap:AccumulatedTranslationAdjustmentMember2022-09-300001781335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-09-300001781335us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-09-300001781335us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310001781335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310001781335us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-310001781335us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-09-300001781335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-09-300001781335us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-09-300001781335otis:UpLiftProgramMember2023-07-012023-09-300001781335otis:UpLiftProgramMember2023-01-012023-09-300001781335otis:NewEquipmentMember2023-07-012023-09-300001781335otis:NewEquipmentMember2022-07-012022-09-300001781335otis:NewEquipmentMember2022-01-012022-09-300001781335otis:ServicesMember2023-07-012023-09-300001781335otis:ServicesMember2022-07-012022-09-300001781335otis:ServicesMember2022-01-012022-09-300001781335us-gaap:CostOfSalesMember2023-07-012023-09-300001781335us-gaap:CostOfSalesMember2022-07-012022-09-300001781335us-gaap:CostOfSalesMember2023-01-012023-09-300001781335us-gaap:CostOfSalesMember2022-01-012022-09-300001781335us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012023-09-300001781335us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-07-012022-09-300001781335us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-09-300001781335us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-09-300001781335otis:CurrentYearActionsMember2023-09-300001781335otis:NewEquipmentMemberotis:CurrentYearActionsMember2023-09-300001781335otis:CurrentYearActionsMemberotis:ServicesMember2023-09-300001781335otis:CurrentAndPriorYearActionsMemberus-gaap:EmployeeSeveranceMember2022-12-310001781335otis:CurrentAndPriorYearActionsMemberus-gaap:EmployeeSeveranceMember2023-01-012023-09-300001781335otis:CurrentAndPriorYearActionsMemberus-gaap:EmployeeSeveranceMember2023-09-300001781335us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-09-300001781335us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2022-12-310001781335us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-09-300001781335us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMember2022-12-310001781335us-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-09-300001781335us-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310001781335us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:AccruedLiabilitiesMember2023-09-300001781335us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:AccruedLiabilitiesMember2022-12-310001781335us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:AccruedLiabilitiesMember2023-09-300001781335us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:AccruedLiabilitiesMember2022-12-310001781335us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMember2023-09-300001781335us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMember2022-12-310001781335us-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-09-300001781335us-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2022-12-310001781335us-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-09-300001781335us-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMember2022-12-310001781335us-gaap:NondesignatedMember2023-09-300001781335us-gaap:NondesignatedMember2022-12-310001781335us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:AccruedLiabilitiesMember2023-09-300001781335us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:AccruedLiabilitiesMember2022-12-310001781335us-gaap:CommodityContractMemberus-gaap:NondesignatedMemberus-gaap:AccruedLiabilitiesMember2023-09-300001781335us-gaap:CommodityContractMemberus-gaap:NondesignatedMemberus-gaap:AccruedLiabilitiesMember2022-12-310001781335us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMember2023-09-300001781335us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMember2022-12-310001781335us-gaap:NetInvestmentHedgingMemberotis:YenDenominatedInvestmentHedgeMember2023-09-300001781335us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2023-09-30iso4217:EURiso4217:HKD0001781335us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeForwardMember2023-09-300001781335us-gaap:NetInvestmentHedgingMemberotis:ForeignCurrencyDenominatedLongTermDebtMember2023-07-012023-09-300001781335us-gaap:NetInvestmentHedgingMemberotis:ForeignCurrencyDenominatedLongTermDebtMember2022-07-012022-09-300001781335us-gaap:NetInvestmentHedgingMemberotis:ForeignCurrencyDenominatedLongTermDebtMember2023-01-012023-09-300001781335us-gaap:NetInvestmentHedgingMemberotis:ForeignCurrencyDenominatedLongTermDebtMember2022-01-012022-09-300001781335us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeForwardMember2023-07-012023-09-300001781335us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeForwardMember2022-07-012022-09-300001781335us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeForwardMember2023-01-012023-09-300001781335us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeForwardMember2022-01-012022-09-300001781335us-gaap:NetInvestmentHedgingMember2023-07-012023-09-300001781335us-gaap:NetInvestmentHedgingMember2022-07-012022-09-300001781335us-gaap:NetInvestmentHedgingMember2023-01-012023-09-300001781335us-gaap:NetInvestmentHedgingMember2022-01-012022-09-300001781335us-gaap:ForeignExchangeContractMember2023-07-012023-09-300001781335us-gaap:ForeignExchangeContractMember2022-07-012022-09-300001781335us-gaap:ForeignExchangeContractMember2023-01-012023-09-300001781335us-gaap:ForeignExchangeContractMember2022-01-012022-09-300001781335otis:ForeignExchangeContractAndCommodityMemberus-gaap:CostOfSalesMember2023-07-012023-09-300001781335otis:ForeignExchangeContractAndCommodityMemberus-gaap:CostOfSalesMember2023-01-012023-09-300001781335otis:ForeignExchangeContractAndCommodityMemberus-gaap:CostOfSalesMember2022-07-012022-09-300001781335otis:ForeignExchangeContractAndCommodityMemberus-gaap:CostOfSalesMember2022-01-012022-09-300001781335us-gaap:FairValueMeasurementsRecurringMember2023-09-300001781335us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001781335us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001781335us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-09-300001781335us-gaap:FairValueMeasurementsRecurringMember2022-12-310001781335us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001781335us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001781335us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001781335us-gaap:CarryingReportedAmountFairValueDisclosureMember2023-09-300001781335us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-09-300001781335us-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310001781335us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001781335us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-09-300001781335us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-09-300001781335us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-09-300001781335us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001781335us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001781335us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001781335us-gaap:FinancialStandbyLetterOfCreditMember2023-09-300001781335otis:EnvironmentalRegulationMember2023-09-300001781335otis:EnvironmentalRegulationMember2022-12-310001781335otis:GermanTaxOfficeAgainstOtiscashpaymentsinprioryearMember2023-01-012023-09-300001781335otis:GermanTaxOfficeAgainstOtiscashpaymentsinprioryearMember2015-01-012015-12-310001781335otis:GermanTaxOfficeAgainstOtiscashpaymentsinprioryearMember2023-09-300001781335srt:MinimumMemberotis:AsbestosMatterMember2022-12-310001781335srt:MinimumMemberotis:AsbestosMatterMember2023-09-300001781335srt:MaximumMemberotis:AsbestosMatterMember2023-09-300001781335srt:MaximumMemberotis:AsbestosMatterMember2022-12-310001781335otis:AsbestosMatterMember2023-09-300001781335otis:AsbestosMatterMember2022-12-3100017813352021-09-132021-09-13otis:defendentotis:segment0001781335us-gaap:OperatingSegmentsMemberotis:NewEquipmentMember2023-07-012023-09-300001781335us-gaap:OperatingSegmentsMemberotis:NewEquipmentMember2022-07-012022-09-300001781335us-gaap:OperatingSegmentsMemberotis:ServicesMember2023-07-012023-09-300001781335us-gaap:OperatingSegmentsMemberotis:ServicesMember2022-07-012022-09-300001781335us-gaap:OperatingSegmentsMember2023-07-012023-09-300001781335us-gaap:OperatingSegmentsMember2022-07-012022-09-300001781335us-gaap:CorporateNonSegmentMember2023-07-012023-09-300001781335us-gaap:CorporateNonSegmentMember2022-07-012022-09-300001781335us-gaap:OperatingSegmentsMemberotis:NewEquipmentMember2023-01-012023-09-300001781335us-gaap:OperatingSegmentsMemberotis:NewEquipmentMember2022-01-012022-09-300001781335us-gaap:OperatingSegmentsMemberotis:ServicesMember2023-01-012023-09-300001781335us-gaap:OperatingSegmentsMemberotis:ServicesMember2022-01-012022-09-300001781335us-gaap:OperatingSegmentsMember2023-01-012023-09-300001781335us-gaap:OperatingSegmentsMember2022-01-012022-09-300001781335us-gaap:CorporateNonSegmentMember2023-01-012023-09-300001781335us-gaap:CorporateNonSegmentMember2022-01-012022-09-300001781335country:US2023-07-012023-09-300001781335country:US2022-07-012022-09-300001781335country:US2023-01-012023-09-300001781335country:US2022-01-012022-09-300001781335country:CN2023-07-012023-09-300001781335country:CN2022-07-012022-09-300001781335country:CN2023-01-012023-09-300001781335country:CN2022-01-012022-09-300001781335otis:OtherMember2023-07-012023-09-300001781335otis:OtherMember2022-07-012022-09-300001781335otis:OtherMember2023-01-012023-09-300001781335otis:OtherMember2022-01-012022-09-300001781335otis:ServiceMaintenanceAndRepairMember2023-07-012023-09-300001781335otis:ServiceMaintenanceAndRepairMember2022-07-012022-09-300001781335otis:ServiceMaintenanceAndRepairMember2023-01-012023-09-300001781335otis:ServiceMaintenanceAndRepairMember2022-01-012022-09-300001781335otis:ServiceModernizationMember2023-07-012023-09-300001781335otis:ServiceModernizationMember2022-07-012022-09-300001781335otis:ServiceModernizationMember2023-01-012023-09-300001781335otis:ServiceModernizationMember2022-01-012022-09-300001781335otis:UpLiftProgramMemberus-gaap:SubsequentEventMember2023-10-050001781335otis:MsMarksMember2023-07-012023-09-300001781335otis:MsMarksMember2023-01-012023-09-300001781335otis:MsMarksMember2023-09-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 ____________________________________ 
FORM 10-Q
____________________________________ 
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2023
OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                  to                 
Commission file number 001-39221
____________________________________ 

logo_otis (2).jpg
OTIS WORLDWIDE CORPORATION
(Exact name of registrant as specified in its charter)
____________________________________ 
Delaware 83-3789412
(State or other jurisdiction of incorporation)(I.R.S. Employer Identification No.)
One Carrier Place, Farmington, Connecticut 06032
(Address of principal executive offices, including zip code)

(860) 674-3000
(Registrant's telephone number, including area code)
____________________________________ 
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange
on which registered
Common Stock ($0.01 par value)OTISNew York Stock Exchange
0.000% Notes due 2023OTIS/23New York Stock Exchange
0.318% Notes due 2026OTIS/26New York Stock Exchange
0.934% Notes due 2031OTIS/31New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý.    No  ¨.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ý.    No  ¨.
1
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large Accelerated FilerýAccelerated Filer¨
Non-accelerated Filer¨Smaller Reporting Company☐
Emerging Growth Company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐.    No  ý.

As of October 16, 2023 there were 409,258,823 shares of Common Stock outstanding.

2
OTIS WORLDWIDE CORPORATION
CONTENTS OF QUARTERLY REPORT ON FORM 10-Q
Quarter Ended September 30, 2023
 
 Page

Otis Worldwide Corporation's and its subsidiaries' names, abbreviations thereof, logos, and product and service designators are all either the registered or unregistered trademarks or tradenames of Otis Worldwide Corporation and its subsidiaries. Names, abbreviations of names, logos, and products and service designators of other companies are either the registered or unregistered trademarks or tradenames of their respective owners. As used herein, the terms "we," "us," "our," "the Company" or "Otis," unless the context otherwise requires, mean Otis Worldwide Corporation and its subsidiaries. References to Internet websites in this Form 10-Q are provided for convenience only. Information available through these websites is not incorporated by reference into this Form 10-Q.
3
PART I – FINANCIAL INFORMATION

Item 1.    Financial Statements

OTIS WORLDWIDE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited) 

 Quarter Ended September 30,
(dollars in millions, except per share amounts; shares in millions)20232022
Net sales:
Product sales$1,435 $1,447 
Service sales2,088 1,897 
3,523 3,344 
Costs and expenses:
Cost of products sold1,195 1,208 
Cost of services sold1,282 1,165 
Research and development36 37 
Selling, general and administrative452 417 
2,965 2,827 
Other income (expense), net13 12 
Operating profit571 529 
Non-service pension cost (benefit)— 1 
Interest expense (income), net39 35 
Net income before income taxes532 493 
Income tax expense137 143 
Net income395 350 
Less: Noncontrolling interest in subsidiaries' earnings19 26 
Net income attributable to Otis Worldwide Corporation$376 $324 
Earnings per share (Note 2):
Basic$0.92 $0.77 
Diluted$0.91 $0.77 
Weighted average number of shares outstanding:
     Basic shares410.8418.5
     Diluted shares413.7421.2

See accompanying Notes to Condensed Consolidated Financial Statements.
4


OTIS WORLDWIDE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited) 

 Nine Months Ended September 30,
(dollars in millions, except per share amounts; shares in millions)20232022
Net sales:
Product sales$4,346 $4,403 
Service sales6,243 5,843 
10,589 10,246 
Costs and expenses:
Cost of products sold3,621 3,689 
Cost of services sold3,843 3,597 
Research and development107 112 
Selling, general and administrative1,386 1,315 
8,957 8,713 
Other income (expense), net32 9 
Operating profit1,664 1,542 
Non-service pension cost (benefit)1 2 
Interest expense (income), net109 107 
Net income before income taxes1,554 1,433 
Income tax expense400 382 
Net income1,154 1,051 
Less: Noncontrolling interest in subsidiaries' earnings71 95 
Net income attributable to Otis Worldwide Corporation$1,083 $956 
Earnings per share (Note 2):
Basic$2.62 $2.27 
Diluted$2.60 $2.25 
Weighted average number of shares outstanding:
Basic shares412.6421.3
Diluted shares415.8424.3

See accompanying Notes to Condensed Consolidated Financial Statements.
5
OTIS WORLDWIDE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)

Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Net income$395 $350 $1,154 $1,051 
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments33 151 (71)56 
Pension and postretirement benefit plan adjustments— 2 — 6 
Change in unrealized cash flow hedging2 (4)(1)(4)
Other comprehensive income (loss), net of tax35 149 (72)58 
Comprehensive income (loss), net of tax430 499 1,082 1,109 
Less: Comprehensive (income) loss attributable to noncontrolling interest(13)(7)(55)30 
Comprehensive income attributable to Otis Worldwide Corporation$417 $492 $1,027 $1,139 

See accompanying Notes to Condensed Consolidated Financial Statements.
6
OTIS WORLDWIDE CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)

(dollars in millions)September 30, 2023December 31, 2022
Assets
Cash and cash equivalents$1,636 $1,189 
Accounts receivable (net of allowance for expected credit losses of $126 and $152)
3,455 3,357 
Contract assets733 664 
Inventories624 617 
Other current assets301 316 
Total Current Assets6,749 6,143 
Future income tax benefits290 285 
Fixed assets (net of accumulated depreciation of $1,196 and $1,151)
708 719 
Operating lease right-of-use assets417 449 
Intangible assets, net336 369 
Goodwill1,547 1,567 
Other assets343 287 
Total Assets$10,390 $9,819 
Liabilities and Equity (Deficit)
Short-term borrowings and current portion of long-term debt$585 $670 
Accounts payable1,655 1,717 
Accrued liabilities1,725 1,794 
Contract liabilities2,784 2,662 
Total Current Liabilities6,749 6,843 
Long-term debt6,822 6,098 
Future pension and postretirement benefit obligations390 392 
Operating lease liabilities293 315 
Future income tax obligations 258 279 
Other long-term liabilities488 556 
Total Liabilities15,000 14,483 
Commitments and contingent liabilities (Note 16)
Redeemable noncontrolling interest123 135 
Shareholders' Equity (Deficit):
Common Stock and additional paid-in capital198 162 
Treasury Stock(2,155)(1,575)
Accumulated deficit(2,183)(2,865)
Accumulated other comprehensive income (loss)(648)(592)
Total Shareholders' Equity (Deficit)(4,788)(4,870)
Noncontrolling interest55 71 
Total Equity (Deficit)(4,733)(4,799)
Total Liabilities and Equity (Deficit)$10,390 $9,819 

See accompanying Notes to Condensed Consolidated Financial Statements.
7
OTIS WORLDWIDE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(Unaudited)

Common Stock and Additional Paid-In CapitalTreasury StockAccumulated DeficitAccumulated Other Comprehensive Income (Loss)Total Shareholders'
(Deficit) Equity		Noncontrolling InterestTotal (Deficit) EquityRedeemable Noncontrolling Interest
(dollars in millions, except per share amounts)
Quarter Ended September 30, 2023
Balance as of June 30, 2023$183 $(1,927)$(2,419)$(689)$(4,852)$101 $(4,751)$126 
Net income— — 376 — 376 17 393 2 
Other comprehensive income (loss), net of tax— — — 41 41 (2)39 (4)
Stock-based compensation and Common Stock issued under employee plans15 — — — 15 — 15 — 
Cash dividends declared ($0.34 per common share)
— — (139)— (139)— (139)— 
Repurchase of Common Shares— (228)— — (228)— (228)— 
Dividends attributable to noncontrolling interest— — — — — (61)(61)— 
Acquisitions, disposals and other changes— — (1)— (1)— (1)(1)
Balance as of September 30, 2023$198 $(2,155)$(2,183)$(648)$(4,788)$55 $(4,733)$123 
Quarter Ended September 30, 2022
Balance as of June 30, 2022$121 $(1,125)$(3,245)$(748)$(4,997)$109 $(4,888)$136 
Net income— — 324 — 324 24 348 2 
Other comprehensive income (loss), net of tax, and foreign currency reclassifications (Note 10)— — — 168 168 (9)159 (10)
Stock-based compensation and Common Stock issued under employee plans13 — — — 13 — 13 — 
Cash dividends declared ($0.29 per common share)
— — (121)— (121)— (121)— 
Repurchase of Common Shares— (300)— — (300)— (300)— 
Dividends attributable to noncontrolling interest— — — — — (68)(68)— 
Acquisitions, disposals and other changes— — — — — (4)(4)— 
Balance as of September 30, 2022$134 $(1,425)$(3,042)$(580)$(4,913)$52 $(4,861)$128 

See accompanying Notes to Condensed Consolidated Financial Statements.
8
OTIS WORLDWIDE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(Unaudited)

Common Stock and Additional Paid-In CapitalAccumulated DeficitAccumulated Other Comprehensive Income (Loss)Total Shareholders'
(Deficit) Equity		Noncontrolling InterestTotal (Deficit) EquityRedeemable Noncontrolling Interest
Treasury Stock
(dollars in millions, except per share amounts)
Nine Months Ended September 30, 2023
Balance as of December 31, 2022$162 $(1,575)$(2,865)$(592)$(4,870)$71 $(4,799)$135 
Net income— — 1,083 — 1,083 64 1,147 7 
Other comprehensive income (loss), net of tax— — — (56)(56)(7)(63)(9)
Stock-based compensation and Common Stock issued under employee plans36 — (1)— 35 — 35 — 
Cash dividends declared ($0.97 per common share)
— — (400)— (400)— (400)— 
Repurchase of Common Shares— (580)— — (580)— (580)— 
Dividends attributable to noncontrolling interest— — — — — (70)(70)(9)
Acquisitions, disposals and other changes— — — — — (3)(3)(1)
Balance as of September 30, 2023$198 $(2,155)$(2,183)$(648)$(4,788)$55 $(4,733)$123 
Nine Months Ended September 30, 2022
Balance as of December 31, 2021$119 $(725)$(2,256)$(763)$(3,625)$481 $(3,144)$160 
Net income— — 956 — 956 82 1,038 13 
Other comprehensive income (loss), net of tax, and foreign currency reclassifications (Note 10)— — — 183 183 (17)166 (108)
Stock-based compensation and Common Stock issued under employee plans32 — (1)— 31 — 31 — 
Cash dividends declared ($0.82 per common share)
— — (345)— (345)— (345)— 
Repurchase of Common Shares— (700)— — (700)— (700)— 
Dividends attributable to noncontrolling interest— — — — — (80)(80)(11)
Reclassification of noncontrolling interest to forward purchase agreement and redeemable noncontrolling interest (Note 1)— — (1,482)— (1,482)(403)(1,885)1,476 
Acquisitions, disposals and other changes(17)— 86 — 69 (11)58 (1,402)
Balance as of September 30, 2022$134 $(1,425)$(3,042)$(580)$(4,913)$52 $(4,861)$128 


See accompanying Notes to Condensed Consolidated Financial Statements.
9
OTIS WORLDWIDE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
 Nine Months Ended September 30,
(dollars in millions)20232022
Operating Activities:
Net income$1,154 $1,051 
Adjustments to reconcile net income to net cash flows provided by operating activities, net of acquisitions and dispositions:
Depreciation and amortization145 145 
Deferred income tax expense (benefit)(34)6 
Stock compensation cost49 41 
Change in operating assets and liabilities:
Accounts receivable, net(214)(171)
Contract assets and liabilities, current68 143 
Inventories(8)(80)
Other current assets(4)(14)
Accounts payable(35)137 
Accrued liabilities(66)(166)
Pension contributions(32)(28)
Other operating activities, net7 32 
Net cash flows provided by (used in) operating activities1,030 1,096 
Investing Activities:
Capital expenditures(96)(81)
Acquisitions of businesses and intangible assets, net of cash (Note 6)(27)(38)
Dispositions of businesses, net of cash (Note 6)— 61 
Proceeds from the sale of (investments in) marketable securities(2)(7)
Receipts (payments) on settlements of derivative contracts(21)121 
Other investing activities, net14 6 
Net cash flows provided by (used in) investing activities(132)62 
Financing Activities:
Net proceeds from (repayments of) borrowings (maturities of 90 days or less)(90)80 
Proceeds from issuance of long-term debt747 — 
Payment of debt issuance costs(6)— 
Repayment of long-term debt— (500)
Dividends paid on Common Stock(400)(345)
Repurchases of Common Stock(575)(700)
Dividends paid to noncontrolling interest(76)(107)
Acquisition of Zardoya Otis shares — (1,802)
Other financing activities, net(18)(28)
Net cash flows provided by (used in) financing activities(418)(3,402)
Effect of exchange rate changes on cash and cash equivalents(34)(191)
Net increase (decrease) in cash, cash equivalents and restricted cash446 (2,435)
Cash, cash equivalents and restricted cash, beginning of year1,195 3,477 
Cash, cash equivalents and restricted cash, end of period1,641 1,042 
Less: Restricted cash5 8 
Cash and cash equivalents, end of period$1,636 $1,034 
See accompanying Notes to Condensed Consolidated Financial Statements.
10
OTIS WORLDWIDE CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

Note 1: General

The Condensed Consolidated Financial Statements as of September 30, 2023 and for the quarters and nine months ended September 30, 2023 and 2022 are unaudited, but in the opinion of management include all adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the results for the interim periods. The Condensed Consolidated Balance Sheet as of December 31, 2022 was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles ("GAAP") in the United States ("U.S."). The results reported in these Condensed Consolidated Financial Statements should not necessarily be taken as indicative of results that may be expected for the entire year. The financial information included herein should be read in conjunction with the Company's annual consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for fiscal year 2022 ("2022 Form 10-K" or "Form 10-K").

Unless the context otherwise requires, references to "Otis," "we," "us," "our" and "the Company" refer to Otis Worldwide Corporation and its subsidiaries.

There have been no changes to the Company's significant accounting policies described in the Company's 2022 Form 10-K that have a material impact on the Company's Condensed Consolidated Financial Statements and the related notes. Certain amounts presented in the prior period have been reclassified to conform to the current period presentation, which are immaterial.

Use of Estimates. The preparation of these Condensed Consolidated Financial Statements and accompanying notes in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ materially from those estimates.

We assessed certain accounting matters that generally require consideration of forecasted financial information in the context of the information reasonably available to us and the unknown future impacts of macroeconomic developments, including inflationary pressures, higher interest rates and tighter credit conditions, as of September 30, 2023 and through the date of this report. The accounting matters assessed included, but were not limited to, our allowance for credit losses, the carrying value of our goodwill and other long-lived assets, financial assets and revenue recognition. While there was not a material impact to our Condensed Consolidated Financial Statements as of September 30, 2023 and for the quarters and nine months ended September 30, 2023 and 2022 resulting from our assessments of these matters, future assessment of our expectations of the magnitude and duration of these macroeconomic developments, as well as other factors, could result in material impacts to our Condensed Consolidated Financial Statements in future reporting periods.

We also assessed certain accounting matters as they relate to the ongoing conflict between Russia and Ukraine and the war in Israel and Gaza, including, but not limited to, our allowance for credit losses, the carrying value of long-lived assets, revenue recognition and the classification of assets. There was not a material impact to our Condensed Consolidated Financial Statements as of September 30, 2023 and for the quarters and nine months ended September 30, 2023 and 2022 resulting from our assessment of these matters. We continue to assess the impact on our results of operations, financial position and overall performance as the situations develop and any broader implications they may have on the global economy.

Supplier Finance Programs. On January 1, 2023, we adopted ASU No. 2022-04, Liabilities - Supplier Finance Programs (Topic 450-50): Disclosure of Supplier Finance Program Obligations that requires entities that use supplier finance programs in connection with the purchase of goods and services to disclose the key terms of the programs and information about obligations outstanding at the end of the reporting period.

11
Certain Otis subsidiaries participate in supplier finance programs, under which we agree to pay third-party financial institutions the stated amounts of confirmed invoices from suppliers on the original maturity dates of the invoices, while the participating suppliers generally have the ability to sell, or otherwise pledge as collateral, their receivables from the Company to the participating financial institutions. Our obligations to suppliers, including the amounts due and scheduled payment dates, are not impacted by the suppliers' decisions to sell their receivables to the financial institutions, or otherwise pledge their receivables as collateral, under these arrangements. The Company is not a party to the arrangements between the suppliers and the financial institutions, and the Company's payment terms to the financial institutions, including the timing and amount of payments, are based on the original supplier invoices. Based on the applicable supplier agreements, the maturity dates of these supplier invoices can range between 30 and 120 days from the invoice date.

The outstanding obligations confirmed by the Company as valid to the financial institutions under our supplier finance programs were $537 million and $564 million as of September 30, 2023 and December 31, 2022, respectively. These obligations are included in Accounts payable in the Condensed Consolidated Balance Sheets, and all activity related to the obligations is presented within operating activities on the Condensed Consolidated Statements of Cash Flows.

The Company or the financial institutions may terminate the agreements with advanced notice. Otis has pledged no assets in connection with its supplier finance programs.

Note 2: Earnings per Share

 Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions, except per share amounts; shares in millions)2023202220232022
Net income attributable to Otis Worldwide Corporation$376 $324 $1,083 $956 
Impact of redeemable noncontrolling interest— — — — 
Net income attributable to common shareholders$376 $324 $1,083 $956 
Basic weighted average number of shares outstanding410.8 418.5 412.6 421.3 
Stock awards and equity units (share equivalent)2.9 2.7 3.2 3.0 
Diluted weighted average number of shares outstanding413.7 421.2 415.8 424.3 
Earnings Per Share of Common Stock:
Basic$0.92$0.77$2.62$2.27
Diluted$0.91$0.77$2.60$2.25

The computation of diluted earnings per share excludes the effect of the potential exercise of stock awards, including stock appreciation rights and stock options, when the average market price of the Common Stock is lower than the exercise price of the related stock awards during the period because the effect would be anti-dilutive. In addition, the computation of diluted earnings per share excludes the effect of the potential exercise of stock awards when the awards' assumed proceeds exceed the average market price of the common shares during the period. There were 1.0 million of anti-dilutive stock awards excluded from the computation for the quarter and nine months ended September 30, 2023, and 2.4 million for the quarter and nine months ended September 30, 2022.

Note 3: Revenue Recognition

We account for revenue in accordance with Accounting Standards Codification ("ASC") Topic 606: Revenue from Contracts with Customers.

Contract Assets and Liabilities. Contract assets reflect revenue recognized in advance of customer billing. Contract liabilities are recognized when a customer pays consideration, or we have a right to receive an amount of unconditional consideration, in advance of the satisfaction of performance obligations under the contract. We typically receive progress payments from our customers as we perform our work over time.

12
Total Contract assets and Contract liabilities as of September 30, 2023 and December 31, 2022 are as follows:

(dollars in millions)September 30, 2023December 31, 2022
Contract assets, current$733 $664 
Total contract assets733 664 
Contract liabilities, current2,784 2,662 
Contract liabilities, non-current (included within Other long-term liabilities)47 52 
Total contract liabilities 2,831 2,714 
Net contract liabilities$2,098 $2,050 

Contract assets increased by $69 million during the nine months ended September 30, 2023 as a result of the progression of current contracts and timing of billing on customer contracts. Contract liabilities increased by $117 million during the nine months ended September 30, 2023 primarily due to billings on contracts in excess of revenue earned.

In the nine months ended September 30, 2023 and 2022, we recognized revenue of $1.8 billion related to contract liabilities as of January 1, 2023 and 2022, respectively.

Remaining Performance Obligations ("RPO"). RPO represents the aggregate amount of total contract transaction price that is unsatisfied or partially unsatisfied. As of September 30, 2023, our total RPO was $17.8 billion. Of the total RPO as of September 30, 2023, we expect approximately 90% will be recognized as sales over the following 24 months.

Note 4: Accounts Receivable, Net

Accounts receivable, net consisted of the following as of September 30, 2023 and December 31, 2022:

(dollars in millions)September 30, 2023December 31, 2022
Trade receivables$3,295 $3,231 
Unbilled receivables123 103 
Miscellaneous receivables100 91 
Customer financing notes receivable63 84 
3,581 3,509 
Less: allowance for expected credit losses126 152 
Accounts receivable, net$3,455 $3,357 

The changes in allowance for expected credit losses related to Accounts receivable, net for the nine months ended September 30, 2023 and 2022, respectively, are as follows:

Nine Months Ended September 30,
(dollars in millions)20232022
Balance as of January 1$152 $175 
Provision for expected credit losses21 4 
Write-offs charged against the allowance for expected credit losses(42)(14)
Foreign exchange and other(5)(9)
Balance as of September 30$126 $156 

13
Note 5: Inventories

Inventories consisted of the following as of September 30, 2023 and December 31, 2022:

(dollars in millions)September 30, 2023December 31, 2022
Raw materials and work-in-process$162 $166 
Finished goods462 451 
Total$624 $617 

Raw materials, work-in-process and finished goods are net of valuation write-downs of $89 million and $96 million as of September 30, 2023 and December 31, 2022, respectively.

Note 6: Business Acquisitions, Disposals, Goodwill and Intangible Assets

Business Acquisitions. Our acquisitions of businesses and intangible assets, net of cash, totaled $27 million and $38 million in the nine months ended September 30, 2023 and 2022, respectively, and were primarily in our Service segment. Transaction costs incurred were not considered significant.

Goodwill. Changes in our Goodwill balances during the nine months ended September 30, 2023 were as follows:

(dollars in millions)Balance as of December 31, 2022Goodwill Resulting
from Business Combinations		Foreign Currency
Translation 
and Other
Balance as of
September 30, 2023
New Equipment$292 $— $(5)$287 
Service1,275 6 (21)1,260 
Total$1,567 $6 $(26)$1,547 

Intangible Assets. Intangible assets cost and accumulated amortization were $2,010 million and $1,674 million, respectively, as of September 30, 2023, and $2,026 million and $1,657 million, respectively, as of December 31, 2022.

Amortization of intangible assets for the quarter and nine months ended September 30, 2023 was $17 million and $51 million, respectively, compared to $18 million and $55 million for the same periods in 2022. Excluding the impact of currency translation adjustments, there were no other significant changes in our Intangible assets during the quarters and nine months ended September 30, 2023 and 2022.

Held For Sale Assets and Liabilities. As of September 30, 2023 and December 31, 2022, assets held for sale were $11 million and $9 million, respectively, and are included in Other current assets in the Condensed Consolidated Balance Sheets.

In June 2022, we entered into an agreement to sell our business in Russia to a third party, which was then sold on July 27, 2022. As of June 30, 2022, our operations in Russia, primarily in the New Equipment segment, were classified as assets and liabilities held for sale of $157 million and $136 million, respectively. The Company recorded the loss on sale and related charges of $6 million and $24 million in Other expense (income), net in the Condensed Consolidated Statements of Operations for the quarter and nine months ended September 30, 2022, respectively, including an impairment loss of $18 million related to the net assets held for sale during the nine months ended September 30, 2022.

Note 7: Borrowings and Lines of Credit

(dollars in millions)September 30, 2023December 31, 2022
Commercial paper$— $94 
Other borrowings54 45 
Total short-term borrowings$54 $139 

14
Commercial Paper. As of September 30, 2023, there were no borrowings outstanding under the Company's $1.5 billion commercial paper programs. We use our commercial paper borrowings for general corporate purposes including to finance acquisitions, pay dividends, repurchase shares and for debt refinancing. The need for commercial paper borrowings may arise if the use of domestic cash for general corporate purposes exceeds the sum of domestic cash generation and foreign cash repatriated to the U.S.

For details regarding the Company's short-term borrowing activity in 2022, refer to Note 10 of the Company's audited consolidated financial statements and notes thereto included in our 2022 Form 10-K.

Long-term debt. On March 10, 2023, the Company entered into a new credit agreement ("Credit Agreement") with various banks providing for a $1.5 billion unsecured, unsubordinated five-year revolving credit facility, with an interest rate on US Dollar denominated borrowings at Otis' option of the Term Secured Overnight Financing Rate ("SOFR") plus 0.10% or a base rate, and an interest rate on Euro denominated borrowings at Otis' option of the EURIBO rate or a daily simple Euro Short Term Rate ("ESTR"), plus, in each case, an applicable margin. The applicable margin initially is 1.25% for Term SOFR rate, EURIBO rate and daily simple ESTR rate borrowings, and 0.25% for base rate borrowings, and can fluctuate determined by reference to Otis' public debt ratings, as specified in the Credit Agreement. As of September 30, 2023, there were no borrowings under the Credit Agreement. The undrawn portion of the Credit Agreement serves as a backstop for the issuance of commercial paper. On March 10, 2023, we also terminated all commitments outstanding under the previous credit agreement, which was scheduled to expire on April 3, 2025.

On August 16, 2023, we issued $750 million unsecured, unsubordinated five-year notes due August 16, 2028 (the "Notes") with an interest rate of 5.25%. The net proceeds of the Notes were used to fund the repayment of Otis' commercial paper borrowings and will be used to fund the repayment at maturity of the €500 million 0.000% notes due November 12, 2023, with the remainder used for other general corporate purposes.

As of September 30, 2023, the Company is in compliance with all covenants in the revolving credit agreement and the indentures governing all outstanding long-term debt. Long-term debt consisted of the following:

(dollars in millions)September 30, 2023December 31, 2022
0.000% notes due 2023 (€500 million principal value)
$531 $531 
2.056% notes due 2025
1,300 1,300 
0.37% notes due 2026 (¥21.5 billion principal value)
145 163 
0.318% notes due 2026 (€600 million principal value)
637 638 
2.293% notes due 2027
500 500 
5.250% notes due 2028
750 — 
2.565% notes due 2030
1,500 1,500 
0.934% notes due 2031 (€500 million principal value)
531 531 
3.112% notes due 2040
750 750 
3.362% notes due 2050
750 750 
Other (including finance leases)4 8 
Total principal long-term debt7,398 6,671 
Other (discounts and debt issuance costs)(45)(42)
Total long-term debt7,353 6,629 
Less: current portion531 531 
Long-term debt, net of current portion$6,822 $6,098 

We may redeem any series of notes at our option pursuant to certain terms. For additional details regarding the Company's debt activity in 2022, refer to Note 10 of the Company's audited consolidated financial statements and notes thereto included in our 2022 Form 10-K.

15
Debt discounts and debt issuance costs are presented as a reduction of debt on the Condensed Consolidated Balance Sheets and are amortized as a component of interest expense over the term of the related debt using the effective interest method. The Condensed Consolidated Statements of Operations for the quarters and nine months ended September 30, 2023 and 2022 reflects the following:

Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Debt issuance costs amortization$2 $1 $5 $6 
Total interest expense on external debt38 35 105 106 

The unamortized debt issuance costs as of September 30, 2023 and December 31, 2022 were $43 million and $42 million, respectively.

The weighted average maturity of our long-term debt as of September 30, 2023 is approximately 7.5 years. The weighted average interest expense rate on our borrowings outstanding as of September 30, 2023 and December 31, 2022 was as follows:

September 30, 2023December 31, 2022
Short-term commercial paper—%4.7%
Total long-term debt2.3%2.0%

The weighted average interest expense rate on our borrowings during the quarters and nine months ended September 30, 2023 and 2022 was as follows:

Quarter Ended September 30,Nine Months Ended September 30,
2023202220232022
Short-term commercial paper5.4%2.5%5.0%1.3%
Total long-term debt2.1%2.0%2.0%2.0%

Note 8: Employee Benefit Plans

Pension and Postretirement Plans. The Company sponsors both funded and unfunded domestic and foreign defined benefit pension and other postretirement benefit plans, and defined contribution plans. Contributions to our plans were as follows:

 Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Defined benefit plans$8 $7 $32 $28 
Defined contribution plans16 14 50 49 
Multi-employer pension and postretirement plans42 40 117 101 

The following table illustrates the components of net periodic benefit cost for the Company's defined benefit pension plans:

 Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Service cost$7 $10 $22 $30 
Interest cost8 4 24 13 
Expected return on plan assets(8)(8)(24)(21)
Recognized actuarial net loss— 3 — 8 
Net settlement and curtailment (gain) loss— 1 — 1 
Total net periodic benefit cost$7 $10 $22 $31 

16
Postretirement Benefit Plans. The Company sponsors postretirement benefit plans that provide health benefits to eligible retirees. The postretirement plans are unfunded. The net periodic benefit cost was less than $1 million for the quarters and nine months ended September 30, 2023 and 2022, respectively.

Stock-based Compensation. The Company adopted the 2020 Long-Term Incentive Plan (the "Plan") effective April 3, 2020. As of September 30, 2023, approximately 23 million shares remain available for awards under the Plan.

Stock-based Compensation Expense

The Company measures the cost of all share-based payments, including stock options, at fair value on the grant date and recognizes this cost in the Condensed Consolidated Statements of Operations over the award's applicable vesting period. A forfeiture rate assumption is applied on grant date to adjust the expense recognition for awards that are not expected to vest.

Stock-based compensation expense and the resulting tax benefits were as follows:

Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Stock-based compensation expense (Share Based)$15 $13 $49 $41 
Stock-based compensation expense (income) (Liability Awards)— — — (1)
Total gross stock-based compensation expense15 13 49 40 
Less: future tax benefit2 2 6 5 
Stock-based compensation expense, net of tax$13 $11 $43 $35 

As of September 30, 2023, following our annual grant issuance on February 7, 2023, there was approximately $76 million of total unrecognized compensation cost related to non-vested equity awards granted under the Plan. This cost is expected to be recognized ratably over a weighted-average period of 1.9 years.

Note 9: Stock

Preferred Stock. There are 125 million shares of $0.01 par value Preferred Stock authorized, of which none were issued as of September 30, 2023 and December 31, 2022.

Common Stock. There are 2 billion shares of $0.01 par value Common Stock authorized. As of September 30, 2023, 436.9 million shares of Common Stock were issued, which includes 27.6 million shares of Treasury Stock. As of December 31, 2022, 435.6 million shares of Common Stock were issued, which included 20.8 million shares of Treasury Stock.

Treasury Stock. As of September 30, 2023, the Company was authorized by the Board of Directors to purchase up to $2.0 billion of Common Stock under a share repurchase program, of which approximately $1.4 billion was remaining at such time.

During the quarter and nine months ended September 30, 2023, the Company repurchased 2.6 million and 6.8 million shares, respectively, for $225 million and $575 million, respectively, compared to 3.8 million and 9.1 million shares in the same periods of 2022 for $300 million and $700 million, respectively. Beginning January 1, 2023, share repurchases in excess of issuances are subject to a 1% excise tax, which is included as part of the cost basis of the shares acquired in Treasury Stock on the Condensed Consolidated Balance Sheets as of September 30, 2023.

The Company's share repurchase program does not obligate it to acquire any specific number of shares. Under this program, shares may be purchased in the open market, in privately negotiated transactions, under accelerated share repurchase programs or under plans complying with Rules 10b5-1 and 10b-18 under the Securities Exchange Act of 1934, as amended (the "Exchange Act").

17
Note 10: Accumulated Other Comprehensive Income (Loss)

A summary of the changes in each component of Accumulated other comprehensive income (loss), net of tax, for the quarters and nine months ended September 30, 2023 and 2022 is provided below:
(dollars in millions)Foreign
Currency
Translation		Defined Benefit
Pension and
Postretirement
Plans		Unrealized
Hedging Gains
(Losses)		Accumulated
Other
Comprehensive
Income (Loss)
Quarter Ended September 30, 2023
Balance as of June 30, 2023$(681)$(8)$— $(689)
Other comprehensive income (loss) before reclassifications, net39 — 1 40 
Amounts reclassified, pre-tax— — 1 1 
Tax benefit reclassified— — — — 
Balance as of September 30, 2023$(642)$(8)$2 $(648)
Nine Months Ended September 30, 2023
Balance as of December 31, 2022$(587)$(8)$3 $(592)
Other comprehensive income (loss) before reclassifications, net(56)— (7)(63)
Amounts reclassified, pre-tax1 — 8 9 
Tax benefit reclassified— — (2)(2)
Balance as of September 30, 2023$(642)$(8)$2 $(648)

(dollars in millions)Foreign
Currency
Translation		Defined Benefit
Pension and
Postretirement
Plans		Unrealized
Hedging Gains
(Losses)		Accumulated
Other
Comprehensive
Income (Loss)
Quarter Ended September 30, 2022
Balance as of June 30, 2022$(631)$(124)$7 $(748)
Other comprehensive income (loss) before reclassifications, net93 — (5)88 
Amounts reclassified, pre-tax77 3 1 81 
Tax benefit reclassified— (1)— (1)
Balance as of September 30, 2022$(461)$(122)$3 $(580)
Nine Months Ended September 30, 2022
Balance as of December 31, 2021$(642)$(128)$7 $(763)
Other comprehensive income (loss) before reclassifications, net173 — (2)171 
Amounts reclassified upon change in Otis' share of Zardoya Otis ownership(69)— — (69)
Amounts reclassified, pre-tax77 8 (2)83 
Tax benefit reclassified— (2)— (2)
Balance as of September 30, 2022$(461)$(122)$3 $(580)

Amounts reclassified that relate to defined benefit pension and postretirement plans include amortization of prior service costs and actuarial net losses recognized during each period presented. These costs are recorded as components of net periodic pension cost for each period presented. See Note 8, "Employee Benefit Plans" for additional information.

Amounts reclassified that relate to foreign currency translation in the quarter and nine months ended September 30, 2022 are related to our Russia business sold during the quarter ended September 30, 2022. See Note 6, "Business Acquisitions, Dispositions, Goodwill and Intangible Assets" for additional information regarding the sale of our Russia business.
18

Note 11: Income Taxes

The decrease in the effective tax rate for the quarter ended September 30, 2023, is primarily due to a reduction in the deferred tax liability related to repatriation of foreign earnings, reversal of tax reserves related to the U.S. foreign tax credit regulations, and the closure of a foreign tax audit.

The decrease in the effective tax rate for the nine months ended September 30, 2023 is due to a lower forecasted tax cost on repatriation in 2023. This is partially offset by the absence of a tax reserve release related to a forward transfer pricing agreement with a European tax authority and the elimination of Base Erosion Anti-Abuse Tax in the U.S., recorded in 2022.

Otis conducts business globally and, as a result, Otis or one or more of its subsidiaries files income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. In the ordinary course of business, Otis could be subject to examination by taxing authorities throughout the world, including such major jurisdictions as Austria, Belgium, Brazil, Canada, China, France, Germany, Hong Kong, India, Italy, Japan, Mexico, Netherlands, Portugal, South Korea, Spain, Switzerland, the United Kingdom, and the United States. With a few exceptions, Otis is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations for years before 2010.

A subsidiary of Otis engaged in tax-related litigation in Belgium received a favorable appellate court decision in 2018. The Belgian tax authorities appealed the decision to the Court of Cassation (the equivalent of the Supreme Court in Belgium). On December 4, 2020, the Court of Cassation overturned the decision of the appellate court and remanded the case to the appellate court for reconsideration. Following a hearing on March 20, 2023, the Antwerp Appellate Court ruled against the Company. Otis has decided not to appeal the decision, which marks the end of this litigation. Otis expects to receive the assessment for tax and interest in the quarter ending December 31, 2023. The associated tax and interest have been fully reserved and are included in the range below.

In the ordinary course of business, there is inherent uncertainty in quantifying our income tax positions. We assess our income tax positions and record tax benefits for all years subject to examination based upon management’s evaluation of the facts, circumstances, and information available at the reporting date. The evaluation considers any additional worldwide uncertain tax positions, the closure of tax statutes or the re-valuation of current uncertain tax positions arising from the issuance of legislation, regulatory or other guidance or developments in examinations, in appeals, or in the courts. Based on the preceding factors, it is reasonably possible that within the next 12 months unrecognized tax benefits could change within the range of a $10 million increase to a $330 million decrease and associated interest could change within the range of a $5 million increase to a $140 million decrease.

See Note 16, “Contingent Liabilities” for discussion regarding uncertain tax positions, included in the above range, related to pending litigation with respect to certain deductions claimed in Germany.

Note 12: Restructuring and Transformation Costs

We initiate restructuring actions to keep our cost structure competitive. Charges generally arise from severance related to workforce reductions, and to a lesser degree, facility exit and lease termination costs associated with the consolidation of office and manufacturing operations.

During the quarter ended September 30, 2023, we announced the UpLift program to transform our operating model. The program will include, among other aspects, the standardization of our processes and improving our supply chain procurement, as well as restructuring actions. During the quarter and nine months ended September 30, 2023, we incurred $4 million of incremental non-restructuring costs associated with the program ("transformation costs"), including consulting and personnel costs, which were recorded in Other income (expense), net in the Condensed Consolidated Statements of Operations. There were no UpLift restructuring actions initiated in the nine months ended September 30, 2023. See Note 19, "Subsequent Events," for discussion regarding UpLift restructuring actions approved following period-end.

19
During the quarters and nine months ended September 30, 2023 and 2022, we recorded restructuring costs for new and ongoing restructuring actions as follows:

Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
New Equipment$10 $2 $15 $18 
Service11 4 21 27 
Total $21 $6 $36 $45 

Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Cost of products and services sold$9 $2 $11 $16 
Selling, general and administrative12 4 25 29 
Total $21 $6 $36 $45 

The restructuring expenses incurred during the quarter and nine months ended September 30, 2023 and 2022, were primarily the result of restructuring programs initiated during 2023 and 2022. We are targeting to complete by the end of 2024 the majority of remaining restructuring actions initiated in the quarter and nine months ended September 30, 2023 and the full year 2022, with certain utilization beyond 2023 due to legal requirements in the applicable jurisdictions. Expected total costs for the restructuring actions initiated are $120 million, including $43 million to New Equipment and $77 million to Service operating segments, respectively. Remaining costs to incur for the restructuring actions initiated are expected to be $28 million, including $6 million to New Equipment and $22 million to Service operating segments, respectively.

The following table summarizes the accrual balance and utilization for restructuring actions, which are primarily for severance costs and most will require cash payment:

(dollars in millions)
Restructuring accruals as of December 31, 2022$41 
Net restructuring costs36 
Utilization, foreign exchange and other costs(35)
Balance as of September 30, 2023$42 

Note 13: Financial Instruments

We enter into derivative instruments primarily for risk management purposes, including derivatives designated as hedging instruments under ASC 815, Derivatives and Hedging. We operate internationally and, in the normal course of business, are exposed to fluctuations in interest rates, commodity prices and foreign exchange rates. These fluctuations can increase the costs of financing, investing in and operating the business. We may use derivative instruments, including swaps, forward contracts and options, to manage certain foreign currency, commodity price and interest rate exposures.

The four-quarter average of the notional amount of foreign exchange contracts hedging foreign currency transactions was $4.3 billion and $3.9 billion as of September 30, 2023 and December 31, 2022, respectively. The four-quarter average of the notional amount of contracts hedging commodity purchases was $24 million and $20 million as of September 30, 2023 and December 31, 2022, respectively.

20
The following table summarizes the fair value and presentation on the Condensed Consolidated Balance Sheets for derivative instruments as of September 30, 2023 and December 31, 2022:

(dollars in millions)Balance Sheet ClassificationSeptember 30, 2023December 31, 2022
Derivatives designated as Cash flow hedging instruments:
Asset Derivatives:
Foreign exchange contractsOther current assets$2 $3 
Foreign exchange contractsOther assets3 2 
Total asset derivatives$5 $5 
Liability Derivatives:
Foreign exchange contractsAccrued liabilities$(3)$(4)
Commodity contractsAccrued liabilities— (1)
Foreign exchange contractsOther long-term liabilities(1)— 
Total liability derivatives$(4)$(5)
Derivatives not designated as Cash flow hedging instruments:
Asset Derivatives:
Foreign exchange contractsOther current assets$31 $25 
Foreign exchange contractsOther assets5 3 
Total asset derivatives$36 $28 
Liability Derivatives:
Foreign exchange contractsAccrued liabilities$(17)$(20)
Commodity contractsAccrued liabilities— (4)
Foreign exchange contractsOther long-term liabilities(4)(2)
Total liability derivatives$(21)$(26)

Derivatives designated as Cash flow hedging instruments. The amounts of gain or (loss) attributable to foreign exchange and commodity contract activity reclassified from Accumulated other comprehensive income (loss) were immaterial for the quarters and nine months ended September 30, 2023 and 2022, respectively.

The effect of cash flow hedging relationships on Accumulated other comprehensive income (loss) as of September 30, 2023 and December 31, 2022 are presented in the table below:

(dollars in millions)September 30, 2023December 31, 2022
Gain (loss) recorded in Accumulated other comprehensive income (loss)$2 $3 

The Company utilizes the critical terms match method in assessing firm commitment derivatives and regression testing in assessing commodity derivatives for hedge effectiveness. Accordingly, the hedged items and derivatives designated as hedging instruments are highly effective.

Assuming current market conditions continue, a pre-tax loss of $1 million is expected to be reclassified from Accumulated other comprehensive income (loss) into Cost of products sold to reflect the fixed prices obtained from foreign exchange and commodity hedging within the next 12 months. All derivative contracts accounted for as cash flow hedges as of September 30, 2023 will mature by December 2028.

21
Net Investment Hedges. We may use non-derivative (foreign currency denominated debt) and derivative (foreign exchange forward contracts) instruments to hedge portions of the Company's investment in foreign subsidiaries and manage foreign exchange risk. For instruments that are designated and qualify as hedges of net investments in foreign operations and that meet the effectiveness requirements, the net gains or losses attributable to changes in spot exchange rates are recorded in foreign currency translation within Other comprehensive income (loss) on the Condensed Consolidated Statements of Comprehensive Income, and will remain in Accumulated other comprehensive income (loss) until the hedged investment is sold or substantially liquidated. The remainder of the change in value of such instruments is recorded in earnings, including to the extent foreign currency denominated debt is not designated in or is de-designated from a net investment hedge relationship.

Our use of foreign exchange forward contracts designated as hedges of the Company's net investment in foreign subsidiaries can vary depending on the Company's desired foreign exchange risk coverage.

We have ¥21.5 billion of Japanese Yen denominated long-term debt, which qualifies as a net investment hedge against our investments in Japanese businesses, as well as notional amounts of foreign exchange forward contracts of €120 million and HK$2 billion which qualify as net investment hedges against our investments in certain European and Asian businesses, respectively. The net investment hedges are deemed to be effective. Additionally, we had a notional amount of a foreign exchange forward contract of €95 million that qualified as a net investment hedge, which matured during the quarter ended June 30, 2023 and the net investment hedge was deemed to be effective until maturity. The maturity dates of the current non-derivative and derivative instruments designated in net investment hedges range from 2024 to 2026.

The amounts of gains (losses) recognized in other comprehensive income (loss) related to non-derivative and derivative instruments designated as net investment hedges are as follows.

Quarter Ended September 30,Nine Months Ended September 30,
2023202220232022
Foreign currency denominated long-term debt$6 $10 $18 $40 
Foreign currency forward contracts2 — 3 — 
Total$8 $10 $21 $40 

Derivatives not designated as Cash flow hedging instruments. The net effect of derivatives not designated as Cash flow hedging instruments within Other income (expense) net, on the Condensed Consolidated Statements of Operations was as follows:

Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Foreign exchange contracts$4 $9 $16 $12 

The effects of derivatives not designated as Cash flow hedge instruments within Cost of products sold on the Condensed Consolidated Statements of Operations were gains of $1 million in the quarter ended September 30, 2023 and losses of $8 million in the nine months ended September 30, 2023, compared to losses of $3 million and $11 million in the same periods of 2022, respectively.

Note 14: Fair Value Measurements

Valuation Techniques. Our marketable securities include investments that are traded in active markets, either domestically or internationally, and are measured at fair value using closing stock prices from active markets. The fair value gains or losses related to our marketable securities are recorded through net income. Our derivative assets and liabilities include foreign exchange and commodity contracts that are measured at fair value using internal models based on observable market inputs such as forward rates, interest rates, our own credit risk and our counterparties' credit risks.

As of September 30, 2023, there has not been any significant impact to the fair value of our derivative liabilities due to our own credit risk. Similarly, there has not been any significant adverse impact to our derivative assets based on our evaluation of our counterparties' credit risks.

22
Due to their short-term nature, the carrying value approximated fair value for the current portion of the Company’s financial instruments not carried at fair value. The fair value of receivables, including customer financing notes receivable, net, that were issued long-term are based on the discounted values of their related cash flows at interest rates reflecting the attributes of the counterparties, including geographic location. Customer-specific risk, including credit risk, is already considered in the carrying value of those receivables. Our notes, as described in Note 7, "Borrowings and Lines of Credit," are measured at fair value using closing bond prices from active markets.

Recurring Fair Value Measurements. In accordance with the provisions of ASC 820: Fair Value Measurements, the following tables provide the valuation hierarchy classification of assets and liabilities that are carried at fair value and measured on a recurring and non-recurring basis in our Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022: 

September 30, 2023
(dollars in millions)TotalLevel 1Level 2Level 3
Recurring fair value measurements:
Marketable securities$31 $31 $— $— 
Derivative assets41 — 41 — 
Derivative liabilities(25)— (25)— 

December 31, 2022
(dollars in millions)TotalLevel 1Level 2Level 3
Recurring fair value measurements:
Marketable securities$30 $30 $— $— 
Derivative assets33 — 33 — 
Derivative liabilities(31)— (31)— 

Fair Value of Financial Instruments. The following table provides carrying amounts and fair values of financial instruments that are not carried at fair value as of September 30, 2023 and December 31, 2022:

 September 30, 2023December 31, 2022
(dollars in millions)Carrying
Amount		Fair
Value		Carrying
Amount		Fair
Value
Long-term receivables, net$49 $49 $55 $53 
Customer financing notes receivable, net31 27 55 51 
Short-term borrowings(54)(54)(139)(139)
Long-term debt, including current portion (excluding leases and other)(7,394)(6,343)(6,663)(5,661)
Long-term liabilities, including current portion(197)(184)(222)(197)

The following tables provide the valuation hierarchy classification of assets and liabilities that are not carried at fair value in the Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022:

September 30, 2023
(dollars in millions)TotalLevel 1Level 2Level 3
Long-term receivables, net$49 $— $49 $— 
Customer financing notes receivable, net27 — 27 — 
Short-term borrowings(54)— (54)— 
Long-term debt, including current portion (excluding leases and other)(6,343)— (6,343)— 
Long-term liabilities, including current portion(184)— (184)— 
23
December 31, 2022
(dollars in millions)TotalLevel 1Level 2Level 3
Long-term receivables, net$53 $— $53 $— 
Customer financing notes receivable, net51 — 51 — 
Short-term borrowings(139)— (139)— 
Long-term debt, including current portion (excluding leases and other)(5,661)— (5,661)— 
Long-term liabilities, including current portion(197)— (197)— 


Note 15: Guarantees

The Company provides service and warranty on its products beyond normal service and warranty policies. The changes in the carrying amount of service and product guarantees for the nine months ended September 30, 2023 and 2022 are as follows:

(dollars in millions)20232022
Balance as of December 31$13 $20 
Warranties3 1 
Settlements made(5)(7)
Foreign exchange and other(1)(1)
Balance as of September 30$10 $13 

The Company provides certain financial guarantees to third parties. As of September 30, 2023, Otis has stand-by letters of credit with maximum potential payment totaling $128 million. We accrue costs associated with guarantees when it is probable that a liability has been incurred and the amount can be reasonably estimated. The most likely cost to be incurred is accrued based on an evaluation of currently available facts, and where no amount within a range of estimates is more likely, the minimum is accrued. In accordance with ASC Topic 460: Guarantees, we record these liabilities at fair value. As of September 30, 2023, Otis has determined there are no estimated costs probable under these guarantees.

Note 16: Contingent Liabilities

Except as otherwise noted, while we are unable to predict the final outcome, based on information currently available, we do not believe that resolution of any of the following matters will have a material adverse effect upon our competitive position, results of operations, cash flows or financial condition. In addition to the specific amounts noted below, where we have recorded loss contingency accruals for the below and other matters, the amounts in aggregate are not material. Legal costs generally are expensed when incurred.

Environmental. As previously disclosed, the Company's operations are subject to environmental regulation by authorities with jurisdiction over its operations. The Company has accrued for the costs of environmental remediation activities, including, but not limited to, investigatory, remediation, operating and maintenance costs and performance guarantees, and periodically reassesses these amounts. Management believes that the likelihood of incurring losses materially in excess of amounts accrued is remote. The outstanding liability for environmental obligations was $5 million as of September 30, 2023 and December 31, 2022, and is principally included in Other long-term liabilities on the Condensed Consolidated Balance Sheets.

Legal Proceedings.

German Tax Litigation

As previously disclosed, we have been involved in administrative review proceedings with the German Tax Office, which concern approximately €215 million (approximately $229 million as of September 30, 2023) of tax benefits that we have claimed related to a 1998 reorganization of the corporate structure of our operations in Germany. Upon audit, these tax benefits were disallowed by the German Tax Office. We estimate interest associated with the aforementioned tax benefits is an additional approximately €118 million (approximately $126 million as of September 30, 2023).

24
In August 2012, a suit was filed in the local German Tax Court (Berlin-Brandenburg). In 2015, our former parent United Technologies Corporation ("UTC"), now RTX Corporation ("RTX"), made tax and interest payments to German tax authorities of €275 million (approximately $300 million) in order to avoid additional interest accruals pending final resolution of this matter. In March 2016, the local German Tax Court dismissed the suit, and we appealed this decision to the German Federal Tax Court. Following a hearing in July 2018, the German Federal Tax Court remanded the matter to the local German Tax Court for further proceedings. In December 2020, the local German Tax Court ruled against the Company.

On January 26, 2021, the Company filed an appeal with the German Federal Tax Court. On February 8, 2022, the Company received the decision of the German Federal Tax Court, in which the Court remanded the case for reconsideration by the local German Tax Court. The local German Tax Court held a hearing on June 12, 2023, and issued a decision in favor of Otis on July 21, 2023. On September 14, 2023, the German tax authorities filed an appeal to the German Federal Tax Court. The German Federal Tax Court is expected to rule on the appeal in 2024. As a result of the appeal filing, this matter remains contested, and the Company cannot assess the ultimate outcome of this case.

Pursuant to the Tax Matters Agreement ("TMA") with our former parent, UTC, the Company retains the liability associated with the remaining interest, and has recorded an interest accrual of €45 million (approximately $47 million as of September 30, 2023), net of payments and other deductions, included within Accrued liabilities on the Condensed Consolidated Balance Sheets as of September 30, 2023. If the Company prevails in this matter, any recoveries would be allocated between RTX and the Company pursuant to the terms of the TMA.

Asbestos Matters

As previously disclosed, we have been named as defendants in lawsuits alleging personal injury as a result of exposure to asbestos. While we have never manufactured any asbestos-containing component parts, and no longer incorporate asbestos in any current products, certain of our historical products have contained components manufactured by third parties incorporating asbestos. A substantial majority of these asbestos-related claims have been dismissed without payment or were covered in full or in part by insurance or other forms of indemnity. Additional cases were litigated and settled without any insurance reimbursement. The amounts involved in asbestos-related claims were not material individually or in the aggregate as of and for the periods ended September 30, 2023 and December 31, 2022.

The estimated range of total liabilities to resolve all pending and unasserted potential future asbestos claims through 2059 is approximately $21 million to $43 million as of September 30, 2023 and December 31, 2022. Since no amount within the range of estimates is more likely to occur than any other, we have recorded the minimum amount of $21 million, which is principally recorded in Other long-term liabilities on our Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022. Amounts are on a pre-tax basis, not discounted, and exclude the Company's legal fees to defend the asbestos claims (which will continue to be expensed as they are incurred). In addition, the Company has an insurance recovery receivable for probable asbestos-related recoveries of approximately $5 million, which is principally included in Other assets on our Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022.

Putative Class Action Lawsuit

On August 12, 2020, a putative class action lawsuit, (Geraud Darnis et al. v. Raytheon Technologies Corporation et al.), was filed in the United States District Court for the District of Connecticut (the "Court") against Otis, RTX, Carrier Global Corporation ("Carrier"), each of their directors, and various incentive and deferred compensation plans in connection with the separation of Otis and Carrier from UTC (the "Separation") in April 2020. On September 13, 2021, plaintiffs filed an amended complaint against the three company defendants only. The named plaintiffs are former employees of UTC and its current and former subsidiaries, including Otis and Carrier. They seek to recover monetary damages, as well as related declaratory and equitable relief, based on claimed decreases in the value of long-term incentive awards and deferred compensation under nonqualified deferred compensation plans allegedly caused by the formula used to calculate the adjustments to such awards and deferred compensation from RTX, Carrier, and Otis following the spin-offs of Carrier and Otis and the subsequent combination of UTC and Raytheon Company. On September 30, 2022, in response to motions to dismiss filed by the defendants, the Court dismissed the class action in its entirety with prejudice. The plaintiffs appealed the decision on October 26, 2022. On August 24, 2023, the Second Circuit Court of Appeals entered judgment in defendants’ favor, upholding the trial court’s decision. This action is concluded.

25
Other. As previously disclosed, we have commitments and contingent liabilities related to legal proceedings, self-insurance programs and matters arising out of the normal course of business. We accrue contingencies based on a range of possible outcomes. If no amount within this range is a better estimate than any other, we accrue the minimum amount. While it is not possible to determine the ultimate disposition of each of these claims and whether they will be resolved consistent with our beliefs, we expect that the outcome of such claims, individually or in the aggregate, will not have a material adverse effect on our business, financial condition, cash flows or results of operations.

As previously disclosed, in certain European countries, claims for overcharges on elevators and escalators related to civil cartel cases have been made, which we have accrued for based on our evaluation of the claims. While it is not possible to determine the ultimate disposition of each of these claims and whether they will be resolved consistent with our beliefs, historical settlement experience of these cases has not been material to the business, financial condition, cash flows or results of operations. However, the future outcome of these cases cannot be determined.

As previously disclosed, in the ordinary course of business, the Company is also routinely a defendant in, party to or otherwise subject to many pending and threatened legal actions, claims, disputes and proceedings. These matters are often based on alleged violations of contract, product liability, warranty, regulatory, environmental, health and safety, employment, intellectual property, tax and other laws. In some of these proceedings, claims for substantial monetary damages are asserted against the Company and its subsidiaries and could result in fines, penalties, compensatory or treble damages or non-monetary relief. We do not believe that these matters will have a material adverse effect upon our competitive position, results of operations, cash flows or financial condition.

Note 17: Segment Financial Data

Our operations are classified into two operating segments: New Equipment and Service. Through the New Equipment segment, we design, manufacture, sell and install a wide range of passenger and freight elevators as well as escalators and moving walkways to customers in the residential and commercial building and infrastructure projects. The Service segment provides maintenance and repair services for both our products and those of other manufacturers, and provides modernization services to upgrade elevators and escalators. The operating segments are generally based on the management structure of the Company, how management allocates resources, assesses performance and makes strategic and operational decisions.

Segment Information. Segment information for the quarters ended September 30, 2023 and 2022 are as follows:

Net SalesOperating ProfitOperating Profit Margin
(dollars in millions)202320222023202220232022
New Equipment$1,435 $1,447 $94 $100 6.6 %6.9 %
Service2,088 1,897 507 446 24.3 %23.5 %
Total segments3,523 3,344 601 546 17.1 %16.3 %
General corporate expenses and other——(30)(17)——
Total$3,523 $3,344 $571 $529 16.2 %15.8 %

Segment information for the nine months ended September 30, 2023 and 2022 are as follows:
Net SalesOperating ProfitOperating Profit Margin
(dollars in millions)202320222023202220232022
New Equipment$4,346 $4,403 $277 $292 6.4 %6.6 %
Service6,243 5,843 1,475 1,328 23.6 %22.7 %
Total segments10,589 10,246 1,752 1,620 16.5 %15.8 %
General corporate expenses and other— — (88)(78)——
Total$10,589 $10,246 $1,664 $1,542 15.7 %15.0 %
Total assets are not presented for each segment as they are not presented to, or reviewed by, the Chief Operating Decision Maker.
26

Geographic Sales. Geographic Net sales are attributed to the geographic regions based on their location of origin. With the exception of the U.S. and China, there were no individually significant countries with sales exceeding 10% of Net sales during the quarters and nine months ended September 30, 2023 and 2022.

Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
United States Operations$1,004 $943 $3,015 $2,873 
International Operations
  China596 672 1,832 1,951 
  Other 1,923 1,729 5,742 5,422 
Total$3,523 $3,344 $10,589 $10,246 

Disaggregated Sales by Type. Segment Net sales disaggregated by product and service type for the quarters and nine months ended September 30, 2023 and 2022 are as follows:

Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
New Equipment$1,435 $1,447 $4,346 $4,403 
Maintenance and Repair1,715 1,555 5,116 4,784 
Modernization373 342 1,127 1,059 
Total Service2,088 1,897 6,243 5,843 
Total$3,523 $3,344 $10,589 $10,246 

Major Customers. There were no customers that individually accounted for 10% or more of the Company's consolidated Net sales for the quarters and nine months ended September 30, 2023 and 2022.

Note 18: Accounting Pronouncements

In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. This ASU clarifies that an acquirer of a business should recognize and measure contract assets and contract liabilities in a business combination in accordance with ASC Topic 606, Revenue from Contracts with Customers. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, with early application permitted. The Company adopted ASU 2021-08 effective January 1, 2023. The adoption of this ASU did not have a material impact on our Condensed Consolidated Financial Statements.

In September 2022, the FASB issued ASU No. 2022-04, Liabilities - Supplier Finance Programs (Topic 450-50): Disclosure of Supplier Finance Program Obligations, which requires entities that use supplier finance programs in connection with the purchase of goods and services to disclose the key terms of the programs and information about obligations outstanding at the end of the reporting period, including a rollforward of those obligations. The guidance does not affect the recognition, measurement or financial statement presentation of supplier finance program obligations. ASU 2022-04 is effective for fiscal years beginning after December 15, 2022, except for the disclosure of rollforward information, which is effective for fiscal years beginning after December 15, 2023. The Company adopted ASU 2022-04 effective January 1, 2023. The adoption of this ASU did not have a material impact on our Condensed Consolidated Financial Statements, as disclosed in Note 1, "General."

27
In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting ("ASU 2020-04"), which provides temporary optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. The amendments in ASU 2020-04 apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. Additionally, in December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 ("ASU 2022-06"), which allows ASU 2020-04 to be adopted and applied prospectively to contract modifications made on or before December 31, 2024. We do not expect the adoption of this standard to have a material impact on our Condensed Consolidated Financial Statements.

In August 2023, the FASB issued ASU 2023-05, Business Combinations - Joint Ventures Formations (Subtopic 805-60): Recognition and initial measurement ("ASU 2023-05"), which requires that joint ventures, upon formation, apply a new basis of accounting by initially measuring assets and liabilities at fair value. The amendments in ASU 2023-05 are effective for joint ventures that are formed on or after January 1, 2025. Early adoption is permitted. We are currently evaluating the impact of this standard, however we do not expect it to have a material impact on our Condensed Consolidated Financial Statements.

Other new accounting pronouncements issued but not effective until after September 30, 2023 did not and are not expected to have a material impact on our financial position, results of operations or liquidity.

Note 19: Subsequent Events

Following period end, on October 5, 2023, UpLift restructuring actions of approximately $55 million were approved, which are expected to be incurred beginning in the fourth quarter of 2023 through 2024. These are primarily severance related costs. We expect these actions to be mostly completed and cash to be paid by the end of 2024, with certain actions to be completed beyond 2024 due to legal requirements in the applicable jurisdictions.
28
With respect to the unaudited condensed consolidated financial information of Otis Worldwide Corporation for the quarters and nine months ended September 30, 2023 and 2022, PricewaterhouseCoopers LLP ("PricewaterhouseCoopers") reported that it has applied limited procedures in accordance with professional standards for a review of such information. However, its report dated October 26, 2023, appearing below, states that the firm did not audit and does not express an opinion on that unaudited condensed consolidated financial information. PricewaterhouseCoopers has not carried out any significant or additional review procedures beyond those that would have been necessary if their report had not been included. Accordingly, the degree of reliance on its report on such information should be restricted in light of the limited nature of the review procedures applied. PricewaterhouseCoopers is not subject to the liability provisions of Section 11 of the Securities Act of 1933, as amended ("the Act") for its report on the unaudited condensed consolidated financial information because that report is not a "report" or a "part" of a registration statement prepared or certified by PricewaterhouseCoopers within the meaning of Sections 7 and 11 of the Act.

Report of Independent Registered Public Accounting Firm


To the Board of Directors and Shareholders of Otis Worldwide Corporation

Results of Review of Interim Financial Information

We have reviewed the accompanying condensed consolidated balance sheet of Otis Worldwide Corporation and its subsidiaries (the “Company”) as of September 30, 2023, and the related condensed consolidated statements of operations, of comprehensive income, and of changes in equity for the three-month and nine-month periods ended September 30, 2023 and 2022 and of cash flows for the nine-month periods ended September 30, 2023 and 2022, including the related notes (collectively referred to as the “interim financial information”). Based on our reviews, we are not aware of any material modifications that should be made to the accompanying interim financial information for it to be in conformity with accounting principles generally accepted in the United States of America.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of the Company as of December 31, 2022, and the related consolidated statements of operations, of comprehensive income, of changes in equity and of cash flows for the year then ended (not presented herein), and in our report dated February 3, 2023, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2022, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

Basis for Review Results

This interim financial information is the responsibility of the Company’s management. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our review in accordance with the standards of the PCAOB. A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

/s/ PricewaterhouseCoopers LLP

Hartford, Connecticut
October 26, 2023
29
Item 2.    Management's Discussion and Analysis of Financial Condition and Results of Operations

BUSINESS OVERVIEW

Business Summary

We are the world’s leading elevator and escalator manufacturing, installation and service company. Our Company is organized into two segments, New Equipment and Service. Through our New Equipment segment, we design, manufacture, sell and install a wide range of passenger and freight elevators, as well as escalators and moving walkways for residential and commercial buildings and infrastructure projects. Our New Equipment customers include real-estate and building developers and general contractors who develop and/or design buildings for residential, commercial, retail or mixed-use activity. We sell our New Equipment directly to customers, as well as through agents and distributors.

Through our Service segment, we perform maintenance and repair services for both our own products and those of other manufacturers and provide modernization services to upgrade elevators and escalators. Maintenance services include inspections to ensure code compliance, preventive maintenance offerings and other customized maintenance offerings tailored to meet customer needs, as well as repair services to address equipment and component wear and tear and breakdowns. Modernization services enhance equipment operation and improve building functionality. Modernization offerings can range from relatively simple upgrades of interior finishes and aesthetics to complex upgrades of larger components and sub-systems. Our typical Service customers include building owners, facility managers, housing associations and government agencies that operate buildings where elevators and escalators are installed.

We serve our customers through a global network of employees. These include sales personnel, field technicians with separate skills in performing installation and service, as well as engineers driving our continued product development and innovation. We function under a centralized operating model whereby a global strategy is set around New Equipment and Service because we seek to grow our maintenance portfolio, in part, through the conversion of new elevator and escalator installations into service contracts. Accordingly, we benefit from an integrated global strategy, which sets priorities and establishes accountability across the full product life cycle.

The current status of significant factors affecting our business environment in 2023 is discussed below. For additional discussion, refer to the "Business Overview" section in Management's Discussion and Analysis of Financial Condition and Results of Operations in our 2022 Form 10-K.

Recent Developments

UpLift Program

The UpLift program was announced in July 2023, with the goal to transform our operating model. The program will include the standardization of our processes and improving our supply chain procurement, among other aspects of the program, as well as restructuring actions. We expect the program to generate approximately $150 million in annual savings by mid-year 2025, with restructuring and other non-recurring costs ("transformation costs") over that period of approximately the same amount. For further details, refer to the discussion on restructuring costs in the "Results of Operations," as well as Note 12 and Note 19 to the Condensed Consolidated Financial Statements.

Impact of Global Macroeconomic Developments on Our Company

Global macroeconomic developments have impacted, and continue to impact, aspects of the Company's operations and overall financial performance during the quarters and nine months ended September 30, 2023 and 2022. These macroeconomic developments include, among others, inflationary pressures, higher interest rates and tighter credit conditions. These macroeconomic trends could continue to impact our business, including impacts to overall financial performance during the remainder of 2023, as a result of the following, among other things:

•Supplier liquidity, as well as supplier and raw material capacity constraints, delays and related costs;
•Customer demand impacting our new equipment, maintenance and repair, and modernization businesses;
•Customer liquidity constraints and related credit reserves; and
•Cancellations or delays of customer orders.

30
We currently do not expect any significant impact to our capital and financial resources from these macroeconomic developments, including to our overall liquidity position based on our available cash and cash equivalents and our access to credit facilities and the capital markets.

See the "Liquidity and Financial Condition" section in this Form 10-Q for further detail and Item 1A. "Risk Factors" in our 2022 Form 10-K for additional risks related to the COVID-19 pandemic, including macroeconomic risks associated therewith, and global economic, capital market and political conditions in general, and conditions in the construction and infrastructure industries in particular.

Risks Associated with the Ongoing Conflict between Russia and Ukraine and Other Geo-political Events

The ongoing conflict between Russia and Ukraine has resulted in worldwide geo-political and macroeconomic uncertainty, including volatile commodity markets, foreign exchange fluctuations, supply chain disruptions, increased risk of cyber incidents, reputational risk, increased operating costs (including fuel and other input costs), environmental, health and safety risks related to securing and maintaining facilities, additional sanctions and other regulations (including restrictions on the transfer of funds to and from Russia).

To the extent possible, we continue to operate our business in Ukraine, which represented less than 1% of our full year 2022 and nine months ended September 30, 2023 revenue and operating profit. As previously disclosed, we sold our business in Russia to a third party on July 27, 2022, which represented approximately 1% of both our revenue and operating profit in 2022.

Additionally, we do not have operations in Israel or Gaza and currently do not expect the recent war in the region to have a material impact on our business.

We cannot predict how the events described above will evolve. If the events continue for a significant time or expand to other countries, they could heighten certain risks disclosed in Item 1A "Risk Factors" in our 2022 Form 10-K, including but not limited to, adverse effects on macroeconomic conditions, including increased inflation, constraints on the availability of commodities, supply chain disruption and decreased business spending; cyber-incidents; disruptions to our or our business partners’ global technology infrastructure, including through cyber-attack or cyber-intrusion; adverse changes in international trade policies and relations; claims, litigation and regulatory enforcement; our ability to implement and execute our business strategy; terrorist activities; our exposure to foreign currency fluctuations; reputational risk; and constraints, volatility, or disruption in the capital markets, any of which could have a material adverse effect on our business, results of operations, cash flows and financial condition.

Environmental, Social and Governance ("ESG")

There have been no, and we do not expect there to be in the near term, material impacts on our business, financial condition or results of operations as a result of compliance with legislation or regulatory rules regarding climate change, from the known physical effects of climate change or as a result of implementing our ESG initiatives. Increased regulation (including pending SEC and European Union requirements) and other climate change concerns, however, could subject us to additional costs and restrictions, and we are not able to predict how such regulations or concerns would affect our business, operations or financial results.

For additional discussion of Otis’ ESG goals, see the discussion under “Environmental, Social and Governance (“ESG”)” in Item 1 in our 2022 Form 10-K.

CRITICAL ACCOUNTING ESTIMATES

Preparation of our Condensed Consolidated Financial Statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. The accounting policies that involve the most significant estimates, assumptions and management judgments used in preparation of the Condensed Consolidated Financial Statements, or are the most sensitive to change due to outside factors, are discussed in the section entitled "Management's Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Estimates" included in our 2022 Form 10-K. Except as disclosed in Note 18 to our Condensed Consolidated Financial Statements in this Form 10-Q, pertaining to adoption of new accounting pronouncements, there have been no material changes in these policies.

31
RESULTS OF OPERATIONS

Net Sales
 Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Net sales$3,523$3,344$10,589 $10,246 
Percentage change year-over-year5.4 %3.3 %

The factors contributing to the total percentage change year-over-year in total Net sales for the quarter and nine months ended September 30, 2023 are as follows:

Components of Net sales change:Quarter Ended September 30, 2023Nine Months Ended September 30, 2023
Organic volume 5.2 %6.1 %
Foreign currency translation0.6 %(2.1)%
Acquisitions and divestitures, net(0.4)%(0.7)%
Total % change5.4 %3.3 %

The Organic volume increase of 5.2% for the quarter ended September 30, 2023 was driven by an increase in organic sales of 8.4% in Service and 1.0% in New Equipment. The Organic volume increase of 6.1% for the nine months ended September 30, 2023 was driven by an increase in organic sales of 8.0% in Service and 3.6% in New Equipment.

The decrease in Net sales due to Acquisitions and divestitures, net is primarily the result of the sale of our Russia business in the third quarter of 2022.

See the "Segment Review" section for a discussion of Net sales by segment.

Cost of Products and Services Sold
 Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Total cost of products and services sold$2,477$2,373$7,464$7,286
Percentage change year-over-year4.4 %2.4 %

The factors contributing to the percentage change year-over-year for the quarter and nine months ended September 30, 2023 in total cost of products and services sold are as follows:

Components of Cost of Products and Services Sold change:Quarter Ended September 30, 2023Nine Months Ended September 30, 2023
Organic volume 4.3 %5.7 %
Foreign currency translation0.4 %(2.2)%
Acquisitions and divestitures, net and other(0.3)%(1.1)%
Total % change4.4 %2.4 %

The organic increase in Total cost of products and services sold for the quarter and nine months ended September 30, 2023 was primarily driven by the organic sales increases noted above. Inflationary pressures, including annual wage increases and higher Service related material costs were mitigated by productivity and lower commodity prices, primarily steel.

The decrease in Total cost of products and services sold due to Acquisitions and divestitures, net is primarily the result of the sale of our Russia business in the third quarter of 2022.
32
Gross Margin
 Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Gross margin$1,046 $971 $3,125 $2,960 
Gross margin percentage29.7 %29.0 %29.5 %28.9 %

Gross margin percentage increased 70 and 60 basis points for the quarter and nine months ended September 30, 2023, respectively, when compared to the same periods for 2022, due to the benefit from Service sales growing faster than New Equipment sales, favorable pricing, lower commodity prices, and the benefits from productivity, partially offset by the inflationary pressures described above.

See the "Segment Review" section below for discussion of operating results by segment.

Research and Development
 Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Research and development$36 $37 $107 $112 
Percentage of Net sales1.0 %1.1 %1.0 %1.1 %

Research and development was relatively flat for the quarter and nine months ended September 30, 2023, when compared to the same periods for 2022.

Selling, General and Administrative
 Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Selling, general and administrative$452 $417 $1,386 $1,315 
Percentage of Net sales12.8 %12.5 %13.1 %12.8 %

Selling, general and administrative expenses increased $35 million for the quarter ended September 30, 2023 driven by annual wage increases, higher other employment related costs, higher restructuring costs and unfavorable foreign exchange impacts of $5 million, partially offset by cost containment actions when compared to the same period in 2022.

Selling, general and administrative expenses increased $71 million for the nine months ended September 30, 2023 driven by annual wage increases and higher other employment related costs, partially offset by cost containment actions, lower restructuring costs and favorable foreign exchange impacts of $14 million. The nine months ended September 30, 2023, compared to the same period in 2022, was also impacted by higher credit loss reserves.

Selling, general and administrative expenses as a percentage of Net sales increased 30 basis points for the quarter and nine months ended September 30, 2023, compared to the same periods in 2022.

Restructuring and Transformation Costs
 Nine Months Ended September 30,
(dollars in millions)20232022
Restructuring costs$36$45

We initiate restructuring actions to keep our cost structure competitive. Charges generally arise from severance related to workforce reductions, and to a lesser degree, facility exit and lease termination costs associated with the consolidation of office and manufacturing operations. We continue to closely monitor the economic environment and may undertake further restructuring actions to keep our cost structure aligned with the demands of the prevailing market conditions.

33
During the nine months ended September 30, 2023, we also incurred $4 million of incremental non-restructuring costs associated with the UpLift program ("transformation costs"), including consulting and personnel costs, which were recorded in Other income (expense), net in the Condensed Consolidated Statements of Operations. There were no UpLift restructuring actions initiated in the nine months ended September 30, 2023. See Note 19 to the Condensed Consolidated Financial Statements for discussion regarding UpLift restructuring actions approved following period-end.

Total restructuring costs were $36 million for the nine months ended September 30, 2023 and included $31 million of costs related to 2023 actions and $5 million of costs related to 2022 actions.

Most of the expected charges will require cash payments, which we have funded and expect to continue to fund with cash generated from operations.

The table below presents approximate cash outflows related to the restructuring actions during the nine months ended September 30, 2023, and the expected cash payments to complete the actions announced:

(dollars in millions)
Cash outflows during the nine months ended September 30, 2023$30 
Expected cash payments remaining to complete actions announced70 

We generally expect to achieve annual recurring savings within the two-year period subsequent to initiating the actions, including $28 million for the 2023 actions and $66 million for the 2022 actions, of which approximately $55 million was realized for the 2023 and 2022 actions during the nine months ended September 30, 2023.

For additional discussion of restructuring, see Note 12 and Note 19 to the Condensed Consolidated Financial Statements.

Other Income (Expense), Net
 Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Other income (expense), net$13$12$32$9

The change in Other Income (Expense), Net, of $1 million and $23 million for the quarter and nine months ended September 30, 2023, respectively, compared to the same periods in 2022, was primarily driven by the absence of the loss on the sale of our Russia business and related charges of $6 million and $24 million when compared to the same periods in 2022, respectively, partially offset by UpLift transformation costs of $4 million in the quarter and nine months ended September 30, 2023. These periods were also impacted by foreign currency mark-to-market adjustments.

Interest Expense (Income), Net
 Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Interest expense (income), net$39$35$109$107

Interest Expense (Income), increased $4 million and $2 million for the quarter and nine months ended September 30, 2023, compared to the same periods in 2022, respectively, driven by higher interest expense related to the $750 million unsecured, unsubordinated debt issued in August 2023, partially offset by higher interest income.

The average interest rate on our long-term debt for each of the quarter and nine months ended September 30, 2023 and 2022 was approximately 2%. For additional discussion of borrowings, see Note 7 to the Condensed Consolidated Financial Statements.

34
Income Taxes
 Quarter Ended September 30,Nine Months Ended September 30,
 2023202220232022
Effective tax rate25.8 %29.0 %25.7 %26.7 %

The decrease in the effective tax rate for the quarter ended September 30, 2023, is primarily due to a reduction in the deferred tax liability related to repatriation of foreign earnings, reversal of tax reserves related to the U.S. foreign tax credit regulations, and the closure of a foreign tax audit.

The decrease in the effective tax rate for the nine months ended September 30, 2023 is due to a lower forecasted tax cost on repatriation in 2023. This is partially offset by the absence of a tax reserve release related to a forward transfer pricing agreement with a European tax authority and the elimination of Base Erosion Anti-Abuse Tax in the U.S., recorded in 2022.

We anticipate some variability in the tax rate quarter to quarter from potential discrete items.

For additional discussion of income taxes and the effective income tax rate, see Note 11 to the Condensed Consolidated Financial Statements.

Noncontrolling Interest in Subsidiaries' Earnings and Net Income Attributable to Otis Worldwide Corporation

 Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Noncontrolling interest in subsidiaries' earnings$19$26$71$95
Net income attributable to Otis Worldwide Corporation$376$324$1,083$956

Noncontrolling interest in subsidiaries' earnings were $(7) million lower for the quarter ended September 30, 2023, compared to the same period in 2022, primarily driven by the impacts of foreign exchange and net income from non-wholly owned subsidiaries. Ownership interest in the underlying non-wholly owned subsidiaries has remained generally consistent year-over-year.

Noncontrolling interest in subsidiaries' earnings were $(24) million lower for the nine months ended September 30, 2023, compared to the same period in 2022, primarily driven by Otis' increased ownership in Otis Mobility (formerly Zardoya Otis) starting in the second quarter of 2022, as well as impacts of foreign exchange and net income from non-wholly owned subsidiaries. For details on the results of the Tender Offer and purchases of shares of Otis Mobility not previously owned by the Company, see Note 1 of the Company's audited consolidated financial statements and notes thereto included in our 2022 Form 10-K.

Net income attributable to Otis Worldwide Corporation increased for the quarter and nine months ended September 30, 2023, compared to the same periods in 2022, due to higher operating profit (including the impact of foreign exchange rates), lower noncontrolling interest in subsidiaries' earnings, and a lower effective tax rate.

35
Segment Review

Summary performance for our operating segments for the quarters ended September 30, 2023 and 2022 was as follows:

Net SalesOperating ProfitOperating Profit Margin
(dollars in millions)202320222023202220232022
New Equipment$1,435 $1,447 $94 $100 6.6 %6.9 %
Service2,088 1,897 507 446 24.3 %23.5 %
Total segment3,523 3,344 601 546 17.1 %16.3 %
General corporate expenses and other— — (30)(17)——
Total$3,523 $3,344 $571 $529 16.2 %15.8 %

Summary performance for our operating segments for the nine months ended September 30, 2023 and 2022 was as follows:

Net SalesOperating ProfitOperating Profit Margin
(dollars in millions)202320222023202220232022
New Equipment$4,346 $4,403 $277 $292 6.4 %6.6 %
Service6,243 5,843 1,475 1,328 23.6 %22.7 %
Total segment10,589 10,246 1,752 1,620 16.5 %15.8 %
General corporate expenses and other— — (88)(78)——
Total$10,589 $10,246 $1,664 $1,542 15.7 %15.0 %
New Equipment

The New Equipment segment designs, manufactures, sells and installs a wide range of passenger and freight elevators, as well as escalators and moving walkways in residential and commercial buildings and infrastructure projects. Our New Equipment customers include real-estate and building developers and general contractors that develop and/or design buildings for residential, infrastructure, commercial, retail or mixed-use activity. We sell directly to customers as well as through agents and distributors. We also sell New Equipment to government agencies to support infrastructure projects, such as airports, railways or metros.

Summary performance for New Equipment for the quarters and nine months ended September 30, 2023 and 2022 was as follows:

 Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)20232022ChangeChange20232022ChangeChange
Net sales$1,435$1,447 $(12)(0.8)%$4,346$4,403 $(57)(1.3)%
Cost of sales1,1951,208 (13)(1.1)%3,6213,689 (68)(1.8)%
240239 10.4 %725714 11 1.5 %
Operating expenses146139 75.0 %448422 26 6.2 %
Operating profit$94$100 $(6)(6.0)%$277$292 $(15)(5.1)%
Operating profit margin6.6 %6.9 %6.4 %6.6 %

36
Summary analysis of the Net sales change for New Equipment for the quarter and nine months ended September 30, 2023 compared with the quarter and nine months ended September 30, 2022 was as follows:

Components of Net sales change:
Quarter Ended September 30, 2023
Nine Months Ended September 30, 2023
Organic volume 1.0 %3.6 %
Foreign currency translation(0.9)%(3.0)%
Acquisitions and divestitures, net and other(0.9)%(1.9)%
Total % change(0.8)%(1.3)%

Quarter Ended September 30, 2023

Net sales

The organic sales increase of 1.0% was driven by high-single digit organic sales growth in Americas and EMEA, partially offset by mid-single digit organic sales decline in Asia.

The decrease in Net sales due to Acquisitions and divestitures, net and other is primarily the result of the sale of our Russia business in the third quarter of 2022.

Operating profit

New Equipment operating profit decreased $(6) million including foreign exchange headwinds of ($9) million with volume relatively flat. Favorable price, improved productivity and commodity tailwinds more than offset regional and product mix headwinds and higher selling, general and administrative costs. Operating profit was also impacted by higher restructuring costs. Operating margin decreased 30 basis points.

Nine Months Ended September 30, 2023

Net sales

The organic sales increase of 3.6% was driven by high-single digit organic sales growth in EMEA, mid-single digit organic sales growth in Americas and low-single digit organic sales growth in Asia.

The decrease in Net sales due to Acquisitions and divestitures, net and other is primarily the result of the sale of our Russia business in the third quarter of 2022.

Operating profit

New Equipment operating profit decreased $(15) million including $(23) million of foreign exchange headwinds. Higher volume, favorable price, improved productivity and commodity tailwinds were partially offset by regional and product mix headwinds and higher selling, general and administrative costs. Operating margin decreased 20 basis points.

Service

The Service segment performs maintenance and repair services for both our products, and those of other manufacturers, and provides modernization services to upgrade elevators and escalators. Maintenance services include inspections to ensure code compliance, preventive maintenance offerings and other customized maintenance offerings tailored to meet customer needs, as well as repair services that address equipment and component wear and tear, and breakdowns. Modernization services enhance equipment operation and improve building functionality. Modernization offerings can range from relatively simple upgrades of interior finishes and aesthetics, to complex upgrades of larger components and sub-systems. Our typical Service customers include building owners, facility managers, housing associations and government agencies that operate buildings where elevators and escalators are installed.

37
Summary performance for Service for the quarters and nine months ended September 30, 2023 and 2022 was as follows:

 Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)20232022ChangeChange20232022ChangeChange
Net sales$2,088$1,897$191 10.1 %$6,243$5,843$400 6.8 %
Cost of sales1,2821,165117 10.0 %3,8433,597246 6.8 %
80673274 10.1 %2,4002,246154 6.9 %
Operating expenses29928613 4.5 %9259187 0.8 %
Operating profit$507$446$61 13.7 %$1,475$1,328$147 11.1 %
Operating profit margin24.3 %23.5 %23.6 %22.7 %

Summary analysis of Service Net sales change for the quarter and nine months ended September 30, 2023 compared with the quarter and nine months ended September 30, 2022 was as follows:

Components of Net sales change:
Quarter Ended September 30, 2023
Nine Months Ended September 30, 2023
Organic volume 8.4 %8.0 %
Foreign currency translation1.8 %(1.3)%
Acquisitions and divestitures, net(0.1)%0.1 %
Total % change10.1 %6.8 %

Quarter Ended September 30, 2023

Net sales

The organic sales increase of 8.4% is due to organic sales increases in maintenance and repair of 8.6% and in modernization of 7.6%.

Components of Net sales change:Maintenance and RepairModernization
Organic volume 8.6 %7.6 %
Foreign currency translation2.0 %0.9 %
Acquisitions and divestitures, net(0.2)%0.3 %
Total % change10.4 %8.8 %

Operating profit

Service operating profit increased $61 million with higher volume of $53 million and foreign exchange tailwinds of $13 million. Improved pricing on maintenance contracts and productivity offset by higher restructuring costs, as well as annual wage increases and other inflationary pressures, including higher material costs. Operating margin increased 80 basis points.

38
Nine Months Ended September 30, 2023

Net sales

The organic sales increase of 8.0% is due to organic sales increases in maintenance and repair of 8.2% and in modernization of 7.3%.

Components of Net sales change:Maintenance and RepairModernization
Organic volume8.2 %7.3 %
Foreign currency translation(1.2)%(1.7)%
Acquisitions and divestitures, net— %0.7 %
Total % change7.0 %6.3 %

Operating profit

Service operating profit increased $147 million with higher volume of $156 million partially offset by foreign exchange headwinds of $(9) million. Improved pricing on maintenance contracts and productivity offset annual wage increases and other inflationary pressures, including higher material costs. Operating margin increased 90 basis points.

General Corporate Expenses and Other
Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
General corporate expenses and other$(30)$(17)$(88)$(78)

General corporate expenses and other for the quarter and nine months ended September 30, 2023 increased $13 million and $10 million, respectively, compared to the same periods in 2022, primarily due to the impact of foreign currency mark-to-market adjustments, UpLift transformation costs of $4 million and higher corporate costs, partially offset by the absence of the loss on the sale of our Russia business and related charges of $6 million and $24 million when compared to the same periods in 2022, respectively.


39
LIQUIDITY AND FINANCIAL CONDITION

(dollars in millions)September 30, 2023December 31, 2022
Cash and cash equivalents$1,636 $1,189 
Total debt7,407 6,768 
Net debt (total debt less cash and cash equivalents)5,771 5,579 
Total equity(4,733)(4,799)
Total capitalization (total debt plus total equity)2,674 1,969 
Net capitalization (total debt plus total equity less cash and cash equivalents)1,038 780 
Total debt to total capitalization277 %344 %
Net debt to net capitalization556 %715 %

As of September 30, 2023, we had cash and cash equivalents of approximately $1.6 billion, of which approximately 64% was held by the Company's foreign subsidiaries. Domestic cash and cash equivalents as of September 30, 2023 includes amounts that will be used to fund the repayment at maturity of the €500 million 0.000% notes due November 12, 2023. We manage our worldwide cash requirements by reviewing available funds among the many subsidiaries through which we conduct our business and the cost-effectiveness with which those funds can be accessed. On occasion, we are required to maintain cash deposits with certain banks with respect to contractual obligations related to acquisitions and divestitures or other legal obligations. As of September 30, 2023 and December 31, 2022, the amount of such restricted cash was approximately $5 million and $6 million, respectively.

From time-to-time we may need to access the capital markets to obtain financing. We may incur indebtedness or issue equity as needed. Although we believe that the arrangements in place as of September 30, 2023 permit us to finance our operations on acceptable terms and conditions, our access to, and the availability of, financing on acceptable terms and conditions in the future could be impacted by many factors, including (1) our credit ratings or absence of a credit rating, (2) the liquidity of the overall capital markets and (3) the current state of the economy, including tighter credit conditions. There can be no assurance that we will continue to have access to the capital markets on terms acceptable to us.

As of September 30, 2023, we had a revolving credit agreement with various banks providing for a $1.5 billion unsecured, unsubordinated five-year revolving credit facility. As of September 30, 2023, there were no borrowings under the revolving credit agreement. The undrawn portion of the revolving credit agreement serves as a backstop for the issuance of commercial paper.

On August 16, 2023, we issued $750 million unsecured, unsubordinated five-year notes due August 16, 2028 (the "Notes") with an interest rate of 5.25%. The net proceeds of the Notes were used to fund the repayment of Otis' commercial paper borrowings and will be used to fund the repayment at maturity of the €500 million 0.000% notes due November 12, 2023, with the remainder used for other general corporate purposes. The Company redeemed the $500 million floating notes originally due in 2023 during the nine months ended September 30, 2022. For additional discussion of borrowings, see Note 7 to the Condensed Consolidated Financial Statements.

The Company does not intend to reinvest certain undistributed earnings of our international subsidiaries that have been previously taxed in the U.S. For the remainder of the Company’s undistributed international earnings, unless tax effective to repatriate, we will continue to permanently reinvest these earnings.

We expect to fund our ongoing operating, investing and financing requirements mainly through cash flows from operations, available liquidity through cash on hand and available bank lines of credit and access to capital markets.

On December 1, 2022, our Board of Directors approved a share repurchase program for up to $2.0 billion of Common Stock, of which approximately $1.4 billion was remaining as of September 30, 2023. Under this program, shares may be purchased on the open market, in privately negotiated transactions, under accelerated share repurchase programs or under plans complying with rules 10b5-1 and 10b-18 under the Securities Exchange Act of 1934, as amended.

40
Cash Flows

The following table reflects the major categories of cash flows. For additional details, see the Condensed Consolidated Statements of Cash Flows.
 Nine Months Ended September 30,
(dollars in millions)20232022
Net cash flows provided by (used in):
Operating activities$1,030 $1,096 
Investing activities(132)62 
Financing activities(418)(3,402)
Effect of foreign exchange rate changes on cash and cash equivalents(34)(191)
Net increase (decrease) in cash and cash equivalents and restricted cash$446 $(2,435)

Operating activities

Cash flows from operating activities primarily represent inflows and outflows associated with our operations. Primary activities include net income from operations adjusted for non-cash transactions, working capital changes and changes in other assets and liabilities.

The year-over-year decrease in net cash provided by operating activities was primarily driven by working capital balances during the periods, including a decrease in Accounts payable in the nine months ended September 30, 2023 compared to an increase the same period in 2022, due to the timing of payments to suppliers and higher balances due as of December 31, 2022 compared to December 31, 2021, as well as a smaller inflow from net Contract assets and liabilities, current in the nine months ended September 30, 2023 compared to the same period in 2022, due to the timing of billings on contracts compared to the progression on current contracts. These were partially offset by the timing of income tax payments and a smaller increase in Inventories in the nine months ended September 30, 2023 compared to the same period in 2022.

During the nine months ended September 30, 2023, net cash provided by operating activities was $1.0 billion. The primary driver of the inflow related to $1.2 billion of net income and changes in Contract assets, current and Contract liabilities, current, net, due to the timing of billings on contracts compared to the progression on current contracts. These were partially offset by an increase in Accounts receivable, net, due to the timing of billings.

During the nine months ended September 30, 2022, net cash provided by operating activities was $1.1 billion. The primary driver of the inflow related to $1.1 billion of net income. An increase in Accounts receivable, net, due to the timing of billings, a decrease in Accrued liabilities due to the timing of payments of employee-related benefits, income taxes and other accruals, and an increase in Inventories to support backlog conversion were partially offset by changes in Contract assets, current and Contract liabilities, current, net, due to the timing of billings on contracts compared to the progression on current contracts and increased Accounts payable due to the timing of payments to suppliers.

Investing activities

Cash flows from investing activities primarily represent inflows and outflows associated with long-term assets, including capital expenditures, investments in businesses and securities, proceeds from the sale of fixed assets and the settlement of derivative contracts.

During the nine months ended September 30, 2023, net cash used in investing activities was $132 million. The primary driver of the outflow related to $96 million of capital expenditures, $27 million of acquisitions of businesses and intangible assets and $21 million of net cash payments from the settlement of derivative instruments.

During the nine months ended September 30, 2022, net cash provided by investing activities was $62 million. The primary drivers of the inflow were $121 million of net cash receipts from the settlement of derivative instruments and $61 million of net proceeds from the sale of our business in Russia in the third quarter of 2022, which were partially offset by $81 million of capital expenditures and $38 million of acquisitions of businesses and intangible assets.

41
As discussed in Note 13 to the Condensed Consolidated Financial Statements, we enter into derivative instruments for risk management purposes. We operate internationally and, in the normal course of business, are exposed to fluctuations in interest rates, foreign exchange rates and commodity prices. These fluctuations can increase the costs of financing, investing and operating the business. We use derivative instruments, including forward contracts and options to manage certain foreign currency and commodity price exposures.

Financing activities

Cash flows from financing activities primarily represent inflows and outflows associated with equity and borrowings. Primary activities include short-term and long-term borrowing activity, paying dividends to shareholders, the repurchase of our Common Stock and dividends or other payments to noncontrolling interests.

During the nine months ended September 30, 2023, net cash used in financing activities was $418 million. The primary drivers of the outflow were the repurchases of our Common Stock of $575 million, dividends paid on our Common Stock of $400 million and net repayments of short-term borrowings of $90 million, which were partially offset by $741 million of net proceeds from the issuance of long-term debt. A portion of the proceeds from the long-term debt issuance will be used to fund the repayment at maturity of the €500 million 0.000% notes due November 12, 2023.

During the nine months ended September 30, 2022, net cash used in financing activities was $3.4 billion. The primary drivers of the outflow were the settlement in cash of the tender offer for shares of Zardoya Otis not previously owned (the "Tender Offer") for $1.8 billion, repurchases of our Common Stock of $700 million, repayments of long-term debt of $500 million and dividends paid on our Common Stock of $345 million.

For additional discussion of the Tender Offer, see Note 1 of the Company's audited consolidated financial statements and notes thereto included in our 2022 Form 10-K. For additional discussion of borrowing activity, see Note 7 to the Condensed Consolidated Financial Statements.
42
Guaranteed Securities: Summarized Financial Information

The following information is provided in compliance with Rule 13-01 of Regulation S-X under the Securities Exchange Act of 1934, as amended, with respect to the 2023 Euro Notes, the 2026 Euro Notes and the 2031 Euro Notes (together the "Euro Notes"), in each case issued by Highland Holdings S.à r.l. (“Highland”), a private limited liability company (société à responsabilité limitée) incorporated and existing under the laws of the Grand Duchy of Luxembourg ("Luxembourg"). The Euro Notes are fully and unconditionally guaranteed by Otis Worldwide Corporation ("OWC") on an unsecured, unsubordinated basis. Refer to "Note 10: Borrowings and Lines of Credit" in Item 8 in our 2022 Form 10-K, for additional information.

Highland is a wholly-owned, indirect consolidated subsidiary of OWC. OWC is incorporated under the laws of Delaware. As a company incorporated and existing under the laws of Luxembourg, and with its registered office in Luxembourg, Highland is subject to Luxembourg insolvency and bankruptcy laws in the event any insolvency proceedings are initiated against it. Luxembourg bankruptcy law is significantly different from, and may be less favorable to creditors than, the bankruptcy law in effect in the United States and may make it more difficult for creditors to recover the amount they could expect to recover in liquidation under U.S. insolvency and bankruptcy rules.

The Euro Notes are not guaranteed by any of OWC's or Highland's subsidiaries (all OWC subsidiaries other than Highland are referred to herein as "non-guarantor subsidiaries"). Holders of the Euro Notes will have a direct claim only against Highland, as issuer, and OWC, as guarantor.

The following tables set forth the summarized financial information as of and for the nine months ended September 30, 2023 and as of December 31, 2022 of each of OWC and Highland on a standalone basis, which does not include the consolidated impact of the assets, liabilities, and financial results of their subsidiaries except as noted on the tables below, nor does it include any impact of intercompany eliminations as there were no intercompany transactions between OWC and Highland. This summarized financial information is not intended to present the financial position or results of operations of OWC or Highland in accordance with U.S. GAAP.

(dollars in millions)Nine Months Ended September 30, 2023
OWC Statement of Operations - Standalone and Unconsolidated
Revenue$— 
Cost of revenue— 
Operating expenses6 
Income from consolidated subsidiaries97 
Income (loss) from operations excluding income from consolidated subsidiaries(7)
Net income (loss) excluding income from consolidated subsidiaries(86)

(dollars in millions)September 30, 2023December 31, 2022
OWC Balance Sheet - Standalone and Unconsolidated
Current assets (excluding intercompany receivables from non-guarantor subsidiaries)$601 $94 
Current assets (intercompany receivables from non-guarantor subsidiaries)— — 
Noncurrent assets (investments in consolidated subsidiaries)1,236 1,236 
Noncurrent assets (excluding investments in consolidated subsidiaries)42 45 
Current liabilities (intercompany payables to non-guarantor subsidiaries)3,979 3,090 
Current liabilities (excluding intercompany payables to non-guarantor subsidiaries)97 166 
Noncurrent liabilities5,869 5,186 

43
(dollars in millions)Nine Months Ended September 30, 2023
Highland Statement of Operations - Standalone and Unconsolidated
Revenue$— 
Cost of revenue— 
Operating expenses— 
Income from consolidated subsidiaries475 
Income (loss) from operations excluding income from consolidated subsidiaries— 
Net income (loss) excluding income from consolidated subsidiaries(136)

(dollars in millions)September 30, 2023December 31, 2022
Highland Balance Sheet - Standalone and Unconsolidated
Current assets (excluding intercompany receivables from non-guarantor subsidiaries)$— $— 
Current assets (intercompany receivables from non-guarantor subsidiaries)43 195 
Noncurrent assets (investments in consolidated subsidiaries)15,711 12,524 
Noncurrent assets (intercompany receivables from non-guarantor subsidiaries)538 572 
Noncurrent assets (excluding investments in consolidated subsidiaries)— — 
Current liabilities (intercompany payables to non-guarantor subsidiaries)— — 
Current liabilities (excluding intercompany payables to non-guarantor subsidiaries)537 532 
Noncurrent liabilities (excluding intercompany payables to non-guarantor subsidiaries)1,162 1,160 
Noncurrent liabilities (intercompany payables to non-guarantor subsidiaries)3,303 — 

Off-Balance Sheet Arrangements and Contractual Obligations

Item 5 "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our 2022 Form 10-K discloses our off-balance sheet arrangements and contractual obligations. As of September 30, 2023, there have been no material changes to these off-balance sheet arrangements and contractual obligations, outside the ordinary course of business except for those disclosed in "Note 7, Borrowings and Lines of Credit" within Item 1 of this Form 10-Q.

Item 3.    Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes to the Company’s market risk during the quarter and nine months ended September 30, 2023. For a discussion of the Company’s exposure to market risk, refer to the Company’s market risk disclosures set forth in Item 7A "Quantitative and Qualitative Disclosures About Market Risk" in our 2022 Form 10-K.

Item 4.    Controls and Procedures

As required by Rule 13a-15 under the Exchange Act, we carried out an evaluation under the supervision and with the participation of our management, including the President and Chief Executive Officer ("CEO"), the Executive Vice President and Chief Financial Officer ("CFO") and the Vice President and Chief Accounting Officer ("CAO"), of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2023. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives. Based upon our evaluation, our CEO, our CFO and our CAO have concluded that, as of September 30, 2023, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the applicable rules and forms, and that it is accumulated and communicated to our management, including our CEO, our CFO and our CAO, as appropriate, to allow timely decisions regarding required disclosure.

There have been no changes in our internal control over financial reporting during the quarter ended September 30, 2023, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
44
Cautionary Note Concerning Factors That May Affect Future Results

This Form 10-Q contains statements which, to the extent they are not statements of historical or present fact, constitute “forward-looking statements” under the securities laws. From time to time, oral or written forward-looking statements may also be included in other information released to the public. These forward-looking statements are intended to provide management’s current expectations or plans for Otis’ future operating and financial performance, based on assumptions currently believed to be valid. Forward-looking statements can be identified by the use of words such as “believe,” “expect,” “expectations,” “plans,” “strategy,” “prospects,” “estimate,” “project,” “target,” “anticipate,” “will,” “should,” “see,” “guidance,” “outlook,” “medium-term,” “near-term,” “confident,” “goals” and other words of similar meaning in connection with a discussion of future operating or financial performance. Forward-looking statements may include, among other things, statements relating to future sales, earnings, cash flow, results of operations, uses of cash, dividends, share repurchases, tax rates, R&D spend, restructuring actions, including UpLift, credit ratings, net indebtedness and other measures of financial performance or potential future plans, strategies or transactions, or statements that relate to climate change and our intent to achieve certain ESG targets or goals, including operational impacts and costs associated therewith, and other statements that are not historical facts. All forward-looking statements involve risks, uncertainties and other factors that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. For those statements, Otis claims the protection of the safe harbor for forward-looking statements contained in the U.S. Private Securities Litigation Reform Act of 1995. Such risks, uncertainties and other factors include, without limitation:

•the effect of economic conditions in the industries and markets in which Otis and its businesses operate and any changes therein, including financial market conditions, fluctuations in commodity prices, and other inflationary pressures, interest rates and foreign currency exchange rates, levels of end market demand in construction, pandemic health issues (including COVID-19 and variants thereof), natural disasters, whether as a result of climate change or otherwise, and the financial condition of Otis’ customers and suppliers;
•the effect of changes in political conditions in the U.S. and other countries in which Otis and its businesses operate, including the effects of the ongoing conflict between Russia and Ukraine, the recent war in Israel and Gaza, and increased tensions between the U.S. and China, on general market conditions, commodity costs, global trade policies and related sanctions and export controls, and currency exchange rates in the near term and beyond;
•challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services;
•future levels of indebtedness, capital spending and research and development spending;
•future availability of credit and factors that may affect such availability or costs, including credit market conditions and Otis’ capital structure;
•the timing and scope of future repurchases of Otis’ common stock ("Common Stock"), which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash;
•fluctuations in prices and delays and disruption in delivery of materials and services from suppliers, whether as a result of COVID-19, the ongoing conflict between Russia and Ukraine or otherwise;
•cost reduction or containment actions, restructuring costs and related savings and other consequences thereof, including with respect to UpLift;
•new business and investment opportunities;
•the outcome of legal proceedings, investigations and other contingencies;
•pension plan assumptions and future contributions;
•the impact of the negotiation of collective bargaining agreements and labor disputes and labor inflation in the markets in which Otis and its businesses operate globally;
•the effect of changes in tax, environmental, regulatory (including among other things import/export) and other laws and regulations in the U.S. and other countries in which Otis and its businesses operate;
•the ability of Otis to retain and hire key personnel;
•the scope, nature, impact or timing of acquisition and divestiture activity, the integration of acquired businesses into existing businesses and realization of synergies and opportunities for growth and innovation and incurrence of related costs;
•the determination by the Internal Revenue Service and other tax authorities that the distribution or certain related transactions in connection with the Separation should be treated as taxable transactions; and
•our obligations and our disputes that have or may hereafter arise under the agreements we entered into with RTX and Carrier in connection with the Separation.

These and other factors are more fully discussed in the "Notes to Condensed Consolidated Financial Statements" under the headings "Note 1: General" and "Note 16: Contingent Liabilities" and in "Management's Discussion and Analysis of Financial
45
Condition and Results of Operations" in this Form 10-Q and in our 2022 Form 10-K under the headings "Item 1. Business," "Item 1A. Risk Factors," "Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Item 8. Financial Statements and Supplementary Data" under the headings "Note 1: Business Overview" and "Note 22: Contingent Liabilities" and elsewhere in each of these filings. The forward-looking statements speak only as of the date of this report or, in the case of any document incorporated by reference, the date of that document. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. Additional information as to factors that may cause actual results to differ materially from those expressed or implied in the forward-looking statements is disclosed from time to time in our other filings with the SEC.
46
PART II – OTHER INFORMATION

Item 1. Legal Proceedings

See Note 16, "Contingent Liabilities to the Condensed Consolidated Financial Statements" for discussion regarding material legal proceedings.

Except as otherwise noted above, there have been no material developments in legal proceedings. For previously reported information about legal proceedings refer to "Part II - Other Information, Item 1. Legal Proceedings" in our Form 10-Q for the quarters ended March 31, 2023 and June 30, 2023 and Item 3 "Legal Proceedings" in our 2022 Form 10-K.

Item 1A. Risk Factors

Additional information regarding risk factors can be found under "Recent Developments" in the "Business Overview" and "Cautionary Note Concerning Factors That May Affect Future Results" sections of Management's Discussion and Analysis of Financial Condition and Results of Operations in this Form 10-Q.

Except as otherwise noted above, there have been no material changes in the Company's risk factors from those disclosed in Item 1A "Risk Factors," in our 2022 Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities

The following table provides information about our purchases during the quarter ended September 30, 2023 of equity securities that are registered by us pursuant to Section 12 of the Exchange Act.

2023Total Number of Shares Purchased
(thousands)
Average Price Paid per Share (1)
Total Number of Shares Purchased as Part of a Publicly Announced Program
(thousands)		Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program
(dollars in millions)
July 1 - July 3155$90.7955$1,645
August 1 - August 312,06785.792,067$1,468
September 1 - September 3051084.21510$1,425
Total2,632$85.512,632

(1)     Average price paid per share includes any broker commissions associated with the repurchases.

On December 1, 2022, our Board of Directors approved a share repurchase program for up to $2.0 billion of Common Stock. As of September 30, 2023, the maximum dollar value of shares that may yet be purchased under this current program was approximately $1.4 billion. Under this program, shares may be purchased on the open market, in privately negotiated transactions, under accelerated share repurchase programs or under plans complying with Rules 10b5-1 and 10b-18 under the Exchange Act.

Item 5. Other Information

Insider Adoption or Termination of Trading Arrangements

During the fiscal quarter ended September 30, 2023, except for Ms. Marks, our Chair, President and Chief Executive Officer, none of our directors or officers adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Regulation S-K. On July 28, 2023, Ms. Marks adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Under this plan, the shares received by Ms. Marks upon the vesting of the performance stock units ("PSUs") granted to her by the Company on February 5, 2021 (after giving effect to tax withholding and a previous election to defer 50% of the PSU shares earned) will be sold at the market price so long as the
47
Company’s common stock is trading at or above a limit price. The plan will terminate at the close of business on the day the shares become available for sale even if the Company’s common stock is trading below the limit price and the shares are not sold. We expect that the plan will terminate in early February 2024, shortly after the date the PSUs are expected to vest.

The number of shares that may be sold by Ms. Marks upon vesting of the PSUs will depend upon the Company’s achievement of the underlying financial performance goals and the application of a multiplier factor based on our relative total shareowner return over the 2021-2023 performance period, and can range from 0 to 200% of the sum of the target PSUs granted plus additional PSUs credited for dividend equivalents. Ms. Marks was granted 65,355 “target” PSUs on February 5, 2021. However, because Ms. Marks previously elected to defer receipt of 50% of the PSUs to be earned under our PSU Deferral Plan, the number of shares delivered to her at vesting and available for sale will be accordingly reduced. Assuming the shares are sold under the plan, we estimate, based on our projected performance against the underlying financial performance goals, our relative total shareholder return through the last trading day of the quarter ending September 30, 2023, current tax withholding rates, future crediting of dividend equivalents assuming our current dividend remains unchanged and a stock price of $80.31 (the closing price of our stock on the last trading day of the quarter ending September 30, 2023), and Ms. Marks election to defer 50% of the PSUs, that 37,080 shares could be sold under the plan.

Item 6. Exhibits

Exhibit
Number		Exhibit Description
4.1
15
31.1
31.2
31.3
32
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.*
101.SCHXBRL Taxonomy Extension Schema Document.*
101.CALXBRL Taxonomy Extension Calculation Linkbase Document.*
101.DEFXBRL Taxonomy Extension Definition Linkbase Document.*
101.LABXBRL Taxonomy Extension Label Linkbase Document.*
101.PREXBRL Taxonomy Extension Presentation Linkbase Document.*
104Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.

Notes to Exhibits List:

*    Submitted electronically herewith.

Attached as Exhibit 101 to this report are the following formatted in XBRL (Extensible Business Reporting Language): (i) Condensed Consolidated Statements of Operations for the quarters and nine months ended September 30, 2023 and 2022, (ii) Condensed Consolidated Statements of Comprehensive Income for the quarters and nine months ended September 30, 2023 and 2022, (iii) Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022, (iv) Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2023 and 2022, (v) Condensed Consolidated Statements of Changes in Equity for the quarters and nine months ended September 30, 2023 and 2022 and (vi) Notes to Condensed Consolidated Financial Statements.
48
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

OTIS WORLDWIDE CORPORATION
(Registrant)
Dated:October 26, 2023by:/s/ ANURAG MAHESHWARI
Anurag Maheshwari
Executive Vice President and Chief Financial Officer
(on behalf of the Registrant and as the Registrant's Principal Financial Officer)
Dated:October 26, 2023by:/s/ MICHAEL P. RYAN
Michael P. Ryan
Vice President and Chief Accounting Officer
(on behalf of the Registrant and as the Registrant's Principal Accounting Officer)

49

Exhibit 15




October 26, 2023


Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549

Commissioners:

We are aware that our report dated October 26, 2023 on our review of interim financial information of Otis Worldwide Corporation, which appears in this Quarterly Report on Form 10-Q, is incorporated by reference in the Registration Statements on Form S-3 (Nos. 333-270830 and 333-270834) and Form S-8 (No. 333-237551) of Otis Worldwide Corporation.



Very truly yours,

/s/ PricewaterhouseCoopers LLP

Hartford, Connecticut



Exhibit 31.1
CERTIFICATION
I, Judith F. Marks, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Otis Worldwide Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.    The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:October 26, 2023 
/s/ JUDITH F. MARKS
 Judith F. Marks
 Chair, President and Chief Executive Officer



Exhibit 31.2
CERTIFICATION
I, Anurag Maheshwari, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Otis Worldwide Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.    The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.     All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.     Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:October 26, 2023 
/s/ ANURAG MAHESHWARI
 Anurag Maheshwari
 Executive Vice President and Chief Financial Officer



Exhibit 31.3
CERTIFICATION
I, Michael P. Ryan, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Otis Worldwide Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.    The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:October 26, 2023 
/s/ MICHAEL P. RYAN
 
Michael P. Ryan
 Vice President and Chief Accounting Officer



Exhibit 32
Section 1350 Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Otis Worldwide Corporation, a Delaware corporation (the “Corporation”), does hereby certify that:

The Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 (the “Form 10-Q”) of the Corporation fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Corporation.


 
Date:October 26, 2023
/s/ JUDITH F. MARKS
Judith F. Marks
Chair, President and Chief Executive Officer
Date:October 26, 2023
/s/ ANURAG MAHESHWARI
Anurag Maheshwari
Executive Vice President and Chief Financial Officer
Date:October 26, 2023
/s/ MICHAEL P. RYAN
Michael P. Ryan
Vice President and Chief Accounting Officer


v3.23.3
Cover Page - shares
 9 Months Ended
Sep. 30, 2023
Oct. 16, 2023
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2023  
Document Transition Report false  
Entity File Number 001-39221  
Entity Registrant Name OTIS WORLDWIDE CORPORATION  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 83-3789412  
Entity Address, Address Line One One Carrier Place  
Entity Address, City or Town Farmington  
Entity Address, State or Province CT  
Entity Address, Postal Zip Code 06032  
City Area Code 860  
Local Phone Number 674-3000  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   409,258,823
Amendment Flag false  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Current Fiscal Year End Date --12-31  
Entity Central Index Key 0001781335  
Common Stock    
Document Information [Line Items]    
Title of 12(b) Security Common Stock ($0.01 par value)  
Trading Symbol OTIS  
Security Exchange Name NYSE  
0.000% Notes due 2023    
Document Information [Line Items]    
Title of 12(b) Security 0.000% Notes due 2023  
Trading Symbol OTIS/23  
Security Exchange Name NYSE  
0.318% Notes due 2026    
Document Information [Line Items]    
Title of 12(b) Security 0.318% Notes due 2026  
Trading Symbol OTIS/26  
Security Exchange Name NYSE  
0.934% Notes due 2031    
Document Information [Line Items]    
Title of 12(b) Security 0.934% Notes due 2031  
Trading Symbol OTIS/31  
Security Exchange Name NYSE  
v3.23.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Net sales:        
Revenues $ 3,523 $ 3,344 $ 10,589 $ 10,246
Costs and expenses:        
Research and development 36 37 107 112
Selling, general and administrative 452 417 1,386 1,315
Costs and expenses 2,965 2,827 8,957 8,713
Other income (expense), net 13 12 32 9
Operating profit 571 529 1,664 1,542
Non-service pension cost (benefit) 0 1 1 2
Interest expense (income), net 39 35 109 107
Net income before income taxes 532 493 1,554 1,433
Income tax expense 137 143 400 382
Net income 395 350 1,154 1,051
Less: Noncontrolling interest in subsidiaries' earnings 19 26 71 95
Net income attributable to Otis Worldwide Corporation $ 376 $ 324 $ 1,083 $ 956
Earnings per share (Note 2):        
Basic (in usd per share) $ 0.92 $ 0.77 $ 2.62 $ 2.27
Diluted (in usd per share) $ 0.91 $ 0.77 $ 2.60 $ 2.25
Weighted average number of shares outstanding:        
Basic shares (in shares) 410,800,000 418,500,000 412,600,000 421,300,000
Diluted shares (in shares) 413,700,000 421,200,000 415,800,000 424,300,000
Product sales        
Net sales:        
Revenues $ 1,435 $ 1,447 $ 4,346 $ 4,403
Costs and expenses:        
Cost of products and services sold 1,195 1,208 3,621 3,689
Service sales        
Net sales:        
Revenues 2,088 1,897 6,243 5,843
Costs and expenses:        
Cost of products and services sold $ 1,282 $ 1,165 $ 3,843 $ 3,597
v3.23.3
Condensed Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Statement of Comprehensive Income [Abstract]        
Net income $ 395 $ 350 $ 1,154 $ 1,051
Other comprehensive income (loss), net of tax:        
Foreign currency translation adjustments 33 151 (71) 56
Pension and postretirement benefit plan adjustments 0 2 0 6
Change in unrealized cash flow hedging 2 (4) (1) (4)
Other comprehensive income (loss), net of tax 35 149 (72) 58
Comprehensive income (loss), net of tax 430 499 1,082 1,109
Less: Comprehensive (income) loss attributable to noncontrolling interest (13) (7) (55) 30
Comprehensive income attributable to Otis Worldwide Corporation $ 417 $ 492 $ 1,027 $ 1,139
v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 1,636 $ 1,189
Accounts receivable (net of allowance for expected credit losses of $126 and $152) 3,455 3,357
Contract assets 733 664
Inventories 624 617
Other current assets 301 316
Total Current Assets 6,749 6,143
Future income tax benefits 290 285
Fixed assets (net of accumulated depreciation of $1,196 and $1,151) 708 719
Operating lease right-of-use assets 417 449
Intangible assets, net 336 369
Goodwill 1,547 1,567
Other assets 343 287
Total Assets 10,390 9,819
Liabilities and Equity (Deficit)    
Short-term borrowings and current portion of long-term debt 585 670
Accounts payable 1,655 1,717
Accrued liabilities 1,725 1,794
Contract liabilities 2,784 2,662
Total Current Liabilities 6,749 6,843
Long-term debt 6,822 6,098
Future pension and postretirement benefit obligations 390 392
Operating lease liabilities 293 315
Future income tax obligations 258 279
Other long-term liabilities 488 556
Total Liabilities 15,000 14,483
Commitments and contingent liabilities (Note 16)
Redeemable noncontrolling interest 123 135
Shareholders' Equity (Deficit):    
Common Stock and additional paid-in capital 198 162
Treasury Stock (2,155) (1,575)
Accumulated deficit (2,183) (2,865)
Accumulated other comprehensive income (loss) (648) (592)
Total Shareholders' Equity (Deficit) (4,788) (4,870)
Noncontrolling interest 55 71
Total Equity (Deficit) (4,733) (4,799)
Total Liabilities and Equity (Deficit) $ 10,390 $ 9,819
v3.23.3
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Accounts receivable, allowance for expected credit losses $ 126 $ 152
Accumulated depreciation $ 1,196 $ 1,151
v3.23.3
Condensed Consolidated Statements of Changes in Equity - USD ($)
$ in Millions
Total
Total Shareholders' (Deficit) Equity
Common Stock and Additional Paid-In Capital
Treasury Stock
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interest
Beginning balance at Dec. 31, 2021 $ (3,144) $ (3,625) $ 119 $ (725) $ (2,256) $ (763) $ 481
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 1,038 956     956   82
Other comprehensive income (loss), net of tax, and foreign currency reclassifications 166 183       183 (17)
Stock-based compensation and Common Stock issued under employee plans 31 31 32   (1)    
Cash dividends declared (345) (345)     (345)    
Repurchase of Common Shares (700) (700)   (700)      
Dividends attributable to noncontrolling interest (80)           (80)
Reclassification of noncontrolling interest to redeemable noncontrolling interest (1,885) (1,482)     (1,482)   (403)
Acquisitions, disposals and other changes 58 69 (17)   86   (11)
Ending balance at Sep. 30, 2022 (4,861) (4,913) 134 (1,425) (3,042) (580) 52
Beginning balance at Dec. 31, 2021 160            
Redeemable Noncontrolling Interest              
Net income 13            
Other comprehensive income (loss), net of tax (108)            
Dividends attributable to noncontrolling interest (11)            
Reclassification of noncontrolling interest to redeemable noncontrolling interest 1,476            
Acquisitions, disposals and other changes (1,402)            
Ending balance at Sep. 30, 2022 128            
Beginning balance at Jun. 30, 2022 (4,888) (4,997) 121 (1,125) (3,245) (748) 109
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 348 324     324   24
Other comprehensive income (loss), net of tax, and foreign currency reclassifications 159 168       168 (9)
Stock-based compensation and Common Stock issued under employee plans 13 13 13        
Cash dividends declared (121) (121)     (121)    
Repurchase of Common Shares (300) (300)   (300)      
Dividends attributable to noncontrolling interest (68)           (68)
Acquisitions, disposals and other changes (4)           (4)
Ending balance at Sep. 30, 2022 (4,861) (4,913) 134 (1,425) (3,042) (580) 52
Beginning balance at Jun. 30, 2022 136            
Redeemable Noncontrolling Interest              
Net income 2            
Other comprehensive income (loss), net of tax (10)            
Ending balance at Sep. 30, 2022 128            
Beginning balance at Dec. 31, 2022 (4,799) (4,870) 162 (1,575) (2,865) (592) 71
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 1,147 1,083     1,083   64
Other comprehensive income (loss), net of tax, and foreign currency reclassifications (63) (56)       (56) (7)
Stock-based compensation and Common Stock issued under employee plans 35 35 36   (1)    
Cash dividends declared (400) (400)     (400)    
Repurchase of Common Shares (580) (580)   (580)      
Dividends attributable to noncontrolling interest (70)           (70)
Acquisitions, disposals and other changes (3)           (3)
Ending balance at Sep. 30, 2023 (4,733) (4,788) 198 (2,155) (2,183) (648) 55
Beginning balance at Dec. 31, 2022 135            
Redeemable Noncontrolling Interest              
Net income 7            
Other comprehensive income (loss), net of tax (9)            
Dividends attributable to noncontrolling interest (9)            
Acquisitions, disposals and other changes (1)            
Ending balance at Sep. 30, 2023 123            
Beginning balance at Jun. 30, 2023 (4,751) (4,852) 183 (1,927) (2,419) (689) 101
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 393 376     376   17
Other comprehensive income (loss), net of tax, and foreign currency reclassifications 39 41       41 (2)
Stock-based compensation and Common Stock issued under employee plans 15 15 15        
Cash dividends declared (139) (139)     (139)    
Repurchase of Common Shares (228) (228)   (228)      
Dividends attributable to noncontrolling interest (61)           (61)
Acquisitions, disposals and other changes (1) (1)     (1)    
Ending balance at Sep. 30, 2023 (4,733) $ (4,788) $ 198 $ (2,155) $ (2,183) $ (648) $ 55
Beginning balance at Jun. 30, 2023 126            
Redeemable Noncontrolling Interest              
Net income 2            
Other comprehensive income (loss), net of tax (4)            
Acquisitions, disposals and other changes (1)            
Ending balance at Sep. 30, 2023 $ 123            
v3.23.3
Condensed Consolidated Statements of Changes in Equity (Parenthetical) - $ / shares
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Statement of Stockholders' Equity [Abstract]        
Cash dividends declared (in usd per share) $ 0.34 $ 0.29 $ 0.97 $ 0.82
v3.23.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Operating Activities:    
Net income $ 1,154 $ 1,051
Adjustments to reconcile net income to net cash flows provided by operating activities, net of acquisitions and dispositions:    
Depreciation and amortization 145 145
Deferred income tax expense (benefit) (34) 6
Stock compensation cost 49 41
Change in operating assets and liabilities:    
Accounts receivable, net (214) (171)
Contract assets and liabilities, current 68 143
Inventories (8) (80)
Other current assets (4) (14)
Accounts payable (35) 137
Accrued liabilities (66) (166)
Pension contributions (32) (28)
Other operating activities, net 7 32
Net cash flows provided by (used in) operating activities 1,030 1,096
Investing Activities:    
Capital expenditures (96) (81)
Acquisitions of businesses and intangible assets, net of cash (27) (38)
Dispositions of businesses, net of cash 0 61
Proceeds from the sale of (investments in) marketable securities (2) (7)
Receipts (payments) on settlements of derivative contracts (21) 121
Other investing activities, net 14 6
Net cash flows provided by (used in) investing activities (132) 62
Financing Activities:    
Net proceeds from (repayments of) borrowings (maturities of 90 days or less) (90) 80
Proceeds from issuance of long-term debt 747 0
Payment of debt issuance costs (6) 0
Repayment of long-term debt 0 (500)
Dividends paid on Common Stock (400) (345)
Repurchases of Common Stock (575) (700)
Dividends paid to noncontrolling interest (76) (107)
Acquisition of Zardoya Otis shares 0 (1,802)
Other financing activities, net (18) (28)
Net cash flows provided by (used in) financing activities (418) (3,402)
Effect of exchange rate changes on cash and cash equivalents (34) (191)
Net increase (decrease) in cash, cash equivalents and restricted cash 446 (2,435)
Cash, cash equivalents and restricted cash, beginning of year 1,195 3,477
Cash, cash equivalents and restricted cash, end of period 1,641 1,042
Less: Restricted cash 5 8
Cash and cash equivalents $ 1,636 $ 1,034
v3.23.3
General
 9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
General General
The Condensed Consolidated Financial Statements as of September 30, 2023 and for the quarters and nine months ended September 30, 2023 and 2022 are unaudited, but in the opinion of management include all adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the results for the interim periods. The Condensed Consolidated Balance Sheet as of December 31, 2022 was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles ("GAAP") in the United States ("U.S."). The results reported in these Condensed Consolidated Financial Statements should not necessarily be taken as indicative of results that may be expected for the entire year. The financial information included herein should be read in conjunction with the Company's annual consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for fiscal year 2022 ("2022 Form 10-K" or "Form 10-K").

Unless the context otherwise requires, references to "Otis," "we," "us," "our" and "the Company" refer to Otis Worldwide Corporation and its subsidiaries.

There have been no changes to the Company's significant accounting policies described in the Company's 2022 Form 10-K that have a material impact on the Company's Condensed Consolidated Financial Statements and the related notes. Certain amounts presented in the prior period have been reclassified to conform to the current period presentation, which are immaterial.

Use of Estimates. The preparation of these Condensed Consolidated Financial Statements and accompanying notes in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ materially from those estimates.

We assessed certain accounting matters that generally require consideration of forecasted financial information in the context of the information reasonably available to us and the unknown future impacts of macroeconomic developments, including inflationary pressures, higher interest rates and tighter credit conditions, as of September 30, 2023 and through the date of this report. The accounting matters assessed included, but were not limited to, our allowance for credit losses, the carrying value of our goodwill and other long-lived assets, financial assets and revenue recognition. While there was not a material impact to our Condensed Consolidated Financial Statements as of September 30, 2023 and for the quarters and nine months ended September 30, 2023 and 2022 resulting from our assessments of these matters, future assessment of our expectations of the magnitude and duration of these macroeconomic developments, as well as other factors, could result in material impacts to our Condensed Consolidated Financial Statements in future reporting periods.

We also assessed certain accounting matters as they relate to the ongoing conflict between Russia and Ukraine and the war in Israel and Gaza, including, but not limited to, our allowance for credit losses, the carrying value of long-lived assets, revenue recognition and the classification of assets. There was not a material impact to our Condensed Consolidated Financial Statements as of September 30, 2023 and for the quarters and nine months ended September 30, 2023 and 2022 resulting from our assessment of these matters. We continue to assess the impact on our results of operations, financial position and overall performance as the situations develop and any broader implications they may have on the global economy.

Supplier Finance Programs. On January 1, 2023, we adopted ASU No. 2022-04, Liabilities - Supplier Finance Programs (Topic 450-50): Disclosure of Supplier Finance Program Obligations that requires entities that use supplier finance programs in connection with the purchase of goods and services to disclose the key terms of the programs and information about obligations outstanding at the end of the reporting period.
Certain Otis subsidiaries participate in supplier finance programs, under which we agree to pay third-party financial institutions the stated amounts of confirmed invoices from suppliers on the original maturity dates of the invoices, while the participating suppliers generally have the ability to sell, or otherwise pledge as collateral, their receivables from the Company to the participating financial institutions. Our obligations to suppliers, including the amounts due and scheduled payment dates, are not impacted by the suppliers' decisions to sell their receivables to the financial institutions, or otherwise pledge their receivables as collateral, under these arrangements. The Company is not a party to the arrangements between the suppliers and the financial institutions, and the Company's payment terms to the financial institutions, including the timing and amount of payments, are based on the original supplier invoices. Based on the applicable supplier agreements, the maturity dates of these supplier invoices can range between 30 and 120 days from the invoice date.

The outstanding obligations confirmed by the Company as valid to the financial institutions under our supplier finance programs were $537 million and $564 million as of September 30, 2023 and December 31, 2022, respectively. These obligations are included in Accounts payable in the Condensed Consolidated Balance Sheets, and all activity related to the obligations is presented within operating activities on the Condensed Consolidated Statements of Cash Flows.

The Company or the financial institutions may terminate the agreements with advanced notice. Otis has pledged no assets in connection with its supplier finance programs.
v3.23.3
Earnings per Share
 9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Earnings per Share Earnings per Share
 Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions, except per share amounts; shares in millions)2023202220232022
Net income attributable to Otis Worldwide Corporation$376 $324 $1,083 $956 
Impact of redeemable noncontrolling interest— — — — 
Net income attributable to common shareholders$376 $324 $1,083 $956 
Basic weighted average number of shares outstanding410.8 418.5 412.6 421.3 
Stock awards and equity units (share equivalent)2.9 2.7 3.2 3.0 
Diluted weighted average number of shares outstanding413.7 421.2 415.8 424.3 
Earnings Per Share of Common Stock:
Basic$0.92$0.77$2.62$2.27
Diluted$0.91$0.77$2.60$2.25

The computation of diluted earnings per share excludes the effect of the potential exercise of stock awards, including stock appreciation rights and stock options, when the average market price of the Common Stock is lower than the exercise price of the related stock awards during the period because the effect would be anti-dilutive. In addition, the computation of diluted earnings per share excludes the effect of the potential exercise of stock awards when the awards' assumed proceeds exceed the average market price of the common shares during the period. There were 1.0 million of anti-dilutive stock awards excluded from the computation for the quarter and nine months ended September 30, 2023, and 2.4 million for the quarter and nine months ended September 30, 2022.
v3.23.3
Revenue Recognition
 9 Months Ended
Sep. 30, 2023
Revenue from Contract with Customer [Abstract]  
Revenue Recognition Revenue Recognition
We account for revenue in accordance with Accounting Standards Codification ("ASC") Topic 606: Revenue from Contracts with Customers.

Contract Assets and Liabilities. Contract assets reflect revenue recognized in advance of customer billing. Contract liabilities are recognized when a customer pays consideration, or we have a right to receive an amount of unconditional consideration, in advance of the satisfaction of performance obligations under the contract. We typically receive progress payments from our customers as we perform our work over time.
Total Contract assets and Contract liabilities as of September 30, 2023 and December 31, 2022 are as follows:

(dollars in millions)September 30, 2023December 31, 2022
Contract assets, current$733 $664 
Total contract assets733 664 
Contract liabilities, current2,784 2,662 
Contract liabilities, non-current (included within Other long-term liabilities)47 52 
Total contract liabilities 2,831 2,714 
Net contract liabilities$2,098 $2,050 

Contract assets increased by $69 million during the nine months ended September 30, 2023 as a result of the progression of current contracts and timing of billing on customer contracts. Contract liabilities increased by $117 million during the nine months ended September 30, 2023 primarily due to billings on contracts in excess of revenue earned.

In the nine months ended September 30, 2023 and 2022, we recognized revenue of $1.8 billion related to contract liabilities as of January 1, 2023 and 2022, respectively.

Remaining Performance Obligations ("RPO"). RPO represents the aggregate amount of total contract transaction price that is unsatisfied or partially unsatisfied. As of September 30, 2023, our total RPO was $17.8 billion. Of the total RPO as of September 30, 2023, we expect approximately 90% will be recognized as sales over the following 24 months.
v3.23.3
Accounts Receivable, Net
 9 Months Ended
Sep. 30, 2023
Receivables [Abstract]  
Accounts Receivable, Net Accounts Receivable, Net
Accounts receivable, net consisted of the following as of September 30, 2023 and December 31, 2022:

(dollars in millions)September 30, 2023December 31, 2022
Trade receivables$3,295 $3,231 
Unbilled receivables123 103 
Miscellaneous receivables100 91 
Customer financing notes receivable63 84 
3,581 3,509 
Less: allowance for expected credit losses126 152 
Accounts receivable, net$3,455 $3,357 

The changes in allowance for expected credit losses related to Accounts receivable, net for the nine months ended September 30, 2023 and 2022, respectively, are as follows:

Nine Months Ended September 30,
(dollars in millions)20232022
Balance as of January 1$152 $175 
Provision for expected credit losses21 4 
Write-offs charged against the allowance for expected credit losses(42)(14)
Foreign exchange and other(5)(9)
Balance as of September 30$126 $156 
v3.23.3
Inventories
 9 Months Ended
Sep. 30, 2023
Inventory Disclosure [Abstract]  
Inventories Inventories
Inventories consisted of the following as of September 30, 2023 and December 31, 2022:

(dollars in millions)September 30, 2023December 31, 2022
Raw materials and work-in-process$162 $166 
Finished goods462 451 
Total$624 $617 

Raw materials, work-in-process and finished goods are net of valuation write-downs of $89 million and $96 million as of September 30, 2023 and December 31, 2022, respectively.
v3.23.3
Business Acquisitions, Disposals, Goodwill and Intangible Assets
 9 Months Ended
Sep. 30, 2023
Business Combinations, Goodwill, and Intangible Assets [Abstract]  
Business Acquisitions, Disposals, Goodwill and Intangible Assets Business Acquisitions, Disposals, Goodwill and Intangible Assets
Business Acquisitions. Our acquisitions of businesses and intangible assets, net of cash, totaled $27 million and $38 million in the nine months ended September 30, 2023 and 2022, respectively, and were primarily in our Service segment. Transaction costs incurred were not considered significant.

Goodwill. Changes in our Goodwill balances during the nine months ended September 30, 2023 were as follows:

(dollars in millions)Balance as of December 31, 2022Goodwill Resulting
from Business Combinations		Foreign Currency
Translation 
and Other
Balance as of
September 30, 2023
New Equipment$292 $— $(5)$287 
Service1,275 6 (21)1,260 
Total$1,567 $6 $(26)$1,547 

Intangible Assets. Intangible assets cost and accumulated amortization were $2,010 million and $1,674 million, respectively, as of September 30, 2023, and $2,026 million and $1,657 million, respectively, as of December 31, 2022.

Amortization of intangible assets for the quarter and nine months ended September 30, 2023 was $17 million and $51 million, respectively, compared to $18 million and $55 million for the same periods in 2022. Excluding the impact of currency translation adjustments, there were no other significant changes in our Intangible assets during the quarters and nine months ended September 30, 2023 and 2022.
Held For Sale Assets and Liabilities. As of September 30, 2023 and December 31, 2022, assets held for sale were $11 million and $9 million, respectively, and are included in Other current assets in the Condensed Consolidated Balance Sheets.

In June 2022, we entered into an agreement to sell our business in Russia to a third party, which was then sold on July 27, 2022. As of June 30, 2022, our operations in Russia, primarily in the New Equipment segment, were classified as assets and liabilities held for sale of $157 million and $136 million, respectively. The Company recorded the loss on sale and related charges of $6 million and $24 million in Other expense (income), net in the Condensed Consolidated Statements of Operations for the quarter and nine months ended September 30, 2022, respectively, including an impairment loss of $18 million related to the net assets held for sale during the nine months ended September 30, 2022.
v3.23.3
Borrowings and Lines of Credit
 9 Months Ended
Sep. 30, 2023
Debt Disclosure [Abstract]  
Borrowings and Lines of Credit Borrowings and Lines of Credit
(dollars in millions)September 30, 2023December 31, 2022
Commercial paper$— $94 
Other borrowings54 45 
Total short-term borrowings$54 $139 
Commercial Paper. As of September 30, 2023, there were no borrowings outstanding under the Company's $1.5 billion commercial paper programs. We use our commercial paper borrowings for general corporate purposes including to finance acquisitions, pay dividends, repurchase shares and for debt refinancing. The need for commercial paper borrowings may arise if the use of domestic cash for general corporate purposes exceeds the sum of domestic cash generation and foreign cash repatriated to the U.S.

For details regarding the Company's short-term borrowing activity in 2022, refer to Note 10 of the Company's audited consolidated financial statements and notes thereto included in our 2022 Form 10-K.

Long-term debt. On March 10, 2023, the Company entered into a new credit agreement ("Credit Agreement") with various banks providing for a $1.5 billion unsecured, unsubordinated five-year revolving credit facility, with an interest rate on US Dollar denominated borrowings at Otis' option of the Term Secured Overnight Financing Rate ("SOFR") plus 0.10% or a base rate, and an interest rate on Euro denominated borrowings at Otis' option of the EURIBO rate or a daily simple Euro Short Term Rate ("ESTR"), plus, in each case, an applicable margin. The applicable margin initially is 1.25% for Term SOFR rate, EURIBO rate and daily simple ESTR rate borrowings, and 0.25% for base rate borrowings, and can fluctuate determined by reference to Otis' public debt ratings, as specified in the Credit Agreement. As of September 30, 2023, there were no borrowings under the Credit Agreement. The undrawn portion of the Credit Agreement serves as a backstop for the issuance of commercial paper. On March 10, 2023, we also terminated all commitments outstanding under the previous credit agreement, which was scheduled to expire on April 3, 2025.

On August 16, 2023, we issued $750 million unsecured, unsubordinated five-year notes due August 16, 2028 (the "Notes") with an interest rate of 5.25%. The net proceeds of the Notes were used to fund the repayment of Otis' commercial paper borrowings and will be used to fund the repayment at maturity of the €500 million 0.000% notes due November 12, 2023, with the remainder used for other general corporate purposes.

As of September 30, 2023, the Company is in compliance with all covenants in the revolving credit agreement and the indentures governing all outstanding long-term debt. Long-term debt consisted of the following:

(dollars in millions)September 30, 2023December 31, 2022
0.000% notes due 2023 (€500 million principal value)
$531 $531 
2.056% notes due 2025
1,300 1,300 
0.37% notes due 2026 (¥21.5 billion principal value)
145 163 
0.318% notes due 2026 (€600 million principal value)
637 638 
2.293% notes due 2027
500 500 
5.250% notes due 2028
750 — 
2.565% notes due 2030
1,500 1,500 
0.934% notes due 2031 (€500 million principal value)
531 531 
3.112% notes due 2040
750 750 
3.362% notes due 2050
750 750 
Other (including finance leases)4 8 
Total principal long-term debt7,398 6,671 
Other (discounts and debt issuance costs)(45)(42)
Total long-term debt7,353 6,629 
Less: current portion531 531 
Long-term debt, net of current portion$6,822 $6,098 

We may redeem any series of notes at our option pursuant to certain terms. For additional details regarding the Company's debt activity in 2022, refer to Note 10 of the Company's audited consolidated financial statements and notes thereto included in our 2022 Form 10-K.
Debt discounts and debt issuance costs are presented as a reduction of debt on the Condensed Consolidated Balance Sheets and are amortized as a component of interest expense over the term of the related debt using the effective interest method. The Condensed Consolidated Statements of Operations for the quarters and nine months ended September 30, 2023 and 2022 reflects the following:

Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Debt issuance costs amortization$2 $1 $5 $6 
Total interest expense on external debt38 35 105 106 

The unamortized debt issuance costs as of September 30, 2023 and December 31, 2022 were $43 million and $42 million, respectively.

The weighted average maturity of our long-term debt as of September 30, 2023 is approximately 7.5 years. The weighted average interest expense rate on our borrowings outstanding as of September 30, 2023 and December 31, 2022 was as follows:

September 30, 2023December 31, 2022
Short-term commercial paper—%4.7%
Total long-term debt2.3%2.0%

The weighted average interest expense rate on our borrowings during the quarters and nine months ended September 30, 2023 and 2022 was as follows:

Quarter Ended September 30,Nine Months Ended September 30,
2023202220232022
Short-term commercial paper5.4%2.5%5.0%1.3%
Total long-term debt2.1%2.0%2.0%2.0%
v3.23.3
Employee Benefit Plans
 9 Months Ended
Sep. 30, 2023
Retirement Benefits [Abstract]  
Employee Benefit Plans Employee Benefit Plans
Pension and Postretirement Plans. The Company sponsors both funded and unfunded domestic and foreign defined benefit pension and other postretirement benefit plans, and defined contribution plans. Contributions to our plans were as follows:

 Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Defined benefit plans$8 $7 $32 $28 
Defined contribution plans16 14 50 49 
Multi-employer pension and postretirement plans42 40 117 101 

The following table illustrates the components of net periodic benefit cost for the Company's defined benefit pension plans:

 Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Service cost$7 $10 $22 $30 
Interest cost8 4 24 13 
Expected return on plan assets(8)(8)(24)(21)
Recognized actuarial net loss— 3 — 8 
Net settlement and curtailment (gain) loss— 1 — 1 
Total net periodic benefit cost$7 $10 $22 $31 
Postretirement Benefit Plans. The Company sponsors postretirement benefit plans that provide health benefits to eligible retirees. The postretirement plans are unfunded. The net periodic benefit cost was less than $1 million for the quarters and nine months ended September 30, 2023 and 2022, respectively.
Stock-based Compensation. The Company adopted the 2020 Long-Term Incentive Plan (the "Plan") effective April 3, 2020. As of September 30, 2023, approximately 23 million shares remain available for awards under the Plan.

Stock-based Compensation Expense

The Company measures the cost of all share-based payments, including stock options, at fair value on the grant date and recognizes this cost in the Condensed Consolidated Statements of Operations over the award's applicable vesting period. A forfeiture rate assumption is applied on grant date to adjust the expense recognition for awards that are not expected to vest.

Stock-based compensation expense and the resulting tax benefits were as follows:

Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Stock-based compensation expense (Share Based)$15 $13 $49 $41 
Stock-based compensation expense (income) (Liability Awards)— — — (1)
Total gross stock-based compensation expense15 13 49 40 
Less: future tax benefit2 2 6 5 
Stock-based compensation expense, net of tax$13 $11 $43 $35 

As of September 30, 2023, following our annual grant issuance on February 7, 2023, there was approximately $76 million of total unrecognized compensation cost related to non-vested equity awards granted under the Plan. This cost is expected to be recognized ratably over a weighted-average period of 1.9 years.
v3.23.3
Stock
 9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Stock Stock
Preferred Stock. There are 125 million shares of $0.01 par value Preferred Stock authorized, of which none were issued as of September 30, 2023 and December 31, 2022.

Common Stock. There are 2 billion shares of $0.01 par value Common Stock authorized. As of September 30, 2023, 436.9 million shares of Common Stock were issued, which includes 27.6 million shares of Treasury Stock. As of December 31, 2022, 435.6 million shares of Common Stock were issued, which included 20.8 million shares of Treasury Stock.

Treasury Stock. As of September 30, 2023, the Company was authorized by the Board of Directors to purchase up to $2.0 billion of Common Stock under a share repurchase program, of which approximately $1.4 billion was remaining at such time.

During the quarter and nine months ended September 30, 2023, the Company repurchased 2.6 million and 6.8 million shares, respectively, for $225 million and $575 million, respectively, compared to 3.8 million and 9.1 million shares in the same periods of 2022 for $300 million and $700 million, respectively. Beginning January 1, 2023, share repurchases in excess of issuances are subject to a 1% excise tax, which is included as part of the cost basis of the shares acquired in Treasury Stock on the Condensed Consolidated Balance Sheets as of September 30, 2023.

The Company's share repurchase program does not obligate it to acquire any specific number of shares. Under this program, shares may be purchased in the open market, in privately negotiated transactions, under accelerated share repurchase programs or under plans complying with Rules 10b5-1 and 10b-18 under the Securities Exchange Act of 1934, as amended (the "Exchange Act").
v3.23.3
Accumulated Other Comprehensive Income (Loss)
 9 Months Ended
Sep. 30, 2023
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss)
A summary of the changes in each component of Accumulated other comprehensive income (loss), net of tax, for the quarters and nine months ended September 30, 2023 and 2022 is provided below:
(dollars in millions)Foreign
Currency
Translation		Defined Benefit
Pension and
Postretirement
Plans		Unrealized
Hedging Gains
(Losses)		Accumulated
Other
Comprehensive
Income (Loss)
Quarter Ended September 30, 2023
Balance as of June 30, 2023$(681)$(8)$— $(689)
Other comprehensive income (loss) before reclassifications, net39 — 1 40 
Amounts reclassified, pre-tax— — 1 1 
Tax benefit reclassified— — — — 
Balance as of September 30, 2023$(642)$(8)$2 $(648)
Nine Months Ended September 30, 2023
Balance as of December 31, 2022$(587)$(8)$3 $(592)
Other comprehensive income (loss) before reclassifications, net(56)— (7)(63)
Amounts reclassified, pre-tax1 — 8 9 
Tax benefit reclassified— — (2)(2)
Balance as of September 30, 2023$(642)$(8)$2 $(648)

(dollars in millions)Foreign
Currency
Translation		Defined Benefit
Pension and
Postretirement
Plans		Unrealized
Hedging Gains
(Losses)		Accumulated
Other
Comprehensive
Income (Loss)
Quarter Ended September 30, 2022
Balance as of June 30, 2022$(631)$(124)$7 $(748)
Other comprehensive income (loss) before reclassifications, net93 — (5)88 
Amounts reclassified, pre-tax77 3 1 81 
Tax benefit reclassified— (1)— (1)
Balance as of September 30, 2022$(461)$(122)$3 $(580)
Nine Months Ended September 30, 2022
Balance as of December 31, 2021$(642)$(128)$7 $(763)
Other comprehensive income (loss) before reclassifications, net173 — (2)171 
Amounts reclassified upon change in Otis' share of Zardoya Otis ownership(69)— — (69)
Amounts reclassified, pre-tax77 8 (2)83 
Tax benefit reclassified— (2)— (2)
Balance as of September 30, 2022$(461)$(122)$3 $(580)

Amounts reclassified that relate to defined benefit pension and postretirement plans include amortization of prior service costs and actuarial net losses recognized during each period presented. These costs are recorded as components of net periodic pension cost for each period presented. See Note 8, "Employee Benefit Plans" for additional information.

Amounts reclassified that relate to foreign currency translation in the quarter and nine months ended September 30, 2022 are related to our Russia business sold during the quarter ended September 30, 2022. See Note 6, "Business Acquisitions, Dispositions, Goodwill and Intangible Assets" for additional information regarding the sale of our Russia business.
v3.23.3
Income Taxes
 9 Months Ended
Sep. 30, 2023
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The decrease in the effective tax rate for the quarter ended September 30, 2023, is primarily due to a reduction in the deferred tax liability related to repatriation of foreign earnings, reversal of tax reserves related to the U.S. foreign tax credit regulations, and the closure of a foreign tax audit.

The decrease in the effective tax rate for the nine months ended September 30, 2023 is due to a lower forecasted tax cost on repatriation in 2023. This is partially offset by the absence of a tax reserve release related to a forward transfer pricing agreement with a European tax authority and the elimination of Base Erosion Anti-Abuse Tax in the U.S., recorded in 2022.

Otis conducts business globally and, as a result, Otis or one or more of its subsidiaries files income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. In the ordinary course of business, Otis could be subject to examination by taxing authorities throughout the world, including such major jurisdictions as Austria, Belgium, Brazil, Canada, China, France, Germany, Hong Kong, India, Italy, Japan, Mexico, Netherlands, Portugal, South Korea, Spain, Switzerland, the United Kingdom, and the United States. With a few exceptions, Otis is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations for years before 2010.

A subsidiary of Otis engaged in tax-related litigation in Belgium received a favorable appellate court decision in 2018. The Belgian tax authorities appealed the decision to the Court of Cassation (the equivalent of the Supreme Court in Belgium). On December 4, 2020, the Court of Cassation overturned the decision of the appellate court and remanded the case to the appellate court for reconsideration. Following a hearing on March 20, 2023, the Antwerp Appellate Court ruled against the Company. Otis has decided not to appeal the decision, which marks the end of this litigation. Otis expects to receive the assessment for tax and interest in the quarter ending December 31, 2023. The associated tax and interest have been fully reserved and are included in the range below.

In the ordinary course of business, there is inherent uncertainty in quantifying our income tax positions. We assess our income tax positions and record tax benefits for all years subject to examination based upon management’s evaluation of the facts, circumstances, and information available at the reporting date. The evaluation considers any additional worldwide uncertain tax positions, the closure of tax statutes or the re-valuation of current uncertain tax positions arising from the issuance of legislation, regulatory or other guidance or developments in examinations, in appeals, or in the courts. Based on the preceding factors, it is reasonably possible that within the next 12 months unrecognized tax benefits could change within the range of a $10 million increase to a $330 million decrease and associated interest could change within the range of a $5 million increase to a $140 million decrease.

See Note 16, “Contingent Liabilities” for discussion regarding uncertain tax positions, included in the above range, related to pending litigation with respect to certain deductions claimed in Germany.
v3.23.3
Restructuring and Transformation Costs
 9 Months Ended
Sep. 30, 2023
Restructuring and Related Activities [Abstract]  
Restructuring and Transformation Costs Restructuring and Transformation Costs
We initiate restructuring actions to keep our cost structure competitive. Charges generally arise from severance related to workforce reductions, and to a lesser degree, facility exit and lease termination costs associated with the consolidation of office and manufacturing operations.

During the quarter ended September 30, 2023, we announced the UpLift program to transform our operating model. The program will include, among other aspects, the standardization of our processes and improving our supply chain procurement, as well as restructuring actions. During the quarter and nine months ended September 30, 2023, we incurred $4 million of incremental non-restructuring costs associated with the program ("transformation costs"), including consulting and personnel costs, which were recorded in Other income (expense), net in the Condensed Consolidated Statements of Operations. There were no UpLift restructuring actions initiated in the nine months ended September 30, 2023. See Note 19, "Subsequent Events," for discussion regarding UpLift restructuring actions approved following period-end.
During the quarters and nine months ended September 30, 2023 and 2022, we recorded restructuring costs for new and ongoing restructuring actions as follows:

Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
New Equipment$10 $2 $15 $18 
Service11 4 21 27 
Total $21 $6 $36 $45 

Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Cost of products and services sold$9 $2 $11 $16 
Selling, general and administrative12 4 25 29 
Total $21 $6 $36 $45 

The restructuring expenses incurred during the quarter and nine months ended September 30, 2023 and 2022, were primarily the result of restructuring programs initiated during 2023 and 2022. We are targeting to complete by the end of 2024 the majority of remaining restructuring actions initiated in the quarter and nine months ended September 30, 2023 and the full year 2022, with certain utilization beyond 2023 due to legal requirements in the applicable jurisdictions. Expected total costs for the restructuring actions initiated are $120 million, including $43 million to New Equipment and $77 million to Service operating segments, respectively. Remaining costs to incur for the restructuring actions initiated are expected to be $28 million, including $6 million to New Equipment and $22 million to Service operating segments, respectively.

The following table summarizes the accrual balance and utilization for restructuring actions, which are primarily for severance costs and most will require cash payment:

(dollars in millions)
Restructuring accruals as of December 31, 2022$41 
Net restructuring costs36 
Utilization, foreign exchange and other costs(35)
Balance as of September 30, 2023$42 
v3.23.3
Financial Instruments
 9 Months Ended
Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Financial Instruments Financial Instruments
We enter into derivative instruments primarily for risk management purposes, including derivatives designated as hedging instruments under ASC 815, Derivatives and Hedging. We operate internationally and, in the normal course of business, are exposed to fluctuations in interest rates, commodity prices and foreign exchange rates. These fluctuations can increase the costs of financing, investing in and operating the business. We may use derivative instruments, including swaps, forward contracts and options, to manage certain foreign currency, commodity price and interest rate exposures.

The four-quarter average of the notional amount of foreign exchange contracts hedging foreign currency transactions was $4.3 billion and $3.9 billion as of September 30, 2023 and December 31, 2022, respectively. The four-quarter average of the notional amount of contracts hedging commodity purchases was $24 million and $20 million as of September 30, 2023 and December 31, 2022, respectively.
The following table summarizes the fair value and presentation on the Condensed Consolidated Balance Sheets for derivative instruments as of September 30, 2023 and December 31, 2022:

(dollars in millions)Balance Sheet ClassificationSeptember 30, 2023December 31, 2022
Derivatives designated as Cash flow hedging instruments:
Asset Derivatives:
Foreign exchange contractsOther current assets$2 $3 
Foreign exchange contractsOther assets3 2 
Total asset derivatives$5 $5 
Liability Derivatives:
Foreign exchange contractsAccrued liabilities$(3)$(4)
Commodity contractsAccrued liabilities— (1)
Foreign exchange contractsOther long-term liabilities(1)— 
Total liability derivatives$(4)$(5)
Derivatives not designated as Cash flow hedging instruments:
Asset Derivatives:
Foreign exchange contractsOther current assets$31 $25 
Foreign exchange contractsOther assets5 3 
Total asset derivatives$36 $28 
Liability Derivatives:
Foreign exchange contractsAccrued liabilities$(17)$(20)
Commodity contractsAccrued liabilities— (4)
Foreign exchange contractsOther long-term liabilities(4)(2)
Total liability derivatives$(21)$(26)

Derivatives designated as Cash flow hedging instruments. The amounts of gain or (loss) attributable to foreign exchange and commodity contract activity reclassified from Accumulated other comprehensive income (loss) were immaterial for the quarters and nine months ended September 30, 2023 and 2022, respectively.

The effect of cash flow hedging relationships on Accumulated other comprehensive income (loss) as of September 30, 2023 and December 31, 2022 are presented in the table below:

(dollars in millions)September 30, 2023December 31, 2022
Gain (loss) recorded in Accumulated other comprehensive income (loss)$2 $3 

The Company utilizes the critical terms match method in assessing firm commitment derivatives and regression testing in assessing commodity derivatives for hedge effectiveness. Accordingly, the hedged items and derivatives designated as hedging instruments are highly effective.

Assuming current market conditions continue, a pre-tax loss of $1 million is expected to be reclassified from Accumulated other comprehensive income (loss) into Cost of products sold to reflect the fixed prices obtained from foreign exchange and commodity hedging within the next 12 months. All derivative contracts accounted for as cash flow hedges as of September 30, 2023 will mature by December 2028.
Net Investment Hedges. We may use non-derivative (foreign currency denominated debt) and derivative (foreign exchange forward contracts) instruments to hedge portions of the Company's investment in foreign subsidiaries and manage foreign exchange risk. For instruments that are designated and qualify as hedges of net investments in foreign operations and that meet the effectiveness requirements, the net gains or losses attributable to changes in spot exchange rates are recorded in foreign currency translation within Other comprehensive income (loss) on the Condensed Consolidated Statements of Comprehensive Income, and will remain in Accumulated other comprehensive income (loss) until the hedged investment is sold or substantially liquidated. The remainder of the change in value of such instruments is recorded in earnings, including to the extent foreign currency denominated debt is not designated in or is de-designated from a net investment hedge relationship.

Our use of foreign exchange forward contracts designated as hedges of the Company's net investment in foreign subsidiaries can vary depending on the Company's desired foreign exchange risk coverage.

We have ¥21.5 billion of Japanese Yen denominated long-term debt, which qualifies as a net investment hedge against our investments in Japanese businesses, as well as notional amounts of foreign exchange forward contracts of €120 million and HK$2 billion which qualify as net investment hedges against our investments in certain European and Asian businesses, respectively. The net investment hedges are deemed to be effective. Additionally, we had a notional amount of a foreign exchange forward contract of €95 million that qualified as a net investment hedge, which matured during the quarter ended June 30, 2023 and the net investment hedge was deemed to be effective until maturity. The maturity dates of the current non-derivative and derivative instruments designated in net investment hedges range from 2024 to 2026.

The amounts of gains (losses) recognized in other comprehensive income (loss) related to non-derivative and derivative instruments designated as net investment hedges are as follows.

Quarter Ended September 30,Nine Months Ended September 30,
2023202220232022
Foreign currency denominated long-term debt$6 $10 $18 $40 
Foreign currency forward contracts2 — 3 — 
Total$8 $10 $21 $40 

Derivatives not designated as Cash flow hedging instruments. The net effect of derivatives not designated as Cash flow hedging instruments within Other income (expense) net, on the Condensed Consolidated Statements of Operations was as follows:

Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Foreign exchange contracts$4 $9 $16 $12 

The effects of derivatives not designated as Cash flow hedge instruments within Cost of products sold on the Condensed Consolidated Statements of Operations were gains of $1 million in the quarter ended September 30, 2023 and losses of $8 million in the nine months ended September 30, 2023, compared to losses of $3 million and $11 million in the same periods of 2022, respectively.
v3.23.3
Fair Value Measurements
 9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
Valuation Techniques. Our marketable securities include investments that are traded in active markets, either domestically or internationally, and are measured at fair value using closing stock prices from active markets. The fair value gains or losses related to our marketable securities are recorded through net income. Our derivative assets and liabilities include foreign exchange and commodity contracts that are measured at fair value using internal models based on observable market inputs such as forward rates, interest rates, our own credit risk and our counterparties' credit risks.

As of September 30, 2023, there has not been any significant impact to the fair value of our derivative liabilities due to our own credit risk. Similarly, there has not been any significant adverse impact to our derivative assets based on our evaluation of our counterparties' credit risks.
Due to their short-term nature, the carrying value approximated fair value for the current portion of the Company’s financial instruments not carried at fair value. The fair value of receivables, including customer financing notes receivable, net, that were issued long-term are based on the discounted values of their related cash flows at interest rates reflecting the attributes of the counterparties, including geographic location. Customer-specific risk, including credit risk, is already considered in the carrying value of those receivables. Our notes, as described in Note 7, "Borrowings and Lines of Credit," are measured at fair value using closing bond prices from active markets.

Recurring Fair Value Measurements. In accordance with the provisions of ASC 820: Fair Value Measurements, the following tables provide the valuation hierarchy classification of assets and liabilities that are carried at fair value and measured on a recurring and non-recurring basis in our Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022: 

September 30, 2023
(dollars in millions)TotalLevel 1Level 2Level 3
Recurring fair value measurements:
Marketable securities$31 $31 $— $— 
Derivative assets41 — 41 — 
Derivative liabilities(25)— (25)— 

December 31, 2022
(dollars in millions)TotalLevel 1Level 2Level 3
Recurring fair value measurements:
Marketable securities$30 $30 $— $— 
Derivative assets33 — 33 — 
Derivative liabilities(31)— (31)— 

Fair Value of Financial Instruments. The following table provides carrying amounts and fair values of financial instruments that are not carried at fair value as of September 30, 2023 and December 31, 2022:

 September 30, 2023December 31, 2022
(dollars in millions)Carrying
Amount		Fair
Value		Carrying
Amount		Fair
Value
Long-term receivables, net$49 $49 $55 $53 
Customer financing notes receivable, net31 27 55 51 
Short-term borrowings(54)(54)(139)(139)
Long-term debt, including current portion (excluding leases and other)(7,394)(6,343)(6,663)(5,661)
Long-term liabilities, including current portion(197)(184)(222)(197)

The following tables provide the valuation hierarchy classification of assets and liabilities that are not carried at fair value in the Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022:

September 30, 2023
(dollars in millions)TotalLevel 1Level 2Level 3
Long-term receivables, net$49 $— $49 $— 
Customer financing notes receivable, net27 — 27 — 
Short-term borrowings(54)— (54)— 
Long-term debt, including current portion (excluding leases and other)(6,343)— (6,343)— 
Long-term liabilities, including current portion(184)— (184)— 
December 31, 2022
(dollars in millions)TotalLevel 1Level 2Level 3
Long-term receivables, net$53 $— $53 $— 
Customer financing notes receivable, net51 — 51 — 
Short-term borrowings(139)— (139)— 
Long-term debt, including current portion (excluding leases and other)(5,661)— (5,661)— 
Long-term liabilities, including current portion(197)— (197)— 
v3.23.3
Guarantees
 9 Months Ended
Sep. 30, 2023
Guarantees and Product Warranties [Abstract]  
Guarantees Guarantees
The Company provides service and warranty on its products beyond normal service and warranty policies. The changes in the carrying amount of service and product guarantees for the nine months ended September 30, 2023 and 2022 are as follows:

(dollars in millions)20232022
Balance as of December 31$13 $20 
Warranties3 1 
Settlements made(5)(7)
Foreign exchange and other(1)(1)
Balance as of September 30$10 $13 

The Company provides certain financial guarantees to third parties. As of September 30, 2023, Otis has stand-by letters of credit with maximum potential payment totaling $128 million. We accrue costs associated with guarantees when it is probable that a liability has been incurred and the amount can be reasonably estimated. The most likely cost to be incurred is accrued based on an evaluation of currently available facts, and where no amount within a range of estimates is more likely, the minimum is accrued. In accordance with ASC Topic 460: Guarantees, we record these liabilities at fair value. As of September 30, 2023, Otis has determined there are no estimated costs probable under these guarantees.
v3.23.3
Contingent Liabilities
 9 Months Ended
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Contingent Liabilities Contingent Liabilities
Except as otherwise noted, while we are unable to predict the final outcome, based on information currently available, we do not believe that resolution of any of the following matters will have a material adverse effect upon our competitive position, results of operations, cash flows or financial condition. In addition to the specific amounts noted below, where we have recorded loss contingency accruals for the below and other matters, the amounts in aggregate are not material. Legal costs generally are expensed when incurred.

Environmental. As previously disclosed, the Company's operations are subject to environmental regulation by authorities with jurisdiction over its operations. The Company has accrued for the costs of environmental remediation activities, including, but not limited to, investigatory, remediation, operating and maintenance costs and performance guarantees, and periodically reassesses these amounts. Management believes that the likelihood of incurring losses materially in excess of amounts accrued is remote. The outstanding liability for environmental obligations was $5 million as of September 30, 2023 and December 31, 2022, and is principally included in Other long-term liabilities on the Condensed Consolidated Balance Sheets.

Legal Proceedings.

German Tax Litigation

As previously disclosed, we have been involved in administrative review proceedings with the German Tax Office, which concern approximately €215 million (approximately $229 million as of September 30, 2023) of tax benefits that we have claimed related to a 1998 reorganization of the corporate structure of our operations in Germany. Upon audit, these tax benefits were disallowed by the German Tax Office. We estimate interest associated with the aforementioned tax benefits is an additional approximately €118 million (approximately $126 million as of September 30, 2023).
In August 2012, a suit was filed in the local German Tax Court (Berlin-Brandenburg). In 2015, our former parent United Technologies Corporation ("UTC"), now RTX Corporation ("RTX"), made tax and interest payments to German tax authorities of €275 million (approximately $300 million) in order to avoid additional interest accruals pending final resolution of this matter. In March 2016, the local German Tax Court dismissed the suit, and we appealed this decision to the German Federal Tax Court. Following a hearing in July 2018, the German Federal Tax Court remanded the matter to the local German Tax Court for further proceedings. In December 2020, the local German Tax Court ruled against the Company.

On January 26, 2021, the Company filed an appeal with the German Federal Tax Court. On February 8, 2022, the Company received the decision of the German Federal Tax Court, in which the Court remanded the case for reconsideration by the local German Tax Court. The local German Tax Court held a hearing on June 12, 2023, and issued a decision in favor of Otis on July 21, 2023. On September 14, 2023, the German tax authorities filed an appeal to the German Federal Tax Court. The German Federal Tax Court is expected to rule on the appeal in 2024. As a result of the appeal filing, this matter remains contested, and the Company cannot assess the ultimate outcome of this case.

Pursuant to the Tax Matters Agreement ("TMA") with our former parent, UTC, the Company retains the liability associated with the remaining interest, and has recorded an interest accrual of €45 million (approximately $47 million as of September 30, 2023), net of payments and other deductions, included within Accrued liabilities on the Condensed Consolidated Balance Sheets as of September 30, 2023. If the Company prevails in this matter, any recoveries would be allocated between RTX and the Company pursuant to the terms of the TMA.

Asbestos Matters

As previously disclosed, we have been named as defendants in lawsuits alleging personal injury as a result of exposure to asbestos. While we have never manufactured any asbestos-containing component parts, and no longer incorporate asbestos in any current products, certain of our historical products have contained components manufactured by third parties incorporating asbestos. A substantial majority of these asbestos-related claims have been dismissed without payment or were covered in full or in part by insurance or other forms of indemnity. Additional cases were litigated and settled without any insurance reimbursement. The amounts involved in asbestos-related claims were not material individually or in the aggregate as of and for the periods ended September 30, 2023 and December 31, 2022.

The estimated range of total liabilities to resolve all pending and unasserted potential future asbestos claims through 2059 is approximately $21 million to $43 million as of September 30, 2023 and December 31, 2022. Since no amount within the range of estimates is more likely to occur than any other, we have recorded the minimum amount of $21 million, which is principally recorded in Other long-term liabilities on our Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022. Amounts are on a pre-tax basis, not discounted, and exclude the Company's legal fees to defend the asbestos claims (which will continue to be expensed as they are incurred). In addition, the Company has an insurance recovery receivable for probable asbestos-related recoveries of approximately $5 million, which is principally included in Other assets on our Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022.

Putative Class Action Lawsuit

On August 12, 2020, a putative class action lawsuit, (Geraud Darnis et al. v. Raytheon Technologies Corporation et al.), was filed in the United States District Court for the District of Connecticut (the "Court") against Otis, RTX, Carrier Global Corporation ("Carrier"), each of their directors, and various incentive and deferred compensation plans in connection with the separation of Otis and Carrier from UTC (the "Separation") in April 2020. On September 13, 2021, plaintiffs filed an amended complaint against the three company defendants only. The named plaintiffs are former employees of UTC and its current and former subsidiaries, including Otis and Carrier. They seek to recover monetary damages, as well as related declaratory and equitable relief, based on claimed decreases in the value of long-term incentive awards and deferred compensation under nonqualified deferred compensation plans allegedly caused by the formula used to calculate the adjustments to such awards and deferred compensation from RTX, Carrier, and Otis following the spin-offs of Carrier and Otis and the subsequent combination of UTC and Raytheon Company. On September 30, 2022, in response to motions to dismiss filed by the defendants, the Court dismissed the class action in its entirety with prejudice. The plaintiffs appealed the decision on October 26, 2022. On August 24, 2023, the Second Circuit Court of Appeals entered judgment in defendants’ favor, upholding the trial court’s decision. This action is concluded.
Other. As previously disclosed, we have commitments and contingent liabilities related to legal proceedings, self-insurance programs and matters arising out of the normal course of business. We accrue contingencies based on a range of possible outcomes. If no amount within this range is a better estimate than any other, we accrue the minimum amount. While it is not possible to determine the ultimate disposition of each of these claims and whether they will be resolved consistent with our beliefs, we expect that the outcome of such claims, individually or in the aggregate, will not have a material adverse effect on our business, financial condition, cash flows or results of operations.

As previously disclosed, in certain European countries, claims for overcharges on elevators and escalators related to civil cartel cases have been made, which we have accrued for based on our evaluation of the claims. While it is not possible to determine the ultimate disposition of each of these claims and whether they will be resolved consistent with our beliefs, historical settlement experience of these cases has not been material to the business, financial condition, cash flows or results of operations. However, the future outcome of these cases cannot be determined.

As previously disclosed, in the ordinary course of business, the Company is also routinely a defendant in, party to or otherwise subject to many pending and threatened legal actions, claims, disputes and proceedings. These matters are often based on alleged violations of contract, product liability, warranty, regulatory, environmental, health and safety, employment, intellectual property, tax and other laws. In some of these proceedings, claims for substantial monetary damages are asserted against the Company and its subsidiaries and could result in fines, penalties, compensatory or treble damages or non-monetary relief. We do not believe that these matters will have a material adverse effect upon our competitive position, results of operations, cash flows or financial condition.
v3.23.3
Segment Financial Data
 9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Segment Financial Data Segment Financial Data
Our operations are classified into two operating segments: New Equipment and Service. Through the New Equipment segment, we design, manufacture, sell and install a wide range of passenger and freight elevators as well as escalators and moving walkways to customers in the residential and commercial building and infrastructure projects. The Service segment provides maintenance and repair services for both our products and those of other manufacturers, and provides modernization services to upgrade elevators and escalators. The operating segments are generally based on the management structure of the Company, how management allocates resources, assesses performance and makes strategic and operational decisions.

Segment Information. Segment information for the quarters ended September 30, 2023 and 2022 are as follows:

Net SalesOperating ProfitOperating Profit Margin
(dollars in millions)202320222023202220232022
New Equipment$1,435 $1,447 $94 $100 6.6 %6.9 %
Service2,088 1,897 507 446 24.3 %23.5 %
Total segments3,523 3,344 601 546 17.1 %16.3 %
General corporate expenses and other——(30)(17)——
Total$3,523 $3,344 $571 $529 16.2 %15.8 %

Segment information for the nine months ended September 30, 2023 and 2022 are as follows:
Net SalesOperating ProfitOperating Profit Margin
(dollars in millions)202320222023202220232022
New Equipment$4,346 $4,403 $277 $292 6.4 %6.6 %
Service6,243 5,843 1,475 1,328 23.6 %22.7 %
Total segments10,589 10,246 1,752 1,620 16.5 %15.8 %
General corporate expenses and other— — (88)(78)——
Total$10,589 $10,246 $1,664 $1,542 15.7 %15.0 %
Total assets are not presented for each segment as they are not presented to, or reviewed by, the Chief Operating Decision Maker.
Geographic Sales. Geographic Net sales are attributed to the geographic regions based on their location of origin. With the exception of the U.S. and China, there were no individually significant countries with sales exceeding 10% of Net sales during the quarters and nine months ended September 30, 2023 and 2022.

Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
United States Operations$1,004 $943 $3,015 $2,873 
International Operations
  China596 672 1,832 1,951 
  Other 1,923 1,729 5,742 5,422 
Total$3,523 $3,344 $10,589 $10,246 

Disaggregated Sales by Type. Segment Net sales disaggregated by product and service type for the quarters and nine months ended September 30, 2023 and 2022 are as follows:

Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
New Equipment$1,435 $1,447 $4,346 $4,403 
Maintenance and Repair1,715 1,555 5,116 4,784 
Modernization373 342 1,127 1,059 
Total Service2,088 1,897 6,243 5,843 
Total$3,523 $3,344 $10,589 $10,246 

Major Customers. There were no customers that individually accounted for 10% or more of the Company's consolidated Net sales for the quarters and nine months ended September 30, 2023 and 2022.
v3.23.3
Accounting Pronouncements
 9 Months Ended
Sep. 30, 2023
Accounting Standards Update and Change in Accounting Principle [Abstract]  
Accounting Pronouncements Accounting Pronouncements
In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. This ASU clarifies that an acquirer of a business should recognize and measure contract assets and contract liabilities in a business combination in accordance with ASC Topic 606, Revenue from Contracts with Customers. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, with early application permitted. The Company adopted ASU 2021-08 effective January 1, 2023. The adoption of this ASU did not have a material impact on our Condensed Consolidated Financial Statements.

In September 2022, the FASB issued ASU No. 2022-04, Liabilities - Supplier Finance Programs (Topic 450-50): Disclosure of Supplier Finance Program Obligations, which requires entities that use supplier finance programs in connection with the purchase of goods and services to disclose the key terms of the programs and information about obligations outstanding at the end of the reporting period, including a rollforward of those obligations. The guidance does not affect the recognition, measurement or financial statement presentation of supplier finance program obligations. ASU 2022-04 is effective for fiscal years beginning after December 15, 2022, except for the disclosure of rollforward information, which is effective for fiscal years beginning after December 15, 2023. The Company adopted ASU 2022-04 effective January 1, 2023. The adoption of this ASU did not have a material impact on our Condensed Consolidated Financial Statements, as disclosed in Note 1, "General."
In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting ("ASU 2020-04"), which provides temporary optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. The amendments in ASU 2020-04 apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. Additionally, in December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 ("ASU 2022-06"), which allows ASU 2020-04 to be adopted and applied prospectively to contract modifications made on or before December 31, 2024. We do not expect the adoption of this standard to have a material impact on our Condensed Consolidated Financial Statements.

In August 2023, the FASB issued ASU 2023-05, Business Combinations - Joint Ventures Formations (Subtopic 805-60): Recognition and initial measurement ("ASU 2023-05"), which requires that joint ventures, upon formation, apply a new basis of accounting by initially measuring assets and liabilities at fair value. The amendments in ASU 2023-05 are effective for joint ventures that are formed on or after January 1, 2025. Early adoption is permitted. We are currently evaluating the impact of this standard, however we do not expect it to have a material impact on our Condensed Consolidated Financial Statements.
Other new accounting pronouncements issued but not effective until after September 30, 2023 did not and are not expected to have a material impact on our financial position, results of operations or liquidity.
v3.23.3
Subsequent Events
 9 Months Ended
Sep. 30, 2023
Subsequent Events [Abstract]  
Subsequent Events Subsequent EventsFollowing period end, on October 5, 2023, UpLift restructuring actions of approximately $55 million were approved, which are expected to be incurred beginning in the fourth quarter of 2023 through 2024. These are primarily severance related costs. We expect these actions to be mostly completed and cash to be paid by the end of 2024, with certain actions to be completed beyond 2024 due to legal requirements in the applicable jurisdictions.
v3.23.3
Pay vs Performance Disclosure - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Pay vs Performance Disclosure        
Net Income (Loss) $ 376 $ 324 $ 1,083 $ 956
v3.23.3
Insider Trading Arrangements
 3 Months Ended 9 Months Ended
Sep. 30, 2023
shares
Sep. 30, 2023
shares
Trading Arrangements, by Individual    
Non-Rule 10b5-1 Arrangement Adopted false  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
Ms. Marks [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement   On July 28, 2023, Ms. Marks adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Under this plan, the shares received by Ms. Marks upon the vesting of the performance stock units ("PSUs") granted to her by the Company on February 5, 2021 (after giving effect to tax withholding and a previous election to defer 50% of the PSU shares earned) will be sold at the market price so long as the Company’s common stock is trading at or above a limit price. The plan will terminate at the close of business on the day the shares become available for sale even if the Company’s common stock is trading below the limit price and the shares are not sold. We expect that the plan will terminate in early February 2024, shortly after the date the PSUs are expected to vest.The number of shares that may be sold by Ms. Marks upon vesting of the PSUs will depend upon the Company’s achievement of the underlying financial performance goals and the application of a multiplier factor based on our relative total shareowner return over the 2021-2023 performance period, and can range from 0 to 200% of the sum of the target PSUs granted plus additional PSUs credited for dividend equivalents. Ms. Marks was granted 65,355 “target” PSUs on February 5, 2021. However, because Ms. Marks previously elected to defer receipt of 50% of the PSUs to be earned under our PSU Deferral Plan, the number of shares delivered to her at vesting and available for sale will be accordingly reduced. Assuming the shares are sold under the plan, we estimate, based on our projected performance against the underlying financial performance goals, our relative total shareholder return through the last trading day of the quarter ending September 30, 2023, current tax withholding rates, future crediting of dividend equivalents assuming our current dividend remains unchanged and a stock price of $80.31 (the closing price of our stock on the last trading day of the quarter ending September 30, 2023), and Ms. Marks election to defer 50% of the PSUs, that 37,080 shares could be sold under the plan.
Name Ms. Marks  
Title Chair, President and Chief Executive Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date July 28, 2023  
Arrangement Duration 215 days  
Aggregate Available 37,080 37,080
v3.23.3
General (Policies)
 9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Use of Estimates Use of Estimates. The preparation of these Condensed Consolidated Financial Statements and accompanying notes in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ materially from those estimates.
v3.23.3
Earnings per Share (Tables)
 9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Schedule of earnings per share, basic and diluted
 Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions, except per share amounts; shares in millions)2023202220232022
Net income attributable to Otis Worldwide Corporation$376 $324 $1,083 $956 
Impact of redeemable noncontrolling interest— — — — 
Net income attributable to common shareholders$376 $324 $1,083 $956 
Basic weighted average number of shares outstanding410.8 418.5 412.6 421.3 
Stock awards and equity units (share equivalent)2.9 2.7 3.2 3.0 
Diluted weighted average number of shares outstanding413.7 421.2 415.8 424.3 
Earnings Per Share of Common Stock:
Basic$0.92$0.77$2.62$2.27
Diluted$0.91$0.77$2.60$2.25
v3.23.3
Revenue Recognition (Tables)
 9 Months Ended
Sep. 30, 2023
Revenue from Contract with Customer [Abstract]  
Schedule of contract assets and liabilities
Total Contract assets and Contract liabilities as of September 30, 2023 and December 31, 2022 are as follows:

(dollars in millions)September 30, 2023December 31, 2022
Contract assets, current$733 $664 
Total contract assets733 664 
Contract liabilities, current2,784 2,662 
Contract liabilities, non-current (included within Other long-term liabilities)47 52 
Total contract liabilities 2,831 2,714 
Net contract liabilities$2,098 $2,050 
v3.23.3
Accounts Receivable, Net (Tables)
 9 Months Ended
Sep. 30, 2023
Receivables [Abstract]  
Schedule of accounts, notes, loans and financing receivable
Accounts receivable, net consisted of the following as of September 30, 2023 and December 31, 2022:

(dollars in millions)September 30, 2023December 31, 2022
Trade receivables$3,295 $3,231 
Unbilled receivables123 103 
Miscellaneous receivables100 91 
Customer financing notes receivable63 84 
3,581 3,509 
Less: allowance for expected credit losses126 152 
Accounts receivable, net$3,455 $3,357 
Accounts receivable, allowance for credit loss
The changes in allowance for expected credit losses related to Accounts receivable, net for the nine months ended September 30, 2023 and 2022, respectively, are as follows:

Nine Months Ended September 30,
(dollars in millions)20232022
Balance as of January 1$152 $175 
Provision for expected credit losses21 4 
Write-offs charged against the allowance for expected credit losses(42)(14)
Foreign exchange and other(5)(9)
Balance as of September 30$126 $156 
v3.23.3
Inventories (Tables)
 9 Months Ended
Sep. 30, 2023
Inventory Disclosure [Abstract]  
Schedule of inventory
Inventories consisted of the following as of September 30, 2023 and December 31, 2022:

(dollars in millions)September 30, 2023December 31, 2022
Raw materials and work-in-process$162 $166 
Finished goods462 451 
Total$624 $617 
v3.23.3
Business Acquisitions, Disposals, Goodwill and Intangible Assets (Tables)
 9 Months Ended
Sep. 30, 2023
Business Combinations, Goodwill, and Intangible Assets [Abstract]  
Schedule of goodwill Changes in our Goodwill balances during the nine months ended September 30, 2023 were as follows:
(dollars in millions)Balance as of December 31, 2022Goodwill Resulting
from Business Combinations		Foreign Currency
Translation 
and Other
Balance as of
September 30, 2023
New Equipment$292 $— $(5)$287 
Service1,275 6 (21)1,260 
Total$1,567 $6 $(26)$1,547 
v3.23.3
Borrowings and Lines of Credit (Tables)
 9 Months Ended
Sep. 30, 2023
Debt Disclosure [Abstract]  
Schedule of short-term debt
(dollars in millions)September 30, 2023December 31, 2022
Commercial paper$— $94 
Other borrowings54 45 
Total short-term borrowings$54 $139 
Schedule of long-term debt Long-term debt consisted of the following:
(dollars in millions)September 30, 2023December 31, 2022
0.000% notes due 2023 (€500 million principal value)
$531 $531 
2.056% notes due 2025
1,300 1,300 
0.37% notes due 2026 (¥21.5 billion principal value)
145 163 
0.318% notes due 2026 (€600 million principal value)
637 638 
2.293% notes due 2027
500 500 
5.250% notes due 2028
750 — 
2.565% notes due 2030
1,500 1,500 
0.934% notes due 2031 (€500 million principal value)
531 531 
3.112% notes due 2040
750 750 
3.362% notes due 2050
750 750 
Other (including finance leases)4 8 
Total principal long-term debt7,398 6,671 
Other (discounts and debt issuance costs)(45)(42)
Total long-term debt7,353 6,629 
Less: current portion531 531 
Long-term debt, net of current portion$6,822 $6,098 
Schedule of debt
Debt discounts and debt issuance costs are presented as a reduction of debt on the Condensed Consolidated Balance Sheets and are amortized as a component of interest expense over the term of the related debt using the effective interest method. The Condensed Consolidated Statements of Operations for the quarters and nine months ended September 30, 2023 and 2022 reflects the following:

Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Debt issuance costs amortization$2 $1 $5 $6 
Total interest expense on external debt38 35 105 106 
The weighted average interest expense rate on our borrowings outstanding as of September 30, 2023 and December 31, 2022 was as follows:
September 30, 2023December 31, 2022
Short-term commercial paper—%4.7%
Total long-term debt2.3%2.0%

The weighted average interest expense rate on our borrowings during the quarters and nine months ended September 30, 2023 and 2022 was as follows:

Quarter Ended September 30,Nine Months Ended September 30,
2023202220232022
Short-term commercial paper5.4%2.5%5.0%1.3%
Total long-term debt2.1%2.0%2.0%2.0%
v3.23.3
Employee Benefit Plans (Tables)
 9 Months Ended
Sep. 30, 2023
Retirement Benefits [Abstract]  
Schedule of defined benefit plans disclosures Contributions to our plans were as follows:
 Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Defined benefit plans$8 $7 $32 $28 
Defined contribution plans16 14 50 49 
Multi-employer pension and postretirement plans42 40 117 101 

The following table illustrates the components of net periodic benefit cost for the Company's defined benefit pension plans:

 Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Service cost$7 $10 $22 $30 
Interest cost8 4 24 13 
Expected return on plan assets(8)(8)(24)(21)
Recognized actuarial net loss— 3 — 8 
Net settlement and curtailment (gain) loss— 1 — 1 
Total net periodic benefit cost$7 $10 $22 $31 
Share-based payment arrangement, expensed and capitalized, amount
Stock-based compensation expense and the resulting tax benefits were as follows:

Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Stock-based compensation expense (Share Based)$15 $13 $49 $41 
Stock-based compensation expense (income) (Liability Awards)— — — (1)
Total gross stock-based compensation expense15 13 49 40 
Less: future tax benefit2 2 6 5 
Stock-based compensation expense, net of tax$13 $11 $43 $35 
v3.23.3
Accumulated Other Comprehensive Income (Loss) (Tables)
 9 Months Ended
Sep. 30, 2023
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Schedule of accumulated other comprehensive income (loss)
A summary of the changes in each component of Accumulated other comprehensive income (loss), net of tax, for the quarters and nine months ended September 30, 2023 and 2022 is provided below:
(dollars in millions)Foreign
Currency
Translation		Defined Benefit
Pension and
Postretirement
Plans		Unrealized
Hedging Gains
(Losses)		Accumulated
Other
Comprehensive
Income (Loss)
Quarter Ended September 30, 2023
Balance as of June 30, 2023$(681)$(8)$— $(689)
Other comprehensive income (loss) before reclassifications, net39 — 1 40 
Amounts reclassified, pre-tax— — 1 1 
Tax benefit reclassified— — — — 
Balance as of September 30, 2023$(642)$(8)$2 $(648)
Nine Months Ended September 30, 2023
Balance as of December 31, 2022$(587)$(8)$3 $(592)
Other comprehensive income (loss) before reclassifications, net(56)— (7)(63)
Amounts reclassified, pre-tax1 — 8 9 
Tax benefit reclassified— — (2)(2)
Balance as of September 30, 2023$(642)$(8)$2 $(648)

(dollars in millions)Foreign
Currency
Translation		Defined Benefit
Pension and
Postretirement
Plans		Unrealized
Hedging Gains
(Losses)		Accumulated
Other
Comprehensive
Income (Loss)
Quarter Ended September 30, 2022
Balance as of June 30, 2022$(631)$(124)$7 $(748)
Other comprehensive income (loss) before reclassifications, net93 — (5)88 
Amounts reclassified, pre-tax77 3 1 81 
Tax benefit reclassified— (1)— (1)
Balance as of September 30, 2022$(461)$(122)$3 $(580)
Nine Months Ended September 30, 2022
Balance as of December 31, 2021$(642)$(128)$7 $(763)
Other comprehensive income (loss) before reclassifications, net173 — (2)171 
Amounts reclassified upon change in Otis' share of Zardoya Otis ownership(69)— — (69)
Amounts reclassified, pre-tax77 8 (2)83 
Tax benefit reclassified— (2)— (2)
Balance as of September 30, 2022$(461)$(122)$3 $(580)
v3.23.3
Restructuring and Transformation Costs (Tables)
 9 Months Ended
Sep. 30, 2023
Restructuring and Related Activities [Abstract]  
Schedule of restructuring and related costs
During the quarters and nine months ended September 30, 2023 and 2022, we recorded restructuring costs for new and ongoing restructuring actions as follows:

Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
New Equipment$10 $2 $15 $18 
Service11 4 21 27 
Total $21 $6 $36 $45 

Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Cost of products and services sold$9 $2 $11 $16 
Selling, general and administrative12 4 25 29 
Total $21 $6 $36 $45 
Schedule of restructuring reserve by type of cost
The following table summarizes the accrual balance and utilization for restructuring actions, which are primarily for severance costs and most will require cash payment:

(dollars in millions)
Restructuring accruals as of December 31, 2022$41 
Net restructuring costs36 
Utilization, foreign exchange and other costs(35)
Balance as of September 30, 2023$42 
v3.23.3
Financial Instruments (Tables)
 9 Months Ended
Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of derivative instruments in statement of financial position, fair value
The following table summarizes the fair value and presentation on the Condensed Consolidated Balance Sheets for derivative instruments as of September 30, 2023 and December 31, 2022:

(dollars in millions)Balance Sheet ClassificationSeptember 30, 2023December 31, 2022
Derivatives designated as Cash flow hedging instruments:
Asset Derivatives:
Foreign exchange contractsOther current assets$2 $3 
Foreign exchange contractsOther assets3 2 
Total asset derivatives$5 $5 
Liability Derivatives:
Foreign exchange contractsAccrued liabilities$(3)$(4)
Commodity contractsAccrued liabilities— (1)
Foreign exchange contractsOther long-term liabilities(1)— 
Total liability derivatives$(4)$(5)
Derivatives not designated as Cash flow hedging instruments:
Asset Derivatives:
Foreign exchange contractsOther current assets$31 $25 
Foreign exchange contractsOther assets5 3 
Total asset derivatives$36 $28 
Liability Derivatives:
Foreign exchange contractsAccrued liabilities$(17)$(20)
Commodity contractsAccrued liabilities— (4)
Foreign exchange contractsOther long-term liabilities(4)(2)
Total liability derivatives$(21)$(26)
Schedule of cash flow hedges included in accumulated other comprehensive income (loss)
The effect of cash flow hedging relationships on Accumulated other comprehensive income (loss) as of September 30, 2023 and December 31, 2022 are presented in the table below:

(dollars in millions)September 30, 2023December 31, 2022
Gain (loss) recorded in Accumulated other comprehensive income (loss)$2 $3 
Schedule of gain (loss) recognized in other comprehensive income (loss) related to derivative and non-derivative instruments designated as net investment hedges
The amounts of gains (losses) recognized in other comprehensive income (loss) related to non-derivative and derivative instruments designated as net investment hedges are as follows.

Quarter Ended September 30,Nine Months Ended September 30,
2023202220232022
Foreign currency denominated long-term debt$6 $10 $18 $40 
Foreign currency forward contracts2 — 3 — 
Total$8 $10 $21 $40 
Derivative instruments, gain (loss) The net effect of derivatives not designated as Cash flow hedging instruments within Other income (expense) net, on the Condensed Consolidated Statements of Operations was as follows:
Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
Foreign exchange contracts$4 $9 $16 $12 
v3.23.3
Fair Value Measurements (Tables)
 9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Fair value measurements, recurring and nonrecurring In accordance with the provisions of ASC 820: Fair Value Measurements, the following tables provide the valuation hierarchy classification of assets and liabilities that are carried at fair value and measured on a recurring and non-recurring basis in our Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022: 
September 30, 2023
(dollars in millions)TotalLevel 1Level 2Level 3
Recurring fair value measurements:
Marketable securities$31 $31 $— $— 
Derivative assets41 — 41 — 
Derivative liabilities(25)— (25)— 

December 31, 2022
(dollars in millions)TotalLevel 1Level 2Level 3
Recurring fair value measurements:
Marketable securities$30 $30 $— $— 
Derivative assets33 — 33 — 
Derivative liabilities(31)— (31)— 
Fair value, by balance sheet grouping The following table provides carrying amounts and fair values of financial instruments that are not carried at fair value as of September 30, 2023 and December 31, 2022:
 September 30, 2023December 31, 2022
(dollars in millions)Carrying
Amount		Fair
Value		Carrying
Amount		Fair
Value
Long-term receivables, net$49 $49 $55 $53 
Customer financing notes receivable, net31 27 55 51 
Short-term borrowings(54)(54)(139)(139)
Long-term debt, including current portion (excluding leases and other)(7,394)(6,343)(6,663)(5,661)
Long-term liabilities, including current portion(197)(184)(222)(197)

The following tables provide the valuation hierarchy classification of assets and liabilities that are not carried at fair value in the Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022:

September 30, 2023
(dollars in millions)TotalLevel 1Level 2Level 3
Long-term receivables, net$49 $— $49 $— 
Customer financing notes receivable, net27 — 27 — 
Short-term borrowings(54)— (54)— 
Long-term debt, including current portion (excluding leases and other)(6,343)— (6,343)— 
Long-term liabilities, including current portion(184)— (184)— 
December 31, 2022
(dollars in millions)TotalLevel 1Level 2Level 3
Long-term receivables, net$53 $— $53 $— 
Customer financing notes receivable, net51 — 51 — 
Short-term borrowings(139)— (139)— 
Long-term debt, including current portion (excluding leases and other)(5,661)— (5,661)— 
Long-term liabilities, including current portion(197)— (197)— 
v3.23.3
Guarantees (Tables)
 9 Months Ended
Sep. 30, 2023
Guarantees and Product Warranties [Abstract]  
Product warranty disclosure The changes in the carrying amount of service and product guarantees for the nine months ended September 30, 2023 and 2022 are as follows:
(dollars in millions)20232022
Balance as of December 31$13 $20 
Warranties3 1 
Settlements made(5)(7)
Foreign exchange and other(1)(1)
Balance as of September 30$10 $13 
v3.23.3
Segment Financial Data (Tables)
 9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Schedule of segment reporting information, by segment Segment information for the quarters ended September 30, 2023 and 2022 are as follows:
Net SalesOperating ProfitOperating Profit Margin
(dollars in millions)202320222023202220232022
New Equipment$1,435 $1,447 $94 $100 6.6 %6.9 %
Service2,088 1,897 507 446 24.3 %23.5 %
Total segments3,523 3,344 601 546 17.1 %16.3 %
General corporate expenses and other——(30)(17)——
Total$3,523 $3,344 $571 $529 16.2 %15.8 %

Segment information for the nine months ended September 30, 2023 and 2022 are as follows:
Net SalesOperating ProfitOperating Profit Margin
(dollars in millions)202320222023202220232022
New Equipment$4,346 $4,403 $277 $292 6.4 %6.6 %
Service6,243 5,843 1,475 1,328 23.6 %22.7 %
Total segments10,589 10,246 1,752 1,620 16.5 %15.8 %
General corporate expenses and other— — (88)(78)——
Total$10,589 $10,246 $1,664 $1,542 15.7 %15.0 %
Schedule of segment reporting information, by geographic markets Geographic Net sales are attributed to the geographic regions based on their location of origin. With the exception of the U.S. and China, there were no individually significant countries with sales exceeding 10% of Net sales during the quarters and nine months ended September 30, 2023 and 2022.
Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
United States Operations$1,004 $943 $3,015 $2,873 
International Operations
  China596 672 1,832 1,951 
  Other 1,923 1,729 5,742 5,422 
Total$3,523 $3,344 $10,589 $10,246 
Segment reporting disclosure, sales type Segment Net sales disaggregated by product and service type for the quarters and nine months ended September 30, 2023 and 2022 are as follows:
Quarter Ended September 30,Nine Months Ended September 30,
(dollars in millions)2023202220232022
New Equipment$1,435 $1,447 $4,346 $4,403 
Maintenance and Repair1,715 1,555 5,116 4,784 
Modernization373 342 1,127 1,059 
Total Service2,088 1,897 6,243 5,843 
Total$3,523 $3,344 $10,589 $10,246 
v3.23.3
General (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Outstanding obligations under supplier finance programs $ 537 $ 564
Minimum    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Maturity term 30 days  
Maximum    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Maturity term 120 days  
v3.23.3
Earnings per Share (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Net Income (Loss) Attributable to Parent [Abstract]        
Net income attributable to Otis Worldwide Corporation $ 376 $ 324 $ 1,083 $ 956
Impact of redeemable noncontrolling interest 0 0 0 0
Net income attributable to common shareholders $ 376 $ 324 $ 1,083 $ 956
Basic weighted average number of shares outstanding (in shares) 410,800,000 418,500,000 412,600,000 421,300,000
Stock awards and equity units (share equivalent) (in shares) 2,900,000 2,700,000 3,200,000 3,000,000.0
Diluted weighted average number of shares outstanding (in shares) 413,700,000 421,200,000 415,800,000 424,300,000
Earnings Per Share of Common Stock:        
Basic (in usd per share) $ 0.92 $ 0.77 $ 2.62 $ 2.27
Diluted (in usd per share) $ 0.91 $ 0.77 $ 2.60 $ 2.25
Antidilutive securities excluded from computation of EPS (in shares) 1,000,000 2,400,000 1,000,000 2,400,000
v3.23.3
Revenue Recognition - Contract With Customer, Assets and Liabilities (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]    
Contract assets, current $ 733 $ 664
Total contract assets 733 664
Contract liabilities, current 2,784 2,662
Contract liabilities, non-current (included within Other long-term liabilities) 47 52
Total contract liabilities 2,831 2,714
Net contract liabilities $ 2,098 $ 2,050
v3.23.3
Revenue Recognition - Narrative (Details)
$ in Millions
 9 Months Ended
Sep. 30, 2023
USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Increase in contract assets $ 69
Increase in contract liabilities 117
Revenue recognized 1,800
Revenue, remaining performance obligation $ 17,800
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligation, percentage 90.00%
Remaining performance obligation, expected timing of satisfaction period 24 months
v3.23.3
Accounts Receivable, Net - Schedule of Accounts Receivable (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Sep. 30, 2022
Dec. 31, 2021
Receivables [Abstract]        
Trade receivables $ 3,295 $ 3,231    
Unbilled receivables 123 103    
Miscellaneous receivables 100 91    
Customer financing notes receivable 63 84    
Total receivables 3,581 3,509    
Less: allowance for expected credit losses 126 152 $ 156 $ 175
Accounts receivable, net $ 3,455 $ 3,357    
v3.23.3
Accounts Receivable, Net - Schedule of Allowance for Credit Losses (Details) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Accounts Receivable, Allowance for Credit Loss [Roll Forward]    
Beginning balance $ 152 $ 175
Provision for expected credit losses 21 4
Write-offs charged against the allowance for expected credit losses (42) (14)
Foreign exchange and other (5) (9)
Ending balance $ 126 $ 156
v3.23.3
Inventories (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Raw materials and work-in-process $ 162 $ 166
Finished goods 462 451
Total 624 617
Inventory valuation reserves $ 89 $ 96
v3.23.3
Business Acquisitions, Disposals, Goodwill and Intangible Assets - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Jun. 30, 2022
Goodwill [Line Items]            
Investments in businesses, net of cash acquired     $ 27 $ 38    
Intangible assets cost $ 2,010   2,010   $ 2,026  
Intangible assets, accumulated amortization 1,674   1,674   1,657  
Amortization of intangible assets 17 $ 18 51 55    
Assets held for sale $ 11   $ 11   $ 9  
RUSSIAN FEDERATION            
Goodwill [Line Items]            
Assets held for sale, disposal group           $ 157
Liabilities held for sale, disposal group           $ 136
Loss on disposal of business   $ 6   24    
Loss on fixed asset impairment       $ 18    
v3.23.3
Business Acquisitions, Disposals, Goodwill and Intangible Assets - Schedule of Goodwill (Details)
$ in Millions
 9 Months Ended
Sep. 30, 2023
USD ($)
Goodwill [Roll Forward]  
Goodwill - Beginning Balance $ 1,567
Goodwill Resulting from Business Combinations 6
Foreign Currency Translation  and Other (26)
Goodwill - Ending Balance 1,547
New Equipment  
Goodwill [Roll Forward]  
Goodwill - Beginning Balance 292
Goodwill Resulting from Business Combinations 0
Foreign Currency Translation  and Other (5)
Goodwill - Ending Balance 287
Services  
Goodwill [Roll Forward]  
Goodwill - Beginning Balance 1,275
Goodwill Resulting from Business Combinations 6
Foreign Currency Translation  and Other (21)
Goodwill - Ending Balance $ 1,260
v3.23.3
Borrowings and Lines of Credit - Short-Term Borrowings (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Debt Disclosure [Abstract]    
Commercial paper $ 0 $ 94,000,000
Other borrowings 54,000,000 45,000,000
Total short-term borrowings $ 54,000,000 $ 139,000,000
v3.23.3
Borrowings and Lines of Credit - Narrative (Details)
¥ in Millions
 9 Months Ended
Aug. 16, 2023
USD ($)
Mar. 10, 2023
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2023
JPY (¥)
Dec. 31, 2022
USD ($)
Line of Credit Facility [Line Items]          
Commercial paper     $ 0   $ 94,000,000
Debt instrument, carrying amount     7,398,000,000   6,671,000,000
Unamortized debt issuance cost     $ 43,000,000   42,000,000
Long term debt, average remaining maturity     7 years 6 months    
Unsubordinated Commercial Paper | Unsecured Notes          
Line of Credit Facility [Line Items]          
Debt instrument, face amount     $ 1,500,000,000    
Five Year Revolving Credit Facility, Amended | Revolving Credit Facility | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate          
Line of Credit Facility [Line Items]          
Credit spread adjustment   0.10%      
Debt instrument, basis spread on variable rate   1.25%      
Five Year Revolving Credit Facility, Amended | Revolving Credit Facility | Base Rate          
Line of Credit Facility [Line Items]          
Debt instrument, basis spread on variable rate   0.25%      
Five Year Revolving Credit Facility, Amended | Unsecured Notes          
Line of Credit Facility [Line Items]          
Line of credit facility, maximum borrowing capacity   $ 1,500,000,000      
Debt instrument, term   5 years      
Debt instrument, carrying amount     0    
Notes 5.250% due 2028          
Line of Credit Facility [Line Items]          
Debt instrument, carrying amount     $ 750,000,000   0
Debt instrument, interest rate, stated percentage     5.25% 5.25%  
Notes 5.250% due 2028 | Unsecured Notes          
Line of Credit Facility [Line Items]          
Debt instrument, face amount $ 750,000,000        
Debt instrument, term 5 years        
Debt instrument, interest rate, stated percentage 5.25%        
Notes 0.000% due 2023          
Line of Credit Facility [Line Items]          
Debt instrument, carrying amount     $ 531,000,000   $ 531,000,000
Debt instrument, interest rate, stated percentage     0.00% 0.00%  
Notes 0.000% due 2023 | Unsecured Notes          
Line of Credit Facility [Line Items]          
Debt instrument, face amount | ¥       ¥ 500  
Debt instrument, interest rate, stated percentage     0.00% 0.00%  
v3.23.3
Borrowings and Lines of Credit - Long-Term Debt (Details)
¥ in Millions, $ in Millions
Sep. 30, 2023
USD ($)
Sep. 30, 2023
JPY (¥)
Aug. 16, 2023
USD ($)
Dec. 31, 2022
USD ($)
Debt Instrument [Line Items]        
Debt instrument, carrying amount $ 7,398     $ 6,671
Other (discounts and debt issuance costs) (45)     (42)
Total long-term debt 7,353     6,629
Less: current portion 531     531
Long-term debt 6,822     6,098
Notes 0.000% due 2023        
Debt Instrument [Line Items]        
Debt instrument, carrying amount $ 531     531
Debt instrument, interest rate, stated percentage 0.00% 0.00%    
Notes 0.000% due 2023 | Unsecured Notes        
Debt Instrument [Line Items]        
Debt instrument, interest rate, stated percentage 0.00% 0.00%    
Debt instrument, face amount | ¥   ¥ 500    
Notes 2.056% due 2025        
Debt Instrument [Line Items]        
Debt instrument, carrying amount $ 1,300     1,300
Debt instrument, interest rate, stated percentage 2.056% 2.056%    
Notes 0.37% due 2026        
Debt Instrument [Line Items]        
Debt instrument, carrying amount $ 145     163
Debt instrument, interest rate, stated percentage 0.37% 0.37%    
Notes 0.37% due 2026 | Unsecured Notes        
Debt Instrument [Line Items]        
Debt instrument, face amount | ¥   ¥ 21,500    
Notes 0.318% due 2026        
Debt Instrument [Line Items]        
Debt instrument, carrying amount $ 637     638
Debt instrument, interest rate, stated percentage 0.318% 0.318%    
Notes 0.318% due 2026 | Unsecured Notes        
Debt Instrument [Line Items]        
Debt instrument, face amount | ¥   ¥ 600    
Notes 2.293% due 2027        
Debt Instrument [Line Items]        
Debt instrument, carrying amount $ 500     500
Debt instrument, interest rate, stated percentage 2.293% 2.293%    
Notes 5.250% due 2028        
Debt Instrument [Line Items]        
Debt instrument, carrying amount $ 750     0
Debt instrument, interest rate, stated percentage 5.25% 5.25%    
Notes 5.250% due 2028 | Unsecured Notes        
Debt Instrument [Line Items]        
Debt instrument, interest rate, stated percentage     5.25%  
Debt instrument, face amount     $ 750  
Notes 2.565% due 2030        
Debt Instrument [Line Items]        
Debt instrument, carrying amount $ 1,500     1,500
Debt instrument, interest rate, stated percentage 2.565% 2.565%    
Notes 0.934% due 2031        
Debt Instrument [Line Items]        
Debt instrument, carrying amount $ 531     531
Debt instrument, interest rate, stated percentage 0.934% 0.934%    
Notes 0.934% due 2031 | Unsecured Notes        
Debt Instrument [Line Items]        
Debt instrument, face amount | ¥   ¥ 500    
Notes 3.112% due 2040        
Debt Instrument [Line Items]        
Debt instrument, carrying amount $ 750     750
Debt instrument, interest rate, stated percentage 3.112% 3.112%    
Notes 3.362% due 2050        
Debt Instrument [Line Items]        
Debt instrument, carrying amount $ 750     750
Debt instrument, interest rate, stated percentage 3.362% 3.362%    
Other Including Finance Leases        
Debt Instrument [Line Items]        
Debt instrument, carrying amount $ 4     $ 8
v3.23.3
Borrowings and Lines of Credit - Schedule of Debt Issuance Expenses (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Debt Disclosure [Abstract]        
Debt issuance costs amortization $ 2 $ 1 $ 5 $ 6
Total interest expense on external debt $ 38 $ 35 $ 105 $ 106
v3.23.3
Borrowings and Lines of Credit - Schedule of Average Interest Rates on Borrowings (Details)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Long-term Debt          
Debt Instrument [Line Items]          
Average interest expense rate on borrowings 2.30%   2.30%   2.00%
Average interest expense rate during period 2.10% 2.00% 2.00% 2.00%  
Short-term Debt          
Debt Instrument [Line Items]          
Average interest expense rate on borrowings 0.00%   0.00%   4.70%
Average interest expense rate during period 5.40% 2.50% 5.00% 1.30%  
v3.23.3
Employee Benefit Plans - Schedule of Defined Benefit Plan Disclosures (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Defined Benefit Plan Disclosure [Line Items]        
Defined benefit plans $ 8 $ 7 $ 32 $ 28
Defined contribution plans 16 14 50 49
Multi-employer pension and postretirement plans 42 40 117 101
Pension Plan        
Defined Benefit Plan Disclosure [Line Items]        
Service cost 7 10 22 30
Interest cost 8 4 24 13
Expected return on plan assets (8) (8) (24) (21)
Recognized actuarial net loss 0 3 0 8
Net settlement and curtailment (gain) loss 0 1 0 1
Total net periodic benefit cost 7 10 22 31
Other Postretirement Benefits Plan        
Defined Benefit Plan Disclosure [Line Items]        
Total net periodic benefit cost $ 1 $ 1 $ 1 $ 1
v3.23.3
Employee Benefit Plans - Schedule of Share-based Compensation and Related Income Tax Benefits (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]        
Stock-based compensation expense $ 15 $ 13 $ 49 $ 40
Less: future tax benefit 2 2 6 5
Stock-based compensation expense, net of tax 13 11 43 35
Share-based Payment Arrangement        
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]        
Stock-based compensation expense 15 13 49 41
Liability Awards, Share-Based Compensation Arrangement        
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]        
Stock-based compensation expense $ 0 $ 0 $ 0 $ (1)
v3.23.3
Employee Benefit Plans - Narrative (Details)
shares in Millions, $ in Millions
 9 Months Ended
Sep. 30, 2023
USD ($)
shares
Retirement Benefits [Abstract]  
Common stock shares available for awards (in shares) | shares 23
Unrecognized compensation cost | $ $ 76
Unrecognized compensation cost, period for recognition 1 year 10 months 24 days
v3.23.3
Stock (Details) - USD ($)
$ / shares in Units, shares in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Equity [Abstract]          
Stock repurchased during period $ 228,000,000 $ 300,000,000 $ 580,000,000 $ 700,000,000  
Class of Stock [Line Items]          
Preferred stock, shares authorized (in shares) 125.0   125.0   125.0
Preferred stock, par value (in usd per share) $ 0.01   $ 0.01   $ 0.01
Preferred stock, shares issued (in shares) 0.0   0.0   0.0
Common stock, shares authorized (in shares) 2,000.0   2,000.0   2,000.0
Common stock, par value (in usd per share) $ 0.01   $ 0.01   $ 0.01
Common stock, shares issued (in shares) 436.9   436.9   435.6
Treasury stock (in shares) 27.6   27.6   20.8
Stock repurchase program, authorized amount $ 2,000,000,000   $ 2,000,000,000    
Stock repurchase program, remaining authorized shares amount 1,400,000,000   1,400,000,000    
Stock repurchased during period 228,000,000 300,000,000 580,000,000 700,000,000  
Treasury Stock          
Equity [Abstract]          
Stock repurchased during period $ 225,000,000 $ 300,000,000 $ 575,000,000 $ 700,000,000  
Class of Stock [Line Items]          
Stock repurchase during period (in shares) 2.6 3.8 6.8 9.1  
Stock repurchased during period $ 225,000,000 $ 300,000,000 $ 575,000,000 $ 700,000,000  
v3.23.3
Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance $ (4,751) $ (4,888) $ (4,799) $ (3,144)
Other comprehensive income (loss) before reclassifications, net 40 88 (63) 171
Amounts reclassified, pre-tax 1 81 9 83
Tax (benefit) expense reclassified 0 (1) (2) (2)
Ending balance (4,733) (4,861) (4,733) (4,861)
Foreign Currency Translation        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance (681) (631) (587) (642)
Other comprehensive income (loss) before reclassifications, net 39 93 (56) 173
Amounts reclassified upon change in Otis' share of Zardoya Otis ownership       (69)
Amounts reclassified, pre-tax 0 77 1 77
Tax (benefit) expense reclassified 0 0 0 0
Ending balance (642) (461) (642) (461)
Defined Benefit Pension and Postretirement Plans        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance (8) (124) (8) (128)
Other comprehensive income (loss) before reclassifications, net 0 0 0 0
Amounts reclassified upon change in Otis' share of Zardoya Otis ownership       0
Amounts reclassified, pre-tax 0 3 0 8
Tax (benefit) expense reclassified 0 (1) 0 (2)
Ending balance (8) (122) (8) (122)
Unrealized Hedging Gains (Losses)        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance 0 7 3 7
Other comprehensive income (loss) before reclassifications, net 1 (5) (7) (2)
Amounts reclassified upon change in Otis' share of Zardoya Otis ownership       0
Amounts reclassified, pre-tax 1 1 8 (2)
Tax (benefit) expense reclassified 0 0 (2) 0
Ending balance 2 3 2 3
Accumulated Other Comprehensive Income (Loss)        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance (689) (748) (592) (763)
Amounts reclassified upon change in Otis' share of Zardoya Otis ownership       (69)
Ending balance $ (648) $ (580) $ (648) $ (580)
v3.23.3
Income Taxes (Details)
$ in Millions
Sep. 30, 2023
USD ($)
Income Tax Disclosure [Abstract]  
Increase in unrecognized tax benefits reasonably possible $ 10
Decrease in unrecognized tax benefits reasonably possible 330
Increase in unrecognized tax benefits, accrued interest, is reasonably possible 5
Decrease in unrecognized tax benefits, accrued interest, is reasonably possible $ 140
v3.23.3
Restructuring and Transformation Costs - Schedule of Pretax Restructuring Costs (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Restructuring Cost and Reserve [Line Items]        
Net restructuring costs $ 21 $ 6 $ 36 $ 45
New Equipment        
Restructuring Cost and Reserve [Line Items]        
Net restructuring costs 10 2 15 18
Services        
Restructuring Cost and Reserve [Line Items]        
Net restructuring costs 11 4 21 27
Cost of products and services sold        
Restructuring Cost and Reserve [Line Items]        
Net restructuring costs 9 2 11 16
Selling, general and administrative        
Restructuring Cost and Reserve [Line Items]        
Net restructuring costs $ 12 $ 4 $ 25 $ 29
v3.23.3
Restructuring and Transformation Costs - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Restructuring Cost and Reserve [Line Items]        
Net restructuring costs $ 21 $ 6 $ 36 $ 45
UpLift Program        
Restructuring Cost and Reserve [Line Items]        
Transformation costs 4   4  
New Equipment        
Restructuring Cost and Reserve [Line Items]        
Net restructuring costs 10 2 15 18
Services        
Restructuring Cost and Reserve [Line Items]        
Net restructuring costs 11 $ 4 21 $ 27
2022 Actions        
Restructuring Cost and Reserve [Line Items]        
Expected costs 120   120  
Remaining costs 28   28  
2022 Actions | New Equipment        
Restructuring Cost and Reserve [Line Items]        
Expected costs 43   43  
Remaining costs 6   6  
2022 Actions | Services        
Restructuring Cost and Reserve [Line Items]        
Expected costs 77   77  
Remaining costs $ 22   $ 22  
v3.23.3
Restructuring and Transformation Costs - Pre-Tax Restructuring Costs (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Restructuring Cost and Reserve [Line Items]        
Net restructuring costs $ 21 $ 6 $ 36 $ 45
Cost of products and services sold        
Restructuring Cost and Reserve [Line Items]        
Net restructuring costs 9 2 11 16
Selling, general and administrative        
Restructuring Cost and Reserve [Line Items]        
Net restructuring costs $ 12 $ 4 $ 25 $ 29
v3.23.3
Restructuring and Transformation Costs - Restructuring Roll forward (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Restructuring Reserve [Roll Forward]        
Net restructuring costs $ 21 $ 6 $ 36 $ 45
Current And Prior Year Actions | Severance costs        
Restructuring Reserve [Roll Forward]        
Restructuring reserve, beginning balance     41  
Net restructuring costs     36  
Utilization, foreign exchange and other costs     (35)  
Restructuring reserve, ending balance $ 42   $ 42  
v3.23.3
Financial Instruments - Narrative (Details)
€ in Millions, $ in Millions, ¥ in Billions, $ in Billions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
JPY (¥)
Sep. 30, 2023
EUR (€)
Sep. 30, 2023
HKD ($)
Dec. 31, 2022
USD ($)
Derivative Instruments and Hedging Activities Disclosures [Line Items]                
Average of notional amount of foreign exchange contracts hedging foreign currency transactions $ 4,300   $ 4,300         $ 3,900
Average of notional amount of commodity contracts hedging commodity purchase transactions 24   24         $ 20
Foreign currency cash flow hedge loss to be reclassified during next 12 months 1   1          
Foreign exchange contracts                
Derivative Instruments and Hedging Activities Disclosures [Line Items]                
Foreign exchange contracts 4 $ 9 16 $ 12        
Foreign Exchange Contract and Commodity | Cost of products and services sold                
Derivative Instruments and Hedging Activities Disclosures [Line Items]                
Foreign exchange contracts $ 1 $ (3) $ (8) $ (11)        
Net Investment Hedging | Foreign exchange contracts                
Derivative Instruments and Hedging Activities Disclosures [Line Items]                
Notional amount of foreign exchange forward contracts           € 120 $ 2.0  
Net Investment Hedging | Foreign currency forward contracts                
Derivative Instruments and Hedging Activities Disclosures [Line Items]                
Notional amount of foreign exchange forward contracts | €           € 95    
Yen Denominated Investment Hedge | Net Investment Hedging                
Derivative Instruments and Hedging Activities Disclosures [Line Items]                
Debt instrument, face amount | ¥         ¥ 21.5      
v3.23.3
Financial Instruments - Schedule of Fair Value of Derivative Instruments (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Designated as Hedging Instrument | Cash Flow Hedging    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Asset derivatives $ 5 $ 5
Liability derivatives (4) (5)
Not Designated as Hedging Instrument    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Asset derivatives 36 28
Liability derivatives (21) (26)
Foreign exchange contracts | Designated as Hedging Instrument | Cash Flow Hedging | Other current assets    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Asset derivatives 2 3
Foreign exchange contracts | Designated as Hedging Instrument | Cash Flow Hedging | Other assets    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Asset derivatives 3 2
Foreign exchange contracts | Designated as Hedging Instrument | Cash Flow Hedging | Accrued liabilities    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Liability derivatives (3) (4)
Foreign exchange contracts | Designated as Hedging Instrument | Cash Flow Hedging | Other long-term liabilities    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Liability derivatives (1) 0
Foreign exchange contracts | Not Designated as Hedging Instrument | Other current assets    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Asset derivatives 31 25
Foreign exchange contracts | Not Designated as Hedging Instrument | Other assets    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Asset derivatives 5 3
Foreign exchange contracts | Not Designated as Hedging Instrument | Accrued liabilities    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Liability derivatives (17) (20)
Foreign exchange contracts | Not Designated as Hedging Instrument | Other long-term liabilities    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Liability derivatives (4) (2)
Commodity contracts | Designated as Hedging Instrument | Cash Flow Hedging | Accrued liabilities    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Liability derivatives 0 (1)
Commodity contracts | Not Designated as Hedging Instrument | Accrued liabilities    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Liability derivatives $ 0 $ (4)
v3.23.3
Financial Instruments - Schedule of Gain (Loss) on Derivative Instruments Reclassified From OCI (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]    
Gain (loss) recorded in Accumulated other comprehensive income (loss) $ 2 $ 3
v3.23.3
Financial Instruments - Schedule of Gain (Loss) on Derivative and Non-Derivative Instruments (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Net Investment Hedging        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Net investment hedge, gain (loss) $ 8 $ 10 $ 21 $ 40
Foreign currency denominated long-term debt | Net Investment Hedging        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Net investment hedge, gain (loss) 6 10 18 40
Foreign currency forward contracts | Net Investment Hedging        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Net investment hedge, gain (loss) 2 0 3 0
Foreign exchange contracts        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Foreign exchange contracts $ 4 $ 9 $ 16 $ 12
v3.23.3
Fair Value Measurements (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Short-term borrowings $ (54) $ (139)
Carrying Amount    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Long-term receivables, net 49 55
Customer financing notes receivable, net 31 55
Short-term borrowings (54) (139)
Long-term debt, including current portion (excluding leases and other) (7,394) (6,663)
Long-term liabilities, including current portion (197) (222)
Fair Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Long-term receivables, net 49 53
Customer financing notes receivable, net 27 51
Short-term borrowings (54) (139)
Long-term debt, including current portion (excluding leases and other) (6,343) (5,661)
Long-term liabilities, including current portion (184) (197)
Fair Value Level 1 | Fair Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Long-term receivables, net 0 0
Customer financing notes receivable, net 0 0
Short-term borrowings 0 0
Long-term debt, including current portion (excluding leases and other) 0 0
Long-term liabilities, including current portion 0 0
Fair Value Level 2 | Fair Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Long-term receivables, net 49 53
Customer financing notes receivable, net 27 51
Short-term borrowings (54) (139)
Long-term debt, including current portion (excluding leases and other) (6,343) (5,661)
Long-term liabilities, including current portion (184) (197)
Fair Value Level 3 | Fair Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Long-term receivables, net 0 0
Customer financing notes receivable, net 0 0
Short-term borrowings 0 0
Long-term debt, including current portion (excluding leases and other) 0 0
Long-term liabilities, including current portion 0 0
Fair Value, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 31 30
Derivative assets 41 33
Derivative liabilities (25) (31)
Fair Value, Recurring | Fair Value Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 31 30
Derivative assets 0 0
Derivative liabilities 0 0
Fair Value, Recurring | Fair Value Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 0 0
Derivative assets 41 33
Derivative liabilities (25) (31)
Fair Value, Recurring | Fair Value Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 0 0
Derivative assets 0 0
Derivative liabilities $ 0 $ 0
v3.23.3
Guarantees - Guarantees and Product Warranties Rollforward (Details) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Movement Warranties [Roll Forward]    
Beginning balance $ 13 $ 20
Warranties 3 1
Settlements made (5) (7)
Foreign exchange and other (1) (1)
Ending balance $ 10 $ 13
v3.23.3
Guarantees - Narrative (Details)
$ in Millions
Sep. 30, 2023
USD ($)
Standby Letter of Credit  
Guarantor Obligations [Line Items]  
Guarantor obligation, maximum exposure $ 128
v3.23.3
Contingent Liabilities (Details)
€ in Millions, $ in Millions
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 13, 2021
defendent
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2023
EUR (€)
Sep. 30, 2022
USD ($)
Dec. 31, 2015
USD ($)
Dec. 31, 2015
EUR (€)
Sep. 30, 2023
EUR (€)
Dec. 31, 2022
USD ($)
Loss Contingencies [Line Items]                    
Income tax benefit   $ (137) $ (143) $ (400)   $ (382)        
Number of defendants | defendent 3                  
Environmental Regulation                    
Loss Contingencies [Line Items]                    
Loss contingency accrual   5   5           $ 5
German Tax Office Against Otis                    
Loss Contingencies [Line Items]                    
Income tax benefit       229 € 215          
Disallowed tax benefit, estimated interest expense       126 € 118          
Unrecognized tax benefits, interest on income taxes expense             $ 300 € 275    
Unrecognized tax benefits, interest on income taxes accrued   47   47         € 45  
Asbestos Matter                    
Loss Contingencies [Line Items]                    
Insurance recovery receivable   5   5           5
Asbestos Matter | Minimum                    
Loss Contingencies [Line Items]                    
Estimate of possible loss   21   21           21
Asbestos Matter | Maximum                    
Loss Contingencies [Line Items]                    
Estimate of possible loss   $ 43   $ 43           $ 43
v3.23.3
Segment Financial Data (Details)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
segment
Sep. 30, 2022
USD ($)
Segment Reporting Information [Line Items]        
Number of operating segments | segment     2  
Revenues $ 3,523 $ 3,344 $ 10,589 $ 10,246
Operating profit $ 571 $ 529 $ 1,664 $ 1,542
Operating profit margin 16.20% 15.80% 15.70% 15.00%
New Equipment        
Segment Reporting Information [Line Items]        
Revenues $ 1,435 $ 1,447 $ 4,346 $ 4,403
Maintenance and Repair        
Segment Reporting Information [Line Items]        
Revenues 1,715 1,555 5,116 4,784
Modernization        
Segment Reporting Information [Line Items]        
Revenues 373 342 1,127 1,059
Service sales        
Segment Reporting Information [Line Items]        
Revenues 2,088 1,897 6,243 5,843
United States Operations        
Segment Reporting Information [Line Items]        
Revenues 1,004 943 3,015 2,873
China        
Segment Reporting Information [Line Items]        
Revenues 596 672 1,832 1,951
Other        
Segment Reporting Information [Line Items]        
Revenues 1,923 1,729 5,742 5,422
Operating Segments        
Segment Reporting Information [Line Items]        
Revenues 3,523 3,344 10,589 10,246
Operating profit $ 601 $ 546 $ 1,752 $ 1,620
Operating profit margin 17.10% 16.30% 16.50% 15.80%
General corporate expenses and other        
Segment Reporting Information [Line Items]        
Revenues $ 0 $ 0 $ 0 $ 0
Operating profit $ (30) $ (17) $ (88) $ (78)
Operating profit margin 0.00% 0.00% 0.00% 0.00%
New Equipment | Operating Segments        
Segment Reporting Information [Line Items]        
Revenues $ 1,435 $ 1,447 $ 4,346 $ 4,403
Operating profit $ 94 $ 100 $ 277 $ 292
Operating profit margin 6.60% 6.90% 6.40% 6.60%
Services | Operating Segments        
Segment Reporting Information [Line Items]        
Revenues $ 2,088 $ 1,897 $ 6,243 $ 5,843
Operating profit $ 507 $ 446 $ 1,475 $ 1,328
Operating profit margin 24.30% 23.50% 23.60% 22.70%
v3.23.3
Subsequent Events (Details)
$ in Millions
Oct. 05, 2023
USD ($)
Subsequent Event | UpLift Program  
Subsequent Event [Line Items]  
Expected costs $ 55
Otis Worldwide (NYSE:OTIS)
Historical Stock Chart
Von Apr 2024 bis Mai 2024 Click Here for more Otis Worldwide Charts.
Otis Worldwide (NYSE:OTIS)
Historical Stock Chart
Von Mai 2023 bis Mai 2024 Click Here for more Otis Worldwide Charts.